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Abstract 
Cellular senescence is thought to play an essential role in many biological functions 
including tumor suppression and organismal aging. Senescent cells, which are 
permanently removed from the cell cycle, can be found both in vivo in many different 
tissue types and in vitro within cultures of non-immortalized cells. Despite their inability 
to proliferate, these cells persist and remain metabolically active for indefinite periods of 
time. This physiologic process occurs in response to a variety of cellular insults including 
oxidative stress, shortened telomeres, constitutive oncogene expression, and DNA 
damage, and can be initiated by upregulation of one of the two known senescent 
pathways, involving p16/Rb or p53/p21. The senescent cell phenotype is also 
characterized by changes to cell and nuclear morphology and to the secretory profile of 
the cell. 
Related to changes in nuclear morphology, epigenetic modifications to the packaging of 
DNA are thought to be key to the initiation and maintenance of the senescence program. 
While a large number of earlier studies focused on the findings that senescent cells gain 
regions of condensed heterochromatin, often in the form of Senescent Associated 
Heterochromatin Foci (SAHF), this thesis work shows that there is a marked loss of 
heterochromatin in the peri/centromeric regions of the genome. In fact, both α-satellite 
and satellite II sequences across the genome distend in a striking and unanticipated 
fashion; this can be readily visualized by fluorescence in situ hybridization (FISH) as 
their structure changes from a condensed spot to highly elongated and fine thread-like 
signals. We have termed this exceptional decondensation of constitutive heterochromatin 
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Senescence Associated Distension of Satellites (SADS). Importantly, a series of 
experiments shows that SADS is both a consistent and an early event in the cell 
senescence process, which occurs as a result of every senescence induction method 
examined. We also observed that this distension was characteristic of both human and 
murine cells and in vivo in human benign Prostatic Intraepithelial Neoplasia (PIN) tissue. 
Furthermore, unlike SAHF formation, SADS can occur due to the activation of either of 
the two senescence pathways, p16/Rb or p53/p21. 
Additionally, the cytological dimensions of the thread-like satellite signals indicates that 
SADS represents “unraveling” of DNA on an unprecedented scale. Thus, it was 
surprising that this event was not facilitated by changes to several canonical histone 
modifications associated with condensed heterochromatin, namely H3K9Me3, 
H3K27Me3, or H3K4Me3, nor is it caused by loss of DNA methylation. Consequently, 
we believe that this marked distension of satellite DNA is due to changes in higher-order 
folding of the chromatin fiber. This is important for understanding fundamental events in 
the cell senescence process, but also provides a unique system for study of chromatin 
packaging that may provide new insights into the organization of DNA well beyond 
nucleosome packaging and the ten nanometer fiber. In fact, initial super resolution 
images of SADS suggest that the satellite sequences may be organized into domains or 
“globules”. Hence, we suggest that the changes to satellite sequence packaging may be 
facilitated by changes to higher-order nuclear structural proteins, such as LaminB1, 
which is reduced in senescent cells.       
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Finally, this work provides analysis of the literature and preliminary experiments to 
consider the possibility that there are increased levels of cell senescence in Down 
syndrome (trisomy 21) cells. As individuals with Down syndrome (DS) experience many 
manifestations of premature aging (including early-onset Alzheimer’s Disease), have a 
resistance to solid tumor formation, are more susceptible to oxidative stress, and are 
trisomic for several genes implicated in causing senescence, our analysis provides 
plausibility for the hypothesis that accelerated rates of senescence may play a significant 
role in DS physiology. We also provide results of preliminary studies and outline the next 
steps for experimentation, using DS fibroblasts and a unique genetically engineered DS 
iPS cell system. As a final note, the quantification of cell senescence in trisomic versus 
disomic cells for these experiments relies substantially on the new single-cell marker of 
senescence discovered and established by this theses work, the Senescence-Associated 
Distension of Satellites.  
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Preface 
The work contained in Chapter II is published in: 
Swanson, E.C., B. Manning, H. Zhang, and J.B. Lawrence. 2013. Higher-order unfolding 
of satellite heterochromatin is a consistent and early event in cell senescence. The Journal 
of Cell Biology.  
With the exception of the bioinformatic analysis in Figure 2.7d, which was performed by 
Dr. Troy Whitfield, it represents my own work. This study first demonstrated that the 
Senescence Associated Distension of Satellites (referred to as SADS) is an unanticipated 
epigenomic event of cell senescence, which also provides a new single-cell marker of the 
senescent state. In-depth characterization of this in several human modes of cell 
senescence and in mouse replicative senescence showed it is common to all types of 
senescence examined, unlike other chromatin changes that have been described in 
senescent cells. In addition, this work shows that this dramatic distension in both α-
satellite and satellite II sequences is mediated by higher-order changes in 
heterochromatin packaging. 
The work in Chapter III will be published as a commissioned perspective in Nucleus, and 
includes new primary observations of SADS using higher-resolution microscopy 
approaches. Figure 3.3 was generated by Dr. Lindsy Rapkin under the direction of Dr. 
Bazett-Jones. The ESI microscopy in Figure 3.3 was performed by Dr. K. Amhed.  
Chapter IV examines the potential role of senescence in Down’s syndrome cells. The 
bioinformatic analysis was performed by Dr. Troy Whitfield and Dr. Oliver King. The 
microarray expression data was gathered as part of a larger project in the Lawrence lab to 
xxi 
 
demonstrate that the expression of a XIST transgene could repress gene expression across 
the extra 21st chromosome and is cited below. This work was also the source of Figure 
4.1a.   
Jiang, J., Y. Jing, G.J. Cost, J.C. Chiang, H.J. Kolpa, A.M. Cotton, D.M. Carone, B.R., 
Carone, D.A. Shivak, D.Y. Guschin, J.R. Pedsarl, E.J. Rebar, M. Byron, P.D. Gregory, 
C.J. Brown, F.D. Urnov, L.L. Hall, and J.B. Lawrence. 2013. Translating dosage 
compensation to trisomy 21. Nature. 500:296-300. 
  
Other Chapter IV experiments used stem cells grown by Dr. Jun Jiang, Yuanchun Jing, or 
Brett Dumas. 
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Chapter I: Introduction to Senescence 
While senescence was a phenomenon first identified in cultured cells, it is now widely 
accepted that it occurs in vivo and plays a role in both development and a diverse array of 
human diseases (Fig 1.1)(Campisi, 2013; Muñoz-Espín et al., 2013; Storer et al., 2013). 
In recent years, there is increasing evidence that senescence plays a prominent role in 
aging and is linked to tissue degeneration in the elderly and age-related diseases, such as 
Osteoarthritis and Alzheimer’s (Oh et al., 2014; van Deursen, 2014). Senescence also 
functions in wound healing and plays a critical role in inhibiting tumorigenesis (Jun and 
Lau, 2010; Sager, 1991; Serrano et al., 1997). Notably, the proteins necessary for 
inducing and maintaining this permanent cell cycle arrest are essential tumor suppressors 
that are mutated in the majority of cancers (Zhang, 2007). Therefore, the study of 
senescence has the potential to reveal key insights for extending lifespan by mitigating 
related aging syndromes and diseases. This chapter will present an introduction to 
senescence starting from the discovery of this process and then moving onto 
characteristics of senescent cells before finishing with a discussion of recent in vivo 
studies of senescence.  
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Figure 1.1 Broad Biological Significance of Cell Senescence. Senescence plays a role 
in tumor suppression, aging, development, and wound healing. Shown here is a senescent 
cell positive for SA-β-galactosidase activity (blue, middle) surrounded by a tissue section 
of a benign nevi (mole) containing senescent cells (light blue, top left), an elderly man 
(top right), a healing laceration (bottom left), and a mouse embryo with senescent cells 
(blue) in the webbed region that breaks down to form the space between the toes (bottom 
right).  
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Figure1.1 Broad Biological Significance of Cell Senescence 
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The Early History of Senescence 
Senescence was first characterized in the 1960s by Leonard Hayflick, who observed that 
most cultures of normal primary fibroblasts do not grow and divide indefinitely; rather 
they undergo a period of proliferation followed by the slowing of growth and an eventual 
cessation of cell division (Hayflick, 1965). Prior to Hayflick’s discovery, it was a widely 
held belief that all vertebrate cells grown in culture were immortal and that the failure of 
cell lines to grow indefinitely was due to improper culture conditions. These beliefs were 
based on work by Nobel laureate Alexis Carrel who cultured a line of actively dividing 
chicken heart fibroblasts for over 34 years (Carrel and Ebeling, 1921). However, Carrel’s 
work could not be reproduced (Hayflick and Moorhead, 1961; Witkowski, 1980) and 
Hayflick determined that the lack of cell division was not due to culture conditions as 
previously thought, so he postulated that the withdrawal of a cell from the cell cycle may 
be due to cellular age.  
Following these initial observations, senescence research focused on examining the 
characteristics of these non-replicating cells. For example, Matsumura et al. showed that 
senescent cells could remain in culture indefinitely without dividing or replicating 
(Matsumura et al., 1979), while other efforts demonstrated that senescent cells normally 
arrest in the G1 phase in a manner that is irreversible, unlike quiescence, which is a 
temporary and reversible cell-cycle arrest caused by lack of nutrients or contact inhibition 
(Cristofalo, 1985; Pardee et al., 1978). Critical discoveries in the early 90s further 
supported Hayflick’s initial observations, and showed that telomeres gradually erode with 
each cell division and that telomerase, the enzyme responsible for extending telomere 
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length, can delay senescence in some cell types, thereby linking senescence to cell age 
(Harley et al., 1990; Yu et al., 1990). The discovery that telomeres played a role in 
senescence not only provided the first biological explanation for the cause of senescence, 
but moved the focus of the now established field towards the examination of how 
senescence occurs.     
Causes and Types of Senescence 
Senescence can be caused by a wide variety of insults to the cell from either natural or 
pharmaceutical sources, including the shortening of telomeric repeats during cell 
replication, which results in the activation of the DNA damage response and upregulation 
of the senescence pathways. The causes of senescence are described in detail below and 
summarized in Figure 1.2.     
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Figure 1.2 Cellular Insults that Cause Senescence. Different events or stresses to a cell 
can result in senescence, including telomere dysfunction, replicative exhaustion through 
serial passaging, oxidative stress, DNA damage, and treating cells with cytotoxic drugs 
(Collado and Serrano, 2006).  
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Figure1. 2 Cellular Insults that Cause Senescence 
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Replicative Senescence in normal human diploid fibroblasts is caused by the serial 
passaging of cells to exhaust their proliferative potential (Hayflick, 1965). With each 
successive passage the number of times individual cells in a culture divide increases, and 
the telomeres become correspondingly shorter (Harley et al., 1990). Replicative 
senescence is avoided in cancer and embryonic stem cells through the expression of 
telomerase (Bodnar et al., 1998; Kim et al., 1994; Kiyono et al., 1998; Thomson et al., 
1998; Vaziri and Benchimol, 1998). In cells that do not express telomerase, senescence 
can be bypassed through the expression of the E6 and E7 oncogenes or the SV-40 
antigen, however as telomere length is still being lost with each successive passage, crisis 
eventually occurs (Shay et al., 1993; Wright and Shay, 1992). The onset of crisis is 
triggered by critically short telomeres that no longer protect the end of each chromosome, 
resulting in chromosome fusion events, mitotic catastrophe, and apoptosis (Shay and 
Wright, 2005).   
As the purpose of telomeres is to protect the integrity of the coding DNA at the end of 
each chromosome, when telomeres reach a critical length the DNA damage response and 
senescence is induced. Interestingly, only one telomere is required to reach a critical 
length before cells enter replicative senescence (Zou et al., 2004). As part of the response 
to shortened telomeres histone γ-H2A.X is recruited, causing ATM dependent activation 
of p53, an important tumor suppressor which induces senescence through the activation 
of its downstream effectors (Fagagna et al., 2003; Herbig et al., 2004).  
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DNA Damage Results in the Onset of Senescence: While telomere shortening can 
induce a DNA damage response, senescence is also caused by telomere-independent 
DNA damage responses (Nakamura et al., 2008). For example, the accumulation of γ-
H2A.X at DNA double strand breaks in non-telomeric regions of the genome has been 
observed in cultured senescent human cells and in aging mice (Sedelnikova et al., 2004). 
In addition, mouse embryonic fibroblasts can senesce after only ten passages despite 
containing telomeres that are much longer than humans, and in these cells, γ-H2A.X foci 
do not colocalize with telomeres (Blasco et al., 1997; Nakamura et al., 2008). Taken 
together, this suggests that senescence can occur in response to DNA damage before 
telomeres reach the critical length needed for cells to enter replicative senescence and 
that DNA damage-induced senescence can be independent of telomere length.   
Oxidative Stress is caused by the cell’s natural production of highly reactive oxygen 
species (ROS). While cells have natural mechanisms to combat the destructive power of 
these compounds, over time their continual presence causes irreversible damage to both 
proteins and DNA (Finkel and Holbrook, 2000). This long-term exposure to ROS has 
been shown to induce senescence in culture and has also been implicated in aging. For 
example, it has been shown that culturing cells at increased oxygen levels leads to greater 
ROS production in the mitochondria (Balaban et al., 2005). While most tissue culture is 
performed at atmospheric oxygen levels (20%), growing fibroblasts under physiological 
oxygen conditions (3-5%) leads to less oxidative stress, an increase in the number of 
population doublings, and delayed senescence (Chen et al., 1995; Packer and Fuehr, 
1977). Consistent with the findings in human fibroblasts, growing MEFs under 
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atmospheric oxygen conditions results in 3-4 fold higher levels of oxidative stress-related 
DNA damage and fewer population doublings prior to senescence (Busuttil et al., 2003; 
Parrinello et al., 2003). Together, these data demonstrate that higher oxygen levels reduce 
the proliferative capacity of cells in culture by increasing levels of ROS and, therefore, 
senescence.   
In addition to natural levels of ROS, senescence can be induced in culture when cells are 
treated with hydrogen peroxide (H2O2) (Chen and Ames, 1994). H2O2 is an unstable 
compound and its natural decomposition produces large numbers of free radicals, a type 
of ROS. These highly reactive free radicals damage DNA, which activates the DNA 
damage response, and induces senescence through the upregulation of p53 (Chen et al., 
1998; Chen et al., 2001; Passos et al., 2010). Additionally, it has recently been shown that 
cells can senesce in an ATM-independent manner (Barascu et al., 2012; Takahashi et al., 
2006), suggesting that oxidative stresses can also cause senescence independent of DNA 
damage and p53.  
Oncogene-induced Senescence has been shown to occur both in tissue culture and in 
tumors, and is thought to serve as an anti-cancer mechanism (Collado and Serrano, 2010). 
In human culture oncogenic RAS, a mutated constitutively active protein found in many 
tumors, induces senescence in the presence of functional tumor suppressing proteins Rb 
or p53 (Figure 1.3) (Serrano et al., 1997). The activation of these key senescence 
regulators occurs because of DNA damage caused by hyperreplication, DNA double 
strand breaks, or increases in the level of ROS (Bartkova et al., 2006; Di Micco et al., 
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2006; Lee et al., 1999). Oncogene induced senescence has also been observed in vivo, 
where analysis of tumors in both humans and mice has shown that senescent cells are 
found in several types of premalignant lesions characterized by the inactivation of PTEN 
or constitutively active oncogenes like RAS and BRAF (Braig et al., 2005; Chen et al., 
2005; Collado et al., 2005; Michaloglou et al., 2005). Thus senescence serves as a key 
anti-cancer mechanism that suppresses the formation of malignant tumors (Figure 
1.3)(Collado and Serrano, 2010). 
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Figure 1.3 Constitutively Active Oncogenes Induce Senescence When Key Tumor 
Suppressors Function as Normal. Constitutive oncogene activation results in a period 
of cell proliferation during which DNA damage accumulates. This DNA damage then 
results in the upregulation of the DNA damage response when p53 or Rb are activated. In 
the absence or loss of these essential tumor suppressors malignant tumors result 
(Funayama and Ishikawa, 2007).   
 
  
13 
 
Figure1.3 Constitutively Active Oncogenes Induce Senescence When Key Tumor 
Suppressors Function as Normal 
 
  
14 
 
Cytotoxic Drugs and SASP: Despite the fact that immortalized cell lines, like HeLa 
cells, do not senesce under normal conditions, a variety of cytotoxic drugs including 
many chemotherapeutic agents can induce senescence in both normal and immortalized 
cancer cell lines (Chang et al., 1999; Eriko et al., 1999; Rebbaa et al., 2006; 
Schnekenburger et al., 2011; Wang et al., 1998; Yeo et al., 2000). It has also been shown 
that when chemotherapeutic agents are used to treat cancer higher levels of senescence 
correlate to better patient prognosis (Schmitt et al., 2002). Senescence occurs in these 
cells due to the activation of one of the tumor suppressors and senescence regulating 
genes, p53 or p16 (Schmitt et al., 2002).  
Interestingly senescent cells, found in both tumors and in culture secrete a characteristic 
profile of soluble factors and cytokines that have collectively been termed the 
Senescence-Associated Secretory Phenotype (SASP)(Coppé et al., 2008). The 
composition of secreted SASP components varies depending on the cell type and how 
senescence occurs, causing variation in the effects of the SASP on nearby cells (Freund et 
al., 2010). For example, some SASP components reinforce the senescent state and 
suppress tumorigenesis via autocrine signaling mechanisms (Acosta et al., 2008; Kuilman 
et al., 2008) while others can induce a senescence response in their neighbors (Acosta et 
al., 2013; Nelson et al., 2012). As certain SASP components are reported to inhibit 
tumorigenesis, it is likely that secretion of the factors contribute to the role of senescence 
as an anti-cancer mechanism.  
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The Upregulation of Senescence Pathways Causes Irreversible Cell 
Cycle Arrest  
Senescence is known to be activated through one of two partially redundant but equally 
important pathways. This redundancy is important as these pathways are composed of 
key tumor suppressors that are mutated in a majority of cancers. As the same cellular 
stress can activate either pathway, inhibiting one of these pathways does not always allow 
a cell to escape senescence thereby inhibiting malignant tumor formation (Figure 1.3).  
The first pathway that cells use to senesce is the p53/p21 pathway which is activated by 
shortened telomeres, DNA damage, or the constitutive expression of oncogenes (Fagagna 
et al., 2003; Herbig et al., 2004; Serrano et al., 1997). This pathway begins with the 
activation of p53 (the terminal event in the DNA damage response pathway) which in 
turn causes the upregulation of p21. The protein, p21, inhibits the cyclinE/Cyclin 
Dependent Kinase 2 (CDK2) complex that is responsible for phosphorylating the 
retinoblastoma protein (Rb) (Sherr and Roberts, 1999). Phosphorylated Rb is inactivated, 
and cannot sequester the E2F family of transcription factors. The E2F family of 
transcription factors controls the expression of genes required for the cell to enter S-
phase, and preventing their transcription blocks cell cycle progression (Classon and 
Harlow, 2002).  
The second of the two pathways is the p16/Rb pathway, which is upregulated in response 
to cellular stress, DNA damage, ROS, or constitutively activated oncogenes (Robles and 
Adami, 1998; Serrano et al., 1997; Takahashi et al., 2006). The activation of this pathway 
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is normally repressed by BMI-1 which decreases when cells are exposed to stress, 
allowing for the expression of p16. Then, p16 inhibits CDKs 4 and 6, which 
phosphorylate and thereby inactivate Rb, blocking the progression of the cell cycle 
(Serrano et al., 1993).     
At the level of individual cells, both pathways can be used to initiate senescence (Herbig 
et al., 2004), in fact both p53 and Rb activity have to be inhibited for many normal 
human fibroblast cell lines to escape senescence (Shay et al., 1991), and senescence can 
still occur via the p53/p21 pathway independent of Rb (Shay et al., 1991; Zhang and 
Cohen, 2004). It has also been demonstrated that there is a temporal component to these 
pathways—p53/p21 expression often initiates senescence, while p16 upregulation occurs 
late in senescence and contributes to the stabilization and irreversibility of this process 
(Herbig et al., 2004; Stein et al., 1999). This is reinforced by the fact that some cell lines 
cells can escape senescence if p16 is not expressed upon the viral inactivation of p53 and 
can replicate their DNA if p16 is expressed and both p53 and Rb are inhibited 
(Beausejour et al., 2003). Senescent cells can also escape permanent cell cycle arrest 
through the transfection of the traditional Yamanaka factors plus two additional genes, 
Lin28 and C-Myc, which allows for the formation of iPSCs (Lapasset et al., 2011). 
However, there is currently no known way for senescent cells to resume the cell cycle 
through naturally existing mechanisms as all examples of cells reentering the cell cycle 
after senescence require genetic intervention. 
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Previously Identified Senescence Markers are not Characteristic of 
Every Type of Senescence 
As summarized above cellular senescence is caused by a multitude of stresses that 
activate two separate pathways. Partly due to the variability in how senescence is 
induced, senescent cells have a wide range of identifying characteristics, including 
changes in gene expression, chromatin packaging, and nuclear morphology. However, 
none of the previously established markers are applicable to every senescent cell (Rodier 
and Campisi, 2011) creating a situation where the presence of senescent cells may escape 
notice due to a lack of ubiquitous marker. Therefore, information as well as the 
applicability of different senescence markers will be presented below. 
The Absence of Cycling: Since senescent cells have irreversibly exited the cell cycle one 
way to define senescence is by the absence of cycling. It is widely accepted that a culture 
of normal fibroblasts is considered senescent when it does not reach confluency for ten 
days after a 1:2 split due to the lack of proliferating cells. Furthermore, even in a culture 
of young and proliferating normal human fibroblasts up to 20% of cells in a culture are 
not cycling as shown by a lack of BrdU incorporation for 48 hours (Herbig et al., 2004). 
In addition, terminally differentiated cells, which do not cease to cycle via either 
senescence pathway or in response to cellular insults, exit the cell cycle as a programmed 
event, but are not senescent (Chandler and Peters, 2013; Kuilman et al., 2010). Hence, in 
terminally differentiated cells the absence of cycling does not necessarily indicate 
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senescence (Jurk et al., 2012), but in fibroblasts and other dividing cell types the failure 
to cycle for 48hrs generally does.    
Cell and Nuclear Morphology: The senescent cell can often, but not always, be 
characterized by a morphology that is often much larger, flatter, and more multinucleated 
than cycling cells (Fig 1.4a)(Kuilman et al., 2010; Matsumura et al., 1979). Cells with 
this morphology are said to take on the appearance of a ‘fried egg’, where the well-
defined and often enlarged nucleus is the ‘yolk’. The DAPI stained DNA also takes on an 
uneven appearance due to changes in chromatin organization that is characteristic of 
senescence in many cells (Fig 1.4a). 
Senescent-Associated β-Galactosidase serves to identify senescent cells in culture (Fig 
1.4b) and in vivo, but it is not a perfect marker as some cells lines are positive for SA-β-
galactosidase activity independent of senescence whereas in others senescent cells are 
negative (Dimri et al., 1995). It has also been shown that SA-β-galactosidase can return 
false positives when cell density is high (Severino et al., 2000). Further characterization 
of this marker showed that it depended on increased lysosomal activity in senescent cells, 
but this increase was not necessary for the induction or maintenance of the senescent state 
(Lee et al., 2006). Despite these limitations SA-β-galactosidase activity remains the most 
widely used marker to identify senescent cells today.  
Senescence Associated Secretory Phenotype (SASP): Microarray analysis of senescent 
cells revealed that the expression of secreted factors that play a role in cell signaling, 
including cytokines and chemokines were increased in comparison to cycling cells 
19 
 
(Shelton et al., 1999; Zhang et al., 2003a). Additional examination of these secreted 
factors, which were collectively termed the SASP, showed that they were upregulated in 
senescence caused by DNA damage (Coppé et al., 2008), and later work showed that the 
SASP can occur via DNA damage independent mechanisms as well (Freund et al., 2011). 
Furthermore, while the SASP components of every cell line are unique it has been 
observed in a wide variety of senescent cell types, including in murine and human cells 
both in culture and in vivo (Coppé et al., 2010; Coppé et al., 2008). Evidence indicates 
that the SASP affects surrounding cells in various ways, including through the induction 
of senescence, provoking inflammatory responses, or inhibiting cancer progression 
(Campisi, 2013). However, the SASP is not upregulated when cells senesce via the 
p16/Rb pathway(Coppe et al., 2011) suggesting that while the SASP is one of the most 
comprehensive markers of senescence it is also not ubiquitous in all types of senescence.  
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Figure 1.4 Senescence Markers. Cycling cells are pictured in the left column while 
senescent cells are pictured in the right except in (d). a) Cycling cells are typically 
substantially smaller than senescent cells, have a round nuclear shape, and an even DNA 
DAPI (blue) staining pattern. Senescent cells are often much larger and take on a ‘fried 
egg’ appearance and are often characterized by nuclear blebbing. Some senescent cells, 
including the ones pictured here, form DNA dense heterochromatic foci called SAHFs. b) 
SA-β-galactosidase, the most common marker of senescence, causes senescent cells to 
appear blue (right). c) The senescent cell (right) is p16 positive (green), while the cycling 
cell (left) is p16 negative. d) In both images the cell with the large nuclear morphology is 
depleted for LaminB1 (red) suggesting that they are senescent.     
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Figure 1.4 Senescence Markers  
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Senescent Associated Heterochromatic Foci and p16: SAHFs are readily visualized 
dense bodies of heterochromatin comprised of a single interphase chromosome (Fig 
1.4a,c)(Funayama et al., 2006; Narita et al., 2003; Zhang et al., 2007a). These nuclear 
structures are enriched in proteins and histone modifications associated with 
transcriptional silencing, including H3K9Me3, H4 hypoacetylation, MacroH2A, and 
bound HP1 (Funayama et al., 2006; Narita et al., 2003; Zhang et al., 2005), and their 
formation requires heterochromatin remodelers and histone chaperones such as HMGA, 
ASFA1, and HIRA (Narita et al., 2006; Ye et al., 2007; Zhang et al., 2005). Some 
evidence suggests that these bodies sequester cell cycle genes, like E2F and CyclinA, 
further establishing the permanence of the senescent state (Narita et al., 2003; Zhang et 
al., 2007b). Although the exact DNA sequences within SAHFs are still not known, 
surprisingly, recent finding suggest that these dense heterochromatin foci form due to a 
reorganization of sequences enriched for H3K9Me3 rather than changes to the 
distribution of histone methylation throughout the genome (Chandra et al., 2012). SAHFs 
are also not characteristic of every cell type or in every senescent cell within a culture as 
they require p16 expression to form, and they have not been detected either in vivo or in 
murine cells (Kennedy et al., 2010; Kreiling et al., 2011; Narita et al., 2003). In addition, 
other work has reported that SAHF formation may be separated from the senescence 
process and appears to occur in cells that are still cycling (Di Micco et al., 2011). 
Together this data raises the possibility that SAHF formation is a byproduct of 
senescence instead of a mechanism to further insure the arrest of the cell cycle.  
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While p16 is required for SAHF formation (Narita et al., 2003) it is repressed and not 
detectable in cycling cells, and in response to many stimuli it is upregulated to detectable 
levels both in vitro and in vivo (Kuilman et al., 2010; Ressler et al., 2006). However, as 
discussed previously, p16 is not necessary for senescence as some cells express p16 later 
in the senescence process and others, like BJ fibroblasts, do not express it significantly 
(Herbig et al., 2004; Narita et al., 2003). Therefore p16 is also not a ubiquitous marker 
for cell senescence. 
Depletion of LaminB1, a nuclear lamina component, was recently shown to occur in 
senescent cells (Shimi et al., 2011). Subsequent characterization of this phenotype 
suggested that this depletion could be used as a marker of senescence as it occurs in vivo 
and is characteristic of senescence induced by both the p53/p21 and p16/Rb pathways 
(Freund et al., 2012). However, recent work has shown that while LaminB1is depleted in 
an age dependent manner, its loss impairs proliferation but does not cause senescence 
(Dreesen et al., 2013). Dreesen et al. then went on to show that the loss of this protein is 
not sufficient to cause premature senescence, as additional cellular stress is required for 
cells with reduced LaminB1 to senesce. Therefore, reduced levels of LaminB1 may be 
strongly correlated in frequency with senescent cell populations or characteristic of cells 
that are still cycling but on the verge of senescence.  
Nuclear Structure and Chromatin Packaging 
As this thesis will focus on the discovery that senescent cells can be identified by 
dramatic changes that occur to their heterochromatin, background on how DNA is 
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packaged and organized in the interphase nucleus becomes necessary. Over two meters of 
DNA is compacted into a nucleus that is roughly 5-10 microns across. Consequently, 
intricate organization is required to condense this DNA into the nucleus while still 
allowing for the regulation of gene expression and DNA accessibility for other key 
nuclear functions. In order to accomplish this, 147 base pairs of naked DNA is wrapped 
around a histone octamer to form the nucleosome (Kornberg, 1974). This process repeats 
throughout the entire genome to form ten nanometer fibers (Olins and Olins, 1974; 
Woodcock et al., 1976). From there, it is a matter of debate as to how chromatin is 
packaged in higher-order structures (Maeshima et al., 2014) such as SAHFs. What is 
clear, however, is that DNA is compartmentalized into two separate regions (Carone and 
Lawrence, 2013). The first is euchromatin, comprised of actively transcribed DNA, while 
the second, heterochromatin, consists of gene poor, repetitive, and repressed regions of 
the genome. Interestingly, the nuclear lamina which is comprised of A and B type lamins, 
is thought to play a role in the organization and silencing of the DNA in the 
heterochromatic compartment located at the nuclear periphery (Kind and van Steensel, 
2010). Since it has been shown that LaminB1 levels decrease during senescence, it is 
fitting that the organization of the chromatin in this compartment changes as well.  
Summary of Previously Known Heterochromatin Changes in 
Senescence 
With the discovery of SAHFs by Narita et al. in 2003 the senescence field shifted their 
collective attention from the cell stimuli that trigger senescence to the study of 
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heterochromatin packaging and organization (Narita et al., 2003). As SAHFs represent an 
apparent dramatic reorganization of heterochromatin subsequent efforts characterized 
these DNA-dense bodies enriched for H3K9Me3 and H3K27Me3, histone modifications 
characteristic of silenced heterochromatin, and showed that they contained high levels of 
heterochromatin proteins such as macroH2A and all three isoforms of HP1(Adams, 2007; 
Funayama et al., 2006; Narita et al., 2003; Zhang et al., 2005). It was also noted that 
histone chaperones HIRA and ASF1a were needed for SAHFs to form (Zhang et al., 
2005), and other work showed that HMGA, a protein normally associated with 
euchromatic DNA, was required (Narita et al., 2006). The linker histone, H1, was also 
depleted in SAHF positive senescent cells further suggesting that increases in 
heterochromatin may not account for all senescent related changes in chromatin 
organization (Funayama et al., 2006).  
In fact, many of the heterochromatin gains seen in senescence do not occur in all cells. As 
mentioned previously not all cell types, including senescent cells in vivo, form SAHFs 
(Kreiling et al., 2011; Narita et al., 2003). Recent evidence suggests that SAHFs do not 
represent a gain in heterochromatin, but rather a reorganization of the same DNA 
sequences enriched in repressive heterochromatin marks (Chandra et al., 2012). This 
reorganization has been shown to depend on the depletion of LaminB1, a component of 
the nuclear lamina that organizes heterochromatin at the nuclear periphery (Sadaie et al., 
2013). In addition, many heterochromatic gene poor regions containing repetitive 
elements including Alu and L1 become more euchromatic and increase expression with 
senescence (De Cecco et al., 2013). Cells from Hutchinson Guilford Progeria Syndrome 
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(HGPS), have also been shown to lose heterochromatin when they exit the cell cycle 
(Pegoraro et al., 2009; Scaffidi and Misteli, 2006; Shumaker et al., 2006). Hence, 
senescent cells experience both gains and losses in their heterochromatin, an idea that 
will be examined in greater detail in the next two chapters of this work.    
The Emerging Role of Senescence in Aging  
The discovery of the Hayflick limit combined with the telomere end-replication problem 
provided insight into the mechanism of cellular aging, and for the first time, 
demonstrated that a link between senescence and aging may exist. Following those initial 
findings, a number of factors implicated in both senescence and aging were identified, for 
example, levels of p16, a key senescence regulator, increase with age in vivo 
(Krishnamurthy et al., 2004; Zindy et al., 1997), and skin biopsies taken from aged 
humans and baboons contained increased levels of senescence (Dimri et al., 1995; Herbig 
et al., 2006; Jeyapalan et al., 2007). The discovery that early aging phenotypes in mice 
expressing constitutively active p53 correlated with higher rates of senescent cells (Maier 
et al., 2004; Tyner et al., 2002) served to further the connection between senescence and 
aging. However, definitive proof that senescence contributes to the onset of aging 
phenotypes occurred when hypomorphic BubR1 (BubR1h/h) mice, a mouse model 
characterized by premature aging phenotypes, were crossed to p16 null mice. 
Importantly, BubR1h/h,p16Ink4a-/-mice from this cross exhibited decreased levels of 
senescence, slower onset of aging phenotypes, and an extended lifespan when compared 
to the BubR1h/h,p16Ink4a+/+ mice (Baker et al., 2008). Further experimentation showed that 
mouse models designed to clear p16 positive cells via apoptosis also delay the onset of 
27 
 
age-related phenotypes in skeletal muscle, adipose tissue, and eyes (Baker et al., 2011). 
Together, these efforts showed that aging phenotypes were directly related to activation 
of p53 or upregulation of p16 and the subsequent onset of senescence.  
Further insights into the link between senescence and aging has emerged from studies 
examining the Hutchinson Guilford Progeria (HGPS) syndrome, a laminopathy caused by 
a spontaneous mutation in the LaminA gene resulting in the production of the 
alternatively spliced product progerin (De Sandre-Giovannoli et al., 2003; Eriksson et al., 
2003). HGPS patients have an average life expectancy of 14 years and often die of 
atherosclerosis, a disease normally characteristic of much older populations (Gordon et 
al., 2014). Furthermore, patients suffering from HGPS experience numerous other aging 
phenotypes, such as joint contractures and muscular degeneration (Gordon et al., 2014). 
One possible cause of the early aging observed in HGPS is a disrupted DNA damage 
response (Gonzalez‐Suarez et al., 2009; Liu et al., 2005) that presumably contributes to 
increased levels of premature senescence (Benson et al., 2010; Huang et al., 2008). 
Interestingly, progerin expression increases with age in normal individuals supporting the 
use of HGPS as an appropriate model of aging (Cao et al., 2011; Luo et al., 2013; 
McClintock et al., 2007; Rodriguez et al., 2009).  
In addition to HGPS, Down syndrome (DS), a disease caused by an extra copy of the 21st 
chromosome that affects 1:700 live births, has also been used as a model for premature 
aging. While DS has long been associated with intellectual disability, it has recently been 
noted that these patients experience many early aging phenotypes including Alzheimer’s 
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disease (AD) and osteoarthritis (Zigman, 2013). It has also recently been shown that 
fibroblasts from DS mice models senescence prematurely (Contestabile et al., 2009). 
Considering that aging is linked to increased levels of senescence in premature aging 
models, such as HGPS and possibly DS, and in normally aged humans and mice, 
identifying and understanding the effects of senescent cells is critical to the treatment and 
prevention of aging diseases. One detrimental effect of senescent cells is the secretion of 
a characteristic SASP which can promote senescence in nearby cells creating a positive 
feedback loop whereby senescence causes additional senescence. Initial evidence that 
secreted factors comprising what is now termed the SASP are implicated in both 
senescence and aging emerged from experiments demonstrating that the proliferation 
potential of aged cells can be rejuvenated by exposure to a young environment (Conboy 
et al., 2005), and more recently by the exposure to the soluble factor GDF11 
(Katsimpardi et al., 2014; Loffredo et al., 2013; Sinha et al., 2014). Furthermore, 
continual WNT (a SASP component) exposure has been noted to reduce the regenerative 
potential of cells both in vitro and in vivo (Liu et al., 2007) and other recent reports 
suggest the secretion of SASP components is connected to increased levels of in vivo 
senescence (Acosta et al., 2013; Nelson et al., 2012). Thereby, SASP components cause 
senescence in vivo resulting in the onset aging phenotypes. For example, astrocytes, the 
most abundant cell type in the human nervous system, exhibit signs of DNA damage in 
Alzheimer’s disease (AD) (Myung et al., 2008), are characterized by increased levels of 
senescence in aged individuals, and secrete a multitude of SASP components (Bhat et al., 
2012; Salminen et al., 2011). It was also observed that the exposure of cultured normal 
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astrocytes to the β-amyloid peptide, an indicator and possible cause of AD induces 
senescence (Bhat et al., 2012). The loss of proliferation capable astrocytes due to 
senescence and the secretion of SASP components (including the β-amyloid peptide) 
eventually leads to the decline in brain function typical of AD patients. Senescence has 
also been implicated in the age-related disorder osteoarthritis (OA), a disease 
characterized by bone degeneration, loss of cartilage, and joint pain primarily in the 
elderly, caused in part by increased levels of senescence in chondrocytes (Rose et al., 
2012; Yudoh et al., 2005). Senescent chondrocytes then enhance OA phenotypes through 
the secretion of inflammatory SASP components (Shen et al., 2013). Moreover, senescent 
cells and the corresponding detrimental effects of SASP components have been 
implicated in aging-related cardiovascular disease (Burton et al., 2010).   
Senescence in Cancer  
Cells enter senescence using one of two pathways comprised of tumor suppressors that 
are mutated, epigenetically silenced, or deleted in the majority of malignant cancers. 
When these tumor suppressors fail to function properly, increased susceptibility to cancer 
results, due in part, to senescence not occurring (Rodier and Campisi, 2011; Zhang, 
2007). In support of the role of senescence in inhibiting tumor formation, the shortening 
of telomeres, which causes replicative senescence, suppresses tumorigenesis (Cosme-
Blanco et al., 2007; Feldser and Greider, 2007) and it has been noted that inducing 
senescence in tumors through the use of chemotherapeutic drugs or the reactivation of 
p53 leads to tumor regression and reduction of tumor size as these cells are eventually 
cleared by the immune system (Schmitt et al., 2002; Ventura et al., 2007; Xue et al., 
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2007). In addition, the onset of oncogene-induced senescence has been shown to prevent 
the formation of malignant tumors in vivo as these non-malignant lesions contain high 
levels of senescent cells (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; 
Michaloglou et al., 2005). SASP components, such as IL-6, IL-8, and WNT16B have also 
been shown to reinforce cell cycle arrest during oncogene induced senescence in vivo 
(Binet et al., 2009; Kuilman et al., 2008; Yang et al., 2006). Hence, senescence and the 
factors secreted from these cells work to prevent the formation of tumors.   
It is also of interest that the two models of premature aging discussed previously, Down 
syndrome (DS) and HGPS, have a remarkable resistance to cancer (except leukemia in 
DS individuals)(de la Rosa et al., 2013; Nizetic and Groet, 2012). This is of note because 
evidence suggests that the senescence response, a key physiologic component of cancer 
prevention, is increased in both diseases (Benson et al., 2010; Contestabile et al., 2009; 
Huang et al., 2008). Taken together HGPS and DS patients may be affected by higher 
levels of senescence resulting in lower levels of cancer but increased presence of aging 
phenotypes. 
Concluding Remarks 
It is now widely accepted that senescence plays a critical role in both the inhibition of 
cancer and some aspects of organismal aging. In vivo these processes are thought to be 
impacted by the secretion of soluble factors that together make up the SASP. While 
certain SASP components can induce senescence in neighboring cells, senescence can 
also occur due to a wide variety of insults to the cell, most prominently DNA damage. 
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These insults cause the upregulation of key tumor suppressors resulting in cells 
permanently exiting the cell cycle. Furthermore, this cell cycle exit involves large 
changes to the organization of heterochromatin in the nucleus. The characterization and 
description of these heterochromatin changes will form the majority of the material 
covered in the next two chapters of this work.   
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Chapter II: Higher-Order Unfolding of Satellite 
Heterochromatin is a Consistent and Early Event in Cell 
Senescence 
Abstract 
Epigenetic changes to chromatin are thought to be essential to cell senescence, which is 
key to tumorigenesis and aging. Although many studies focus on heterochromatin gain, 
this work demonstrates large-scale unraveling of peri/centromeric satellites, which occurs 
in all models of human and mouse senescence examined. This was not seen in cancer 
cells, except in a benign senescent tumor in vivo. Senescence-associated distension of 
satellites (SADS) occurs earlier and more consistently than heterochromatin foci 
formation, and SADS is not exclusive to either the p16 or p21 pathways. Because 
Hutchinson Guilford progeria syndrome patient cells do not form excess 
heterochromatin, the question remained whether or not proliferative arrest in this aging 
syndrome involved distinct epigenetic mechanisms. Here, we show that SADS provides a 
unifying event in both progeria and normal senescence. Additionally, SADS represents a 
novel, cytological-scale unfolding of chromatin, which is not concomitant with change to 
several canonical histone marks nor a result of DNA hypomethylation. Rather, SADS is 
likely mediated by changes to higher-order nuclear structural proteins, such as LaminB1. 
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Introduction 
Cultured human primary cells have a limited life span and ultimately become incapable 
of further division despite remaining metabolically active. This irreversible exit from the 
cell cycle, widely referred to as cellular senescence, has important implications not only 
for aging and stem cell biology but also as a key anti-tumorigenesis mechanism. 
Senescence can be induced by a variety of mechanisms, including shortened telomeres 
(replicative senescence), oncogene expression, oxidative stress, and replicative 
exhaustion, or via expression of regulatory factors, such as the ubiquitin ligase SMURF2 
(Zhang, 2007; Zhang and Cohen, 2004). 
Cellular senescence is accompanied by changes in gene expression and chromatin 
packaging; however, the absence of cell cycling is the only hallmark that consistently 
distinguishes senescent cells (Cristofalo, 2005; Di Micco et al., 2011; Herbig et al., 2004; 
Kosar et al., 2011). Formation of senescence-associated heterochromatic foci (SAHF) has 
received much attention, not only as a senescence marker but also as a proposed 
mechanism to promote and stabilize the senescent state (Narita et al., 2003; Zhang, 
2007). Although SAHF exhibit repressive chromatin modifications, including H3K9Me3, 
H4 hypoacetylation, macroH2A, and HP1(Adams, 2007), some marks commonly 
associated with heterochromatin are lost during senescence and aging, such as linker 
histone H1 and DNA methylation (Funayama et al., 2006; Misteli, 2010). 
Although SAHF are common in human senescence, they are not found in all senescent 
human cells or any senescent mouse cells (Kennedy et al., 2010; Narita et al., 2003). In 
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particular, cells from patients with Hutchinson Guilford progeria syndrome (HGPS) and 
from aged individuals tend to show loss of visible heterochromatin blocks and associated 
marks (Misteli, 2010; Shumaker et al., 2006). These inconsistencies leave open the 
question of whether or not cells in premature aging syndromes such as HGPS undergo the 
same process for loss of proliferative capacity as normal primary fibroblasts senescing in 
culture. Furthermore, even within normal cultured senescing fibroblasts it is not known 
whether SAHF are a key part of the senescence pathway or arise as a consequence of a 
senescent end state (Di Micco et al., 2011; Kennedy et al., 2010; Narita et al., 2003; 
Zhang et al., 2007a). It would thus be important to identify a broad epigenomic change to 
chromatin that consistently occurs during senescence in a variety of human and mouse 
systems and during premature arrest in cells from patients afflicted by HGPS. 
In contrast to the formation of excess facultative heterochromatin, constitutive 
heterochromatin in senescent cells has received little attention. Here, we demonstrate that 
the peri/centromeric satellite heterochromatin undergoes a striking decondensation in 
senescent cells. This dramatic change to structures key to cell division occurs consistently 
in a variety of senescence models, is not exclusive to either known senescent pathway, 
and happens independently of and before SAHF formation. It has also been observed in 
senescent human and mouse cells and appears to be prevalent in vivo in benign prostatic 
intraepithelial neoplasia (PIN) tumors. Importantly, this change to satellite 
heterochromatin is particularly prevalent in cultured fibroblasts from two HGPS patients. 
Thus, what we term senescence-associated distension of satellites (SADS) is a new 
marker that constitutes an early and potentially key event in the process of cell 
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senescence. We further show that SADS retain several canonical histone hallmarks of 
heterochromatin, suggesting that this visible unraveling represents change to higher-order 
chromatin folding potentially at an unprecedented level. 
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Figure 2.1 Satellite DNA Signals Markedly Distend in Senescent Fibroblasts. (A) α-
Sat (green) and sat II (red) hybridization in early passage culture. Distended satellites are 
found in a small percentage of nuclei (right; see 3D images and Videos 1 and 2). (B) 
Most cells in late passage senescent cultures show distended satellites. Note that these 
cells do not have enlarged nuclei, but contain SAHF (DAPI). Insets show examples of 
threadlike satellite extensions, some of which extend to and contact the nuclear 
membrane (indicated by arrows and arrowheads). Inset of boxed region shown in black 
and white to enhance contrast. (C and D) β-Gal staining confirms that the cycling culture 
(C) contains few senescent cells and the senescent culture (D) contains many. (E) 
Quantification showing that senescent cultures contain more cells with distended 
satellites than cycling cultures. (F–J) Senescence was confirmed by staining for p16 (F), 
p21 (H), and SAHF (DAPI; G), and quantified (J; error bars are standard error). (K) HeLa 
cultures do not contain cells with distended satellites. 
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Results 
Marked Distension of Satellite DNA in a Subset of Primary Human Fibroblasts 
In a culture of proliferative normal diploid fibroblasts (Tig1) hybridized with a probe to 
α-satellite (α-sat) DNA, we first noted that a small subset of cells appear to have 
dramatically distended satellites, such that the normally compact round centric-satellite 
signals (Figure 2.1a, left) form linear extensions that appear “strung out” (Figure 2.1a, 
right). These thin threads of distended DNA can be difficult to reproduce in print, but 
were unambiguous through the microscope. This highly distended pattern was not a 
sporadic variation peculiar to a few centromeres, but evident in most if not all α-sat 
signals in a given cell. For quantitative scoring (Figure 2.1e), a cell nucleus had distended 
satellites when the majority of signals lost their discrete round shape, had threadlike 
extensions, and elongated along a longitudinal axis. Furthermore, satellite II DNA, found 
at the pericentromeres of several chromosomes, showed a similarly dramatic loss of its 
normally tight packaging (Figure 2.1a). Similar patterns were seen in a variety of diploid 
fibroblast lines including IMR90, WI38, BJ, and LF1, but not in several tumor-derived 
immortal cell lines. Although some of the fibroblasts with distended satellite DNA had 
enlarged nuclear morphology (Figure 2.1a, right) others did not (Figure 2.1b); this and 
other evidence rules out that satellite distention reflects global DNA decondensation 
throughout the genome. 
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Satellite Distension is a Hallmark of Cells Undergoing Replicative Senescence in 
Culture 
The “fried egg” morphology of some cells with markedly distended satellites in early 
passage cultures suggested that they may represent senescent primary fibroblasts. Thus 
we compared early passage, proliferative cultures to those that had undergone replicative 
senescence. Remarkably, 84% of cells in senescent cultures (Figure 2.1b,e ; n = 3) had 
distended α-sat, compared with only 14% of early passage fibroblasts (Figure 2.1e). 
These cells had several other markers of senescence, including positive senescence-
associated β-galactosidase (β-gal) staining, up-regulation of p16 and p21, and often 
SAHF (Figure 2.1c,d,f-j). We also examined several transformed cell lines (HeLa, PC3, 
and U2OS) and despite numerous genetic and epigenetic aberrations in these neoplastic 
lines we found essentially no cells in these cultures with distended satellite (Figure 2.1k). 
Next, to ensure satellite decondensation is not a property of quiescent cells, we examined 
Tig1 cells serum starved for 48 h or allowed to recover in normal serum for 24 h. 
Compared with controls, the percentage of cells exhibiting satellite unraveling did not 
change as a result of serum starvation (Figure 2.2a). Thus, satellite distension is not a 
property of stressed cells undergoing quiescence, nor a function of general epigenetic 
aberration in tumor cells, suggesting it is a regulated chromatin change specific to the 
senescence program. 
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Figure 2.2BrdU labeling demonstrates that distended satellites are characteristic of 
and specific to senescent fibroblasts. (A) Satellites do not distend in quiescent, serum-
starved cells. (B and C) BrdU (red) labels cells with condensed satellites (green; B) but 
not cells with decondensed satellites (C). Inset shows high magnification of a distended 
satellite (arrowhead; cells are from same field). (D and E) Quantification of satellite 
distension in early (D) and late (E) passage cultures subjected to a 20-min BrdU pulse, 
confirming that cells with decondensed satellites are rarely in S phase. (F) Almost all 
cells that did not incorporate BrdU during a 48-h pulse had distended satellites (n = 100–
200, from one of three repeats). (G) Early passage and senescent cells with distended 
satellites rarely incorporate BrdU during the previous 48-h period (n = 100–200, 
representative of one of three repeats). In presenescent late passage cultures in which 
more cells are entering senescence, a significant fraction of cells with distended satellites 
incorporated BrdU (error bars represent standard error). 
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Figure 2.2 BrdU Labeling Demonstrates that Distended Satellite are Chraracteristic 
of and Specific to Senescent Fibroblasts. 
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We also used BrdU incorporation in replicating DNA to discriminate proliferative versus 
nonproliferative cells, to address whether the ∼15% of cells exhibiting satellite distension 
in low/mid passage cultures are still cycling or are indeed senescent. A 20-min BrdU 
pulse in low passage Tig1 fibroblasts demonstrated that the subset of cells exhibiting 
satellite distension rarely incorporate BrdU (Figure 2.2b-d). As shown in Figure 2.2d, 
35.3% of the cells with compact centromeric DNA also labeled with BrdU, whereas <1% 
(0.64%) had both BrdU and decondensed satellite, demonstrating that cells with satellite 
distension do not simultaneously replicate DNA. Similar results were seen in late passage 
fibroblasts (five passages from full senescence; Figure 2.2e). We then used a 48-h BrdU 
pulse to ask what percentage of senescent cells (defined by lack of DNA replication over 
2 days) exhibit satellite distension. Importantly, in both early and late passage cultures, 
almost all BrdU-negative cells had decondensed satellite DNA, indicating this is a 
consistent change characteristic of senescent cells (Figure 2.2f). 
Exposing cells to BrdU for a long period (48 h) is helpful to mark cells that are no longer 
cycling, but is long enough that some cells could label during their last S phase and then 
withdraw from the cell cycle. This would occur more frequently in late passage cultures 
in which many cells are entering senescence. Consistent with this, of the 15% of early 
passage cells that contained distended satellite DNA (Figure 2.2d), only 1.8% of these 
also incorporated BrdU during the 48-h label (Figure 2.2g). In contrast, in late passage, 
rapidly senescing cultures, ∼25% of cells had distended satellites (Figure 2.2e) and up to 
38% of these also labeled with BrdU (Figure 2.2g). This difference was observed in 
multiple experiments and suggests that within 48 h of the last DNA replication, cells 
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entering senescence have already undergone major structural changes to satellite DNA. 
To test this further, the 48-h label was done on a fully senescent culture; in this case 
∼85% of cells had distended satellites, but only 6% of these stained positive for BrdU 
(Figure 2.2g). 
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Figure 2.3 SADS is a Property Common to Multiple Different Senescence Models 
and Pathways. (A and B) SADS is present in a SMURF2-induced senescent BJ 
fibroblast, yet these cells do not form SAHF (B). (C and D) Oxidative stress-induced 
senescence of a Tig1 fibroblast results in distension of α-sat (green) and sat II (red) in a 
cell with SAHF (DAPI; D). (E and F) Quantification of SADS and SAHF in LF1 and BJ 
fibroblasts, induced with wild-type SMURF2 (n = 200, representative of one of three 
repeats). (G) Tig1 fibroblasts with SADS (green) may or may not be positive for p21 
staining (red). (H–J) SADS in LF1 p21 knockout cells are quantified (n = 204; J) and a 
SAHF-positive senescent cell is shown (H and I) with α-sat (green), sat II (red), and 
DAPI (I). 
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SADS is a Hallmark of Senescence Induced by SMURF2 Expression, Oxidative 
Stress, or Oncogenic Ras 
We next addressed whether SADS occur in human cells induced to senesce via 
mechanisms that do not include telomere shortening (replicative senescence), thus we 
tested this in cells induced to senesce by three other methods: overexpression of 
SMURF2, oxidative stress, and oncogenic Ras. Previous work has shown that up-
regulation of the ubiquitin ligase SMURF2 induces early onset senescence in cycling 
fibroblasts (Zhang and Cohen, 2004). Subsequently, several days after infection with 
SMURF2, cultures were largely senescent as judged by the presence of SADS (Figure 
2.3a,b,e,f), SAHF (Figure 2.3e,f; and Figure 2.S1c), and β-gal staining (Figure 2.S1a,b). 
Importantly, in multiple experiments the majority of infected cells (up to 90%) exhibited 
satellite distension within 10 d, whereas cells infected with a control vector did not 
(Figure 2.3e,f). Additionally, we induced early passage Tig1 fibroblasts to senesce by 
either oxidative stress or overexpression of oncogenic Ras, and subsequently observed 
that neither culture became confluent, many cells contained SAHF, and 73% and 71% of 
the cells had distended satellites, respectively (Figure 2.3c,d). These findings show that 
satellite distension is not exclusive to replicative senescence, but can be induced fairly 
rapidly by expression of the senescence regulator SMURF2, through oxidative stress or 
oncogenic Ras. 
Satellite Distension is Not Exclusive to Either p21 or p16 Senescence Pathways 
Previous work has revealed two pathways that fibroblasts use to undergo senescence, 
either the p53/p21 or p16/Rb (Zhang, 2007). Interestingly, cells do not up-regulate both 
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p21 and p16 until late in senescence (Herbig et al., 2004). Although SAHF formation 
occurs primarily via the p16 pathway, cells such as BJ fibroblasts, which lack significant 
p16 expression, do not form SAHF (Figure 2.3a,b; and Figure 2.S1c)(Narita et al., 2003). 
Thus it was important to address whether satellite distension is specific to one of these 
pathways or is a more consistent event that can occur by either pathway. We began by 
performing p21 staining together with DNA FISH to α-sat in late passage Tig1 
fibroblasts, using an antibody confirmed to show p21-specific staining (Figure 2.S1d,e). 
Interestingly, some cells with distended satellites expressed high levels of p21 (56%), 
whereas others expressed little or none (Figure 2.3g). To further validate that SADS can 
occur before or independent of p21 expression, we examined p21 knockout LF1 
fibroblasts, which showed distended satellites in 86% of cells, similar to the frequency in 
normal senescent Tig1 fibroblasts (Figure 2.3h-j;Figure 2.1b; and Figure 2.S1i). This 
supports that SADS can occur independent of the p21 pathway. 
Because SADS do not require p21, they may occur via the p16 pathway, but a distinct 
question is whether p16 is required. When we used SMURF2 to induce senescence in BJ 
fibroblasts, satellite distension was only slightly reduced compared with SMURF2-
induced LF1 senescent fibroblasts (Figure 2.3e,f). Although there is a near complete loss 
of SAHF in BJ cells that lack substantial p16 expression, SADS are still highly prevalent. 
As further evidence that SADS do not require p16 we examined p16 null mammary 
epithelial cells, which also formed distended satellites (Figure 2.S1f-i). Hence, SADS 
does not require p16 and is not restricted to either of the two established senescence 
pathways.  
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Figure 2.4 SADS Occur in MEFs and Senescent Cells Within Human Tumors. (A) 
Cycling MEFs (top right) have condensed minor satellite (red), whereas senescent MEFs 
(bottom left) have distended minor satellite. (B–D) A senescent MEF with coalesced and 
elongated chromocenters (DAPI) and stringy minor satellite (red). The arrowhead points 
to a particularly elongated chromocenter (D) associated with a highly decondensed minor 
satellite (C). (E) Senescent MEFs, as shown in B, stain positive for β-gal. (F–J) Serial 
sections reveal SADS in PIN tissue. Using H&E staining (F and magnified in G) to 
identify PIN, which contains senescent cells as indicated by positive β-gal staining (H) 
and distended satellites by α-sat (green) and sat II (red; I). Signals from I (white box) are 
enlarged in J. (K and L) Malignant prostate (K) and thyroid (L) tumors, which lack 
senescent cells, typically have round, compact signals of α-sat (green) and sat II (red). 
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Satellite Distension is an Early Event in Senescence and Independent of SAHF 
Formation 
Several observations support that SADS occurs early in cell senescence, well before and 
independent of SAHF formation. As shown in Figure 2.3(a and b), we observed cells 
with decondensed satellites and no SAHF, but the opposite was never true. Furthermore, 
SAHF formation is very uncommon in BJ fibroblasts with low p16 expression, but SADS 
still occurs after SMURF2-induced senescence (Figure2.3a,b and f; and Figure 2.S1c). 
Further evidence that SADS occurs before SAHF formation came from LF1 cells 
transfected with SMURF2. Just 2 days after selection of SMURF2 expressing cells, only 
5% had SAHF, whereas 39% had SADS. By 5 d, more cells had SAHF (48%) but still 
more had SADS (67%; Figure2 .3e and Figure 2.S1c). As such, satellite decondensation 
appears to occur irrespective of and before SAHF formation in all senescent fibroblasts 
examined. 
SADS Occurs in Senescent Murine Cells and in vivo in a Human Benign Tumor 
Our findings show that senescence of normal human cells in vitro involves not only gain 
of facultative heterochromatin (SAHF) but also breakdown of constitutive 
heterochromatin (SADS), which is a consistent and early hallmark of senescence. Given 
the differences between human and mouse senescence (Itahana et al., 2004; Kennedy et 
al., 2010), it would be significant if SADS constitutes a hallmark common to both 
species. As such, we tested the universality of SADS by examining senescent cultures of 
normal mouse embryonic fibroblasts (MEFs). In many of these cells, the normally round 
chromocenters, organized clusters of the pericentric major satellite visible by DAPI 
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staining, did indeed show structural aberrations (Figure 2.4b and d) exemplified by 
irregular shapes that coalesced, frequently with fibrous interconnections. In situ 
hybridization to the smaller blocks of minor satellite DNA (the centromere proper) 
demonstrated that 86% of cells in a culture of senescent MEFs (Figure 2.4e, β-gal 
staining) no longer formed small, round, and compact signals (Figure 2.4a, top), but 
clearly was extended, irregular, and often threadlike (Figure 2.4a-c). Therefore, SADS is 
a prominent chromatin change common to both mouse and human senescence. 
Because some markers of human senescence, including SAHF, have not been verified in 
vivo (Kreiling et al., 2011), we obtained sections of premalignant PIN tissue (Figure 2.4f, 
g) known to have high levels of senescence (Chen et al., 2005). We then used β-gal 
staining to verify the presence of senescence in this tissue (Figure 2.4h) and DNA FISH 
to α-sat and sat II sequences in serial sections to reveal that distended satellite signals are 
present in cells within the positive β-gal–stained regions of PIN tissue (Figure 2. 4i,j). In 
contrast, examination of tissue sections from several malignant cancers that lack 
senescent cells, including breast, thyroid, pancreatic, and prostate, showed that the 
satellites were condensed (Figure 2.4k,l; and not depicted), demonstrating that only in the 
senescent PIN tumor were there large sections of cells with distended satellites, which 
indicates that SADS are an in vivo marker characteristic of senescent cells. 
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Figure 2.5 SADS is characteristic of HGPS cells that undergo premature arrest. (A) 
Frequency of distended satellites in early passage cells from two HGPS patients (1-yr-old 
HGADFN155 and 8-yr-old HGADFN167) and the older healthy mother of 
HGADFN167, HGMDFM090 (n = 100 in one of three representative experiments). (B) 
A 20-min BrdU pulse demonstrates that very few early passage HGADFN167 cells with 
decondensed satellites label, confirming that cells with SADS are rarely in S phase (n = 
202). (C) Almost all cells that did not incorporate BrdU during a 48-h label had distended 
satellites (n = 100). (D–F) DNA FISH to α-sat (green) and sat II (red) shows that some 
HGPS cells have normal appearing compact satellites (E), whereas senescent cells in both 
the HGADFN167 (D) and HGADFN155 (F) cell lines contain SADS. Also notice the 
blebbed nuclear membrane (DAPI; F) characteristic of laminopathies. Arrows and 
arrowheads indicate a particularly distended α-sat signal that is enlarged in the 
corresponding insets. 
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SADS Occurs in HGPS Patient Cells Undergoing Premature Proliferative Arrest 
We next addressed whether SADS would also be seen in cells of patients with a 
devastating human disease that is an important model of in vivo aging—HGPS. HGPS 
patients express a mutated form of lamin A/C that causes global defects in the nuclear 
heterochromatic compartment. Consistent with the rapid aging phenotype, HGPS cells 
undergo premature senescence in culture, providing an in vitro model for human aging. 
However, neither in vivo nor in vitro do HGPS cells exhibit gain of visible 
heterochromatin blocks (SAHF) or heterochromatic marks. Instead, a general decrease in 
H3K9me3, HP1, and NURD-associated factors has been reported (Pegoraro et al., 2009; 
Scaffidi and Misteli, 2006; Shumaker et al., 2006). This apparent contradiction leaves 
open the question of whether HGPS cells undergo proliferative arrest by mechanisms 
distinct from senescence in normal cells. Therefore, we obtained primary HGPS skin 
fibroblasts to examine if satellite distension is evident in these cells as they arrest. We 
examined three different early passage cultured fibroblast lines: a 1-yr-old male 
(HGADFN155 passage 10, PD 21), an 8-yr-old female (HGADFN167 passage 11, PD 
20), and that female’s 37-yr-old healthy biological mother (HGMDFM090 passage 13, 
PD 23). This demonstrated that although a fraction of cells had compact satellites (Figure 
2.5a,e), satellite distension is indeed a hallmark of many cultured HGPS cells (Figure 
2.5a,d,f). For example, almost 50% of the 1-yr-old boy’s cells, which displayed a marked 
HGPS phenotype (blebbed and contorted nuclei), had distended satellites. Additionally, 
cells with SADS were confirmed to be noncycling by a 20-min BrdU pulse in the 8-yr-
old girl’s cell line, with just 1.5% of total cells having both SADS and BrdU label versus 
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29% with SADS and no BrdU (Figure 2.5b). We then asked if cells that failed to 
incorporate BrdU after 48 h had visibly distended satellites, and similar to normal 
senescing cultures almost all did (Figure 2.5c). These findings reinforce that a high 
fraction of HGPS cells have removed themselves from the cell cycle despite the young 
age and early passage of these cultures. Most importantly, the prevalence of SADS 
indicates that this premature proliferative arrest shares a fundamental epigenomic change 
with replicative as well as induced senescence of normal human and mouse cells. 
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Figure 2.6 Loss of Compaction is Specific to Satellite DNA and is not Caused by 
Increased Nuclear Size. (A and B) DNA FISH to Chr. 17 α-sat (green) shows compact 
satellite signals in a cycling cell (A) and distended satellites in a senescent cell (B) as 
determined by the presence of SAHF (DAPI). The size of the corresponding signal is 
shown above the brackets. (C) The mean length of Chr. 17 α-sat in senescent cells is six 
times the mean length in cycling cells. (D) The shortest Chr. 17 α-sat measured in 
senescent cells is longer than the largest satellite measured in cycling cells. (E–H) 
Differences in satellite length cannot be explained by the twofold increase in nuclear 
diameter (E). The mean size of the Chr. 21 BAC signal (red) did not change (F) in 
cycling (G) or senescent (H) cells. (I–L) Telomere signal size (red) in cycling (I and J) or 
SMURF2-induced senescent (K and L) LF1 cells did not change. Senescence is judged 
by distension of the α-sat (green) and presence of SAHF (DAPI; error bars represent 
standard error). 
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SADS is a Unique Higher-order Unfolding of Chromatin Distinct from DNA 
Decondensation Linked to Expression 
Several aspects of our findings suggest that SADS represents a unique change to higher-
order chromatin folding, of a much different nature than in other studies of DNA 
decondensation. Changes in DNA condensation are known to be linked to active 
chromatin and certain histone modifications, but such molecular-scale changes are below 
the resolution of light microscopy and can only be determined by techniques such as 
DNase sensitivity. In contrast, SADS can be readily seen despite the limited resolution of 
light microscopy. To address whether SADS is linked to expression of the corresponding 
satellite sequences, we examined satellite RNA expression in senescence cells using well 
established techniques (Lawrence et al., 1989). In primary normal fibroblasts with visible 
SADS, sat II RNA is not substantially expressed (see Figure 2.7a,b) despite the dramatic 
decondensation of the DNA. In contrast, we and others have shown that sat II RNA is 
highly expressed in many rapidly cycling cancer cells (Ting et al., 2011), including 
cancer cell lines that we show have tightly packaged satellite DNA signals (Figure 2.1k 
and Figure 2.7f) Thus, visible satellite distension was not related to satellite RNA 
expression. 
To quantify the extent of this striking satellite distension, we measured the signal using a 
probe specific to the α-sat on human chromosome 17 (Chr. 17), in proliferative versus 
senescent Tig1 fibroblasts. The Chr. 17 α-sat in senescent, SAHF-positive Tig1 
fibroblasts had a mean length of 5.44 µm, in contrast to 0.88 µm in cycling cells (Figure 
2.6a-e). As shown in Figure 2.6d, the shortest Chr. 17 satellite signal in SAHF-positive 
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cells was more extended than the largest found in cycling cells. This increased satellite 
length does not merely reflect changes in nuclear size because large cycling nuclei with 
condensed satellites were observed as well as small nuclei with decondensed satellites 
(Figure 2.1b) and mean satellite length increased over sixfold, whereas nuclear diameter 
increased slightly less than twofold (Figure 2.6c,e). In addition, the signal size of a 
randomly selected 156-kb BAC (containing the Chr. 21 DYRK1A locus) showed no 
decondensation in senescent cells (Figure 2.6f-h), and there was no visible difference in 
the condensation of traditionally heterochromatic telomere signals in senescent 
(SMURF2 induced) and nonsenescent control cells (Figure 2.6i-l). Hence, satellite 
distension is not merely a reflection of nuclear size nor indiscriminate chromatin 
decondensation. 
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Figure 2.7 Analysis of Expression, Heterochromatin Proteins, DNA Methylation, 
and Histone Modifications in Satellites. (A and B) FISH to sat II RNA (green) shows 
no increased expression with SADS formation in senescent (left) versus cycling (right) 
cells, with satellite chromatin marked by CENP-B staining (red). (C) CENP-A (green) 
and CENP-B (red) are still present in senescent cells as determined by the presence of 
SAHF (DAPI) and decondensed CENP-B staining (magnified in inset). (D) Comparison 
of H3K9me3, H3K27me3, and H3K4me3 read densities between cycling and senescent 
IMR90 cells and between cycling IMR90 and H1hES cells on α-sat (RepeatMasker class: 
HSATII) sequences with corresponding Pearson’s r values. (E and F) As all cancer 
samples examined, U2OS cells have compact satellites (F; α-sat, green; sat II, red) and do 
not form SADS unless treated with 5-AzaC, which induces senescence (E). (G) 
Quantification of mean 1q12 signal areas (n > 60) in different cell samples (error bars 
represent standard error). (H) A DNA methylation-sensitive Southern blot with U2OS 
and cycling Tig1 cells digested by BstB1 (B), HpaII (H), or MspI (M) and detected with a 
probe for sat II 1q12 sequences. The arrow points to a band size that is lacking in some of 
the methylation-sensitive HpaII lanes, indicating that the 1q12 region is methylated in the 
corresponding cell types. (I–K) Cells with normal levels of LaminB1 (red; top left) rarely 
contain distended α-sat (green; I and K), but in cells with SADS (bottom right) LaminB1 
is often diminished (J and K; n = 100 from one of three replicates). 
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Satellite Unfolding Occurs on Chromatin that Retains Canonical Histone Marks of 
Heterochromatin 
Because SADS represents such a marked change in chromatin packaging, we anticipated 
that heterochromatin-associated modifications and possibly centromere-specific CENP 
proteins would change dramatically. We found that both CENP-A and -B still associate 
with distended satellites in senescent cells. Consistent with CENP-B remaining bound 
across the broader segment of α-sat DNA, the normally compact CENP-B signal becomes 
visibly decondensed in senescent cells (Figure 2.7c and Figure 2.S2a,b). In contrast, 
CENP-A, which binds to the much smaller α-sat core, was not visibly distended (Figure 
2.S2a,b, see linescans comparing CENP-A and -B). Although CENP-A is still present, it 
did appear dimmer in many (but not all) senescent cells, consistent with a recent report of 
overall lower CENP-A levels in senescent cells (Maehara et al., 2010). 
We next examined several heterochromatin modifications typically associated with DNA 
condensation, which we anticipated to be depleted from highly distended satellite DNA, 
such as linker histone H1, which has been shown to decrease during senescence 
(Funayama et al., 2006). We noted that in cells with SADS 64% still had high levels of 
H1, suggesting that nuclear H1 depletion occurs after SADS form, consistent with other 
evidence that this H1 loss is concomitant with SAHF formation (Figure 2.S3d-f). We and 
others also noted that SAHF stain strongly for repressive heterochromatin marks 
H3K9me3 and HP1γ (Narita et al., 2003; Zhang et al., 2005), and the accumulation of 
these marks on SAHF is concomitant with sharply lower levels of H3K9me3 and HP1γ in 
nucleoplasmic regions between SAHF, where the distended satellites reside (Figure 2.1b; 
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Figure2.S3a-c; and Figure 2.S4c)(Funayama et al., 2006). Although SADS had formed in 
many cells that had clearly not redistributed H3K9Me3 (Figure 2.S3b,c), the threadlike 
nature of SADS makes it difficult to determine by molecular cytology if the canonical 
heterochromatin marks (H3K9Me3 and H3K27Me3) are still on the DNA. 
Therefore, to address H3K9Me3 and H3K27Me3 distribution at higher resolution, we 
analyzed the α-sat sequences for these histone modifications, using publically available 
ChIP-seq data (Chandra et al., 2012). Surprisingly, the number of reads in α-sat 
sequences for heterochromatin marks H3K9Me3 and H3K27Me3 was tightly correlated 
in cycling and senescent cells, indicating that there was not a change in the level of these 
marks despite satellite distension (Figure 2.7d). These observations are in stark contrast 
to the differences in these histone modifications on satellite DNA between 
undifferentiated ES cells and cycling IMR-90 fibroblasts (Figure 2.7d) even though the 
packaging of these satellites remains visibly unchanged (not depicted). We then 
examined the histone modification H3K4Me3, which is associated with gene expression, 
and noticed that levels of this mark changed slightly between both cycling and senescent 
cells and less so between ES and cycling fibroblasts (Figure 2.7d). Collectively, these 
results indicate that SADS formation involves higher-order unfolding of satellite 
chromatin that does not require changes in canonical histone marks associated with 
condensed heterochromatin (H3K9Me3 and H3K27Me3) or decondensed euchromatin 
(H3K4Me3). 
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We also considered whether loss of DNA methylation could trigger SADS formation. 
Interestingly, hypomethylation of satellite DNA is prevalent in most cancer samples 
(Ehrlich, 2009), yet the 13 different cancer samples (cell lines and tumors) examined here 
did not exhibit SADS (with the exception of the senescent benign PIN tissue). 
Surprisingly, we noted that 5-azacytidine (5-AzaC) induced SADS in U20S cancer cells 
after several days of treatment (Figure 2.7e-g). However, these cells no longer cycled, 
presumably because 5-AzaC is known to induce senescence in normal and cancer cells 
through activation of the p16/INK4a promoter (which is often hypermethlyated in cancer) 
(Fang et al., 2004; Schnekenburger et al., 2011). To validate the interpretation that SADS 
formation after 5-AzaC treatment was a result of senescence, rather than a direct result of 
DNA hypomethylation, we examined untreated U2OS cells by a DNA methylation-
sensitive Southern blot that confirmed that untreated U2OS sat II at 1q12 was 
hypomethylated (Figure 2.7h). In contrast, cycling Tig1 fibroblasts had methylated 
satellites as expected (and results suggest little or no change to satellite methylation upon 
senescence; Figure 2.7h and Figure 2.S5d). Further evidence that DNA demethylation 
does not cause SADS came from examination of α-sat and sat II 1q12 in fibroblasts from 
a patient with immunodeficiency, centromeric instability, and facial anomalies (ICF) 
syndrome (Figure 2.S5a,b), a disease characterized by a lack of DNA methylation on 
1q12 caused by a mutation in DNA methytransferase3b (Ehrlich et al., 2008). 
Measurement of sat II DNA 1q12 signals in interphase nuclei showed at most a very 
slight increase and was similar to normal fibroblasts or untreated U2OS cells (Figure 
2.7e-g; and Figure 2.S5b,c). Similarly, the α-sat signals did not show significant 
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distension (Figure 2.S5a). Collectively, these results indicate that the striking unfolding 
of satellite heterochromatin within nuclei of noncycling cells is tightly linked to cell 
senescence and is not triggered by DNA hypomethylation. 
The magnitude of satellite DNA distension described here suggests that senescence likely 
involves changes to nuclear structural proteins that play a role in higher-order folding of 
the chromatin fiber. In this context, it is significant that we show a prevalence of SADS 
in HGPS cells (Figure 2.5), considering that defects in lamina have been shown to have 
an impact in the nuclear organization of centromeric satellites (Taimen et al., 2009), that 
lamina-associated domains are enriched in pericentric satellite DNA (Guelen et al., 
2008), and that SADS frequently extend along the nuclear periphery or stretch from 
central regions all the way to the lamina (e.g., Figures 2.1b, 2.6b, and 2.S5c). Recent 
work also shows marked decreases in LaminB1 levels in both HGPS and normal cell 
senescence (Freund et al., 2012; Shimi et al., 2011). Consequently, we performed α-sat 
DNA FISH and antibody staining to LaminB1 in mid passage WI-38 fibroblasts and 
found that 95% of cells with normal LaminB1 levels had condensed satellites (Figure 
2.7i,k). In contrast, in cells with obviously depleted LaminB1 staining, 73% had clearly 
distended satellites (Figure 2.7j,k; and Figure 2.S2c,d). As further considered in the 
Discussion, this suggests that changes in LaminB1 and potentially other nuclear structural 
proteins may contribute to higher-order unraveling of satellite DNA during senescence. 
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Discussion 
Epigenetic changes to chromatin are thought key to senescence and have received 
substantial attention; however, this study demonstrates a prominent, genome-wide 
chromatin change that has eluded discovery and runs counter to expectations that 
senescence is marked primarily by gain of large blocks of heterochromatin. We reveal 
that large-scale distension or “unraveling” of centric and pericentric satellite 
heterochromatin is a distinguishing mark of senescent cells that occurs in all senescence 
models studied here, with both high sensitivity and specificity. Furthermore, this 
distension occurs early in the senescence process and, unlike SAHF formation, is not 
exclusive to either the p16 or p21 senescence pathways. 
Although SADS occurs earlier and more consistently than SAHF formation, that both 
occur in the same senescent nuclei resolves the seemingly incompatible or paradoxical 
findings regarding gain versus loss of heterochromatin marks in senescent and aged cells 
(Funayama et al., 2006; Kosar et al., 2011; Kreiling et al., 2011; Narita et al., 2006; 
Scaffidi and Misteli, 2006). Our findings clearly show that loss of constitutive 
heterochromatin and gain of facultative heterochromatin occurs in the same nucleus. 
Although bright accumulations of many heterochromatin marks, such as H3K9me3 or 
HP1γ, become prominent in senescent cells, the whole nucleus does not gain these 
heterochromatin marks; rather, senescence is characterized by redistribution of condensed 
and decondensed genomic regions. 
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A UnifyingEpigenetic Feature of all Senescence Models Examined Including Mouse 
and HGPS 
An important point demonstrated here is that SADS occurs during permanent cell cycle 
withdrawal for all of many different cell types and methods examined to induce cell 
senescence. Human cells that lack SAHF (BJ fibroblasts) still form SADS but, more 
importantly, SADS bridges what has been a major gap between mouse and human cell 
senescence: both the major and minor satellites distend with threadlike extensions in 
senescent MEFs. This clarifies our previous observation that the chromocenters of Dicer-
depleted MEFs, which senesce prematurely, lost their round compact shape and appeared 
to connect and coalesce (Mudhasani et al., 2008). Additionally, we observed distended 
satellite heterochromatin in senescent cells within PIN cancer tissues, which is significant 
because other heterochromatin changes (SAHF) have not been observed in vivo (Kreiling 
et al., 2011). 
The importance of SADS providing a unifying theme of senescent cells is especially 
evident in relation to the debate regarding HGPS. Interestingly, HGPS cells do not 
exhibit increases in repressive marks typical of normal senescent fibroblasts; rather they 
show depletion of repressive factors (Scaffidi and Misteli, 2005; Shumaker et al., 2006). 
Thus there has been a lingering question as to whether chromatin changes in HGPS cells 
reflect mechanisms of cell cycle arrest that are fundamentally distinct from that of normal 
cell senescence. Importantly, early passage fibroblasts from two young HGPS patients 
undergoing proliferative arrest showed a high rate of SADS. Therefore, this marked 
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distension of satellites constitutes a more universal epigenetic program that underlies the 
biology of both HGPS and normal cell senescence. 
Integration of SADS into the Senescence Process: A Model 
Figure 2.8a provides an overview of SADS formation relative to several changes 
characteristic of senescent cells. Multiple points of evidence demonstrate that unraveling 
of compact satellite DNA is a relatively early step, and the rapid nature with which SADS 
occurs contrasts sharply with the broader changes to chromatin seen by FAIRE analysis 
3–4 months after entry into senescence (De Cecco et al., 2013). For example, BrdU 
labeling of cultures nearing senescence showed satellite distension present in cells within 
48 h of the last S phase. SADS are often evident before SAHF formation, but never vice 
versa, and similarly, SADS can be observed before nuclear enlargement. As previously 
reported (Herbig et al., 2004) and indicated by results here, early in senescence cells 
often express either p21 or p16, but not both, but we see SADS irrespective of which 
pathway may trigger senescence. SADS could also be seen in cells that were not yet 
depleted for histone H1, which is consistent with other evidence that loss of H1 is a late 
event (Funayama et al., 2006). Additionally, many nuclei containing SADS had not 
redistributed heterochromatin marks (H3K9Me3 and HP1γ) onto SAHF. Hence, our 
model conveys that satellite DNA distension occurs before and irrespective of a more 
global redistribution of facultative heterochromatin. 
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SADS is Large-scale Chromatin Unfolding Facilitated by Nuclear Structural 
Proteins Rather than Histone Modifications 
We have referred to the changes in satellite packaging reported here, and modeled in 
Figure 2.8b, as distension rather than decondensation to emphasize that the change in 
packaging is on a different scale then the decondensation that has been widely studied in 
the control of gene expression. To our knowledge, such a marked extension of chromatin 
in an interphase nucleus is relatively unique in biology and may be unprecedented. That a 
single centromeric α-sat was often as long as 5 µm (Figure 2.6) suggests that these α-sat 
blocks (ranging from ∼0.5 to 3 Mb) exhibit significant decompaction ∼5× below the 
level of condensed chromatin and lower than levels seen in a large genic locus (Lawrence 
et al., 1990). This clearly cytological scale distension, coupled with the surprising finding 
that the DNA is still packaged in nucleosomes that retain three canonical histone marks 
(Figure 2.7d), leads us to propose that SADS involves changes of higher-order chromatin 
loops, such as release of satellite DNA from scaffolding and other chromosomal 
structural proteins, rather than modifications of core histones. 
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Figure 2.8 Satellite Distension in Relation to Other Events in the Cell Senescence 
Process. (A) In nuclei of cycling cells, the peri/centromeric satellite DNA signals are 
tightly compacted, but dramatically distend in senescent cells. This occurs before and 
irrespective of the later formation of SAHF, and in some cells within 48 h of the last S 
phase. SADS is seen in essentially all noncycling cells and occurs in cells that first up-
regulate either the p21 or p16 pathway. In late stage senescence, both pathways are up-
regulated, and the p16 pathway promotes formation of SAHF. During this process there 
is a reorganization of several heterochromatin factors as seen by immunofluorescence 
including H3K9Me3 and HP1γ, whereas H1 levels uniformly decrease with the formation 
of SAHF. Whereas nuclear diameter increases progressively and is most pronounced in 
cells with SAHF, SADS are seen in some cells before nuclear enlargement. The nuclear 
lamina protein (LaminB1) may play a role in the higher-order folding of the DNA as it is 
diminished in most cells before SADS form. (B) Sat DNA in cycling cells is tightly 
packaged and this packaging is lost during senescence as the DNA distends. Because 
three canonical histone modifications remain unchanged during senescence the difference 
in DNA packaging may be attributed to changes in higher-order folding. 
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Given that HGPS is caused by mutations in LaminA/C and is characterized by higher 
levels of SADS, and that LaminB1 is depleted in HGPS and senescent normal fibroblasts, 
an important possibility is that changes to these scaffold proteins could play a role in 
satellite distension (Freund et al., 2012; Shimi et al., 2011). Although our evidence 
indicates that cells with SADS do not always have low LaminB1 staining, SADS did not 
appear to occur in cells that have high LaminB1 staining (Figure 2.8a, model). Therefore, 
LaminB1 may be one of several proteins that anchor satellite heterochromatin in nuclei 
and its loss may contribute to increased destabilization of satellite architecture and 
subsequent higher-order unfolding of DNA. 
Potential Implications of SADS for Cell Cycle Withdrawal 
This discovery raises the possibility that the early unraveling of satellite heterochromatin 
could contribute to permanent cell cycle withdrawal. In this context, it is interesting to 
note that the cell cycle regulator Rb has been reported to interact with the nuclear lamina 
and play a role in the stabilization of satellite heterochromatin (Dorner et al., 2007; 
Gonzalo and Blasco, 2005; Marji et al., 2010). In addition, various other components of 
the interphase centromere/kinetochore could be impacted; for example, CENP-F, which 
interacts with Rb and blocks cells at the G1–S transition (Du et al., 2010), or CENP-G, 
which associates with α-sat throughout the cell cycle and may interact with the nuclear 
matrix (He et al., 1998). 
Hence, the discovery of SADS provides the field with a prominent, early, and consistent 
marker of senescence, and is likely to spark new avenues of research into how unraveling 
73 
 
of interphase centromeres arises. SADS also helps to resolve a paradox between the loss 
of heterochromatin reported within some aging and senescence models and the gain of 
heterochromatin reported in others by showing that all cell types studied here consistently 
lose higher-order folding in satellite DNA. Finally, the magnitude of centromeric 
heterochromatin distension revealed here opens new avenues of inquiry into higher-order 
chromatin packaging, as well as its relationship to cell senescence. 
Materials and Methods 
Cell Culture 
Lung fibroblasts including Tig1, WI-38, and IMR-90 (Coriell) as well as ICF cells 
(GM08747; Coriell) were grown in MEM containing 15% FBS. LF1 and BJ fibroblasts, 
LF1 p21 knockouts, and HGPS cell lines (The Progeria Research Foundation) were 
grown in DMEM containing 15% FBS. MEFs (a gift from D. Carone, University of 
Massachusetts Medical School, Worcester, MA) and neoplastic cancer lines (PC3, 
HELA, and U2OS; American Type Culture Collection) were grown in DMEM with 10% 
FBS. 48R human mammary epithelial cells (from normal female breast tissues) were 
maintained in mammary epithelial cell growth medium. Cells were passaged 1:2 when 
cultures reached confluency. Cultures were defined as senescent when they failed to 
reach confluency 10 days after a 1:2 split. Oxidative stress was induced by treating early 
passage confluent Tig1 fibroblasts with 250 µM H2O2 for 2 hours. The cells were allowed 
to recover for 2 days before they were replated on coverslips and fixed after 6 d. 
SMURF2-induced senescent cells (LF1 and BJ fibroblasts) were transfected and selected 
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before being replated onto coverslips and fixed either 7 or 10 days after transfection 
(Zhang and Cohen, 2004). For Ras-induced senescence, Tig1 cells were infected with 
ocogenic ras or control retrovirus containing a puro selection marker overnight, allowed 
to recover for 24 hr, selected for 3 days, and allowed to recover for 3 days before being 
plated on coverslips and fixed the following day. 
Cell and Tissue Preparation for in situ Hybridization or Immunoflourescence 
Cells were extracted in CSK buffer with 0.5% Triton X-100 for 3–5 min and fixed in 4% 
PFA for 10 min (Johnson et al., 1991a). Cells used for p16, p21, and LaminB1 staining 
were fixed before Triton X-100 extraction. SADS were observed independent of fixation 
technique. Prepared cells were stored in 70% ethanol until use. Tissues were acquired 
from the University of Massachusetts Cancer Center Tissue Bank and fixed in the same 
manner as the cells. 
In situ DNA and RNA Hybridization 
For DNA hybridizations, cells were denatured for 2 min at 75°C and then hybridized with 
biotin or direct labeled oligos (Bentley Lawrence et al., 1988). Oligos were hybridized in 
15% formamide. The Chr. 21 BAC containing the DYRK1A gene, the Chr. 17–specific 
α-sat, and the satellite II 1q12 probes were nick translated and hybridized in 50% 
formamide (Johnson et al., 1991b). In addition, some senescent cells were denatured for 
2–6 min to increase signal intensity and hybridization efficiency. Tissues were denatured 
for 10–15 min. Oligo sequences were α-sat (FITC direct label, 5′-
CTTTTGATAGAGCAGTTTTGAAACACTCTTTTTGTAGAATCTGCAAGTGGATA
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TTTGG-3′), sat II (LNA, biotin, 5′-ATTCCATTCAGATTCCATTCGATC-3′), and 
mouse minor satellite (equal parts biotin labeled, 5′-
GAACAGTGTATATCAATGAGTTAC-3′ and 5′-
CCACACTGTAGAACATATTAGATG-3′). 
Immunofluorescence and Cell Staining 
Cells were incubated with antibodies at 1:250 dilution in PBS 1% BSA at 37°C for 1 h. 
Slides were rinsed in PBS, PBS with 0.01% Triton X-100, and PBS again for 10 min 
each before detection. Antibodies included p16 (Abcam), p21 (Santa Cruz 
Biotechnology, Inc.), CENP-A (Abcam), CENP-B (Santa Cruz Biotechnology, Inc.), 
HP1γ (EMD Millipore), H3K9Me3 (EMD Millipore), LaminB1 (Santa Cruz 
Biotechnology, Inc.), and H1 (a gift from M. Bustin, Texas Woman’s University, Denton, 
TX). In cells with both antibodies and in situ hybridizations to α-sat DNA, the DNA 
hybridization was performed first, followed by antibody staining. Slides were stained 
with DAPI for 30 s and mounted with Vectashield media. 
BrdU labeling and in situ hybridization was performed on nonconfluent Tig1 fibroblasts 
using 30 µM BrdU. They were extracted, fixed, denatured, and hybridized with an α-sat 
probe (as described in “In situ DNA and RNA hybridization”) and incubated with a BrdU 
antibody (Partec) at a 1:200 dilution and washed before detection as described earlier. 
Finally, senescence-specific β-gal staining was performed according to(Dimri et al., 
1995). 
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Image Analysis 
The threadlike satellite sequences may be hard to see in print but were unmistakable 
through the microscope. As such, sections of images were often magnified for reader 
convenience and we encourage the viewing of our images in a digital format. We 
performed the imaging using an Axiovert 200 or an Axiophot microscope (Carl Zeiss) 
equipped with a 100× PlanApo objective (NA 1.4) and Chroma 83000 multi-bandpass 
dichroic and emission filter sets, set up in a wheel to prevent optical shift. Images were 
captured with a camera (Orca-ER) or a 200 series CCD camera (Photometrics) using 
AxioVison 4.8 software (Carl Zeiss). Z stacks were a compilation of 15–30 images taken 
at an interval of 0.1 to 0.25 µm, and subsequent image deconvolution was done using 
AxioVision 3D software theoretical PSF (Carl Zeiss) and either the nearest neighbor or 
fast iterative algorithm. Distances were measured using either Axiovision 4.8 or 
MetaMorph 4.6 software. Most experiments were performed a minimum of three times 
and scored by at least two independent investigators. All findings were easily visible by 
eye through the microscope (unless otherwise noted). 
Analysis of ChIP-seq Data 
Publicly available ChIP-seq data (Chandra et al., 2012) were collected and analyzed. 
ChIP-seq and input sequence reads were mapped to the GRCh37.p11 (hg19) reference 
genome using bowtie (v. 0.2.8)(Langmead et al., 2009) and read densities and regions of 
statistically significant enrichment (“peaks”) were determined using model-based 
analysis of ChIP-Seq (v. 1.4.1)(Zhang et al., 2008) using default settings. Tandem repeat 
sequences in hg19 were annotated using RepeatMasker (Smit, 1996-2010). For the 
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purposes of visualization, read densities were normalized by scaling such that mean read 
densities for common ChIP-seq peaks were equal to one another, similar to the approach 
of MAnorm (Shao et al., 2012). The RepeatMasker α-sat sequences were divided into 
100-bp fragments over which the mean normalized read densities were compared. 
Western Blots 
35 µg of each lysate was run over 15% SDS-PAGE and electroblotted onto 0.2 µm of 
immunoblot PVDF (Bio-Rad Laboratories) for 90 min at 350 mA, 4°C. Western analysis 
was performed in PBS and 0.1% Tween 20, with or without 5% nonfat dry milk powder 
as necessary. Antibody concentrations and incubations are as follows: 1:500 rabbit α-p16 
overnight at 4°C, 1:1,000 mouse α-p21 overnight at 4°C, 1:8,000 mouse α-tubulin 1 h at 
room temp, 1:1,000 HRP goat α-mouse (Thermo Fisher Scientific) 1 h at room temp, and 
1:1,000 HRP α-rabbit (GE Healthcare) 2 h at room temperature. 
Methylation-Sensitive Southern Blots 
Cells were pelleted and resuspended in 50 µl of lysis buffer (400 mM Tris-Cl, 60 mM 
EDTA, 150 mM NaCl, and 1% SDS), incubated with RNase for 30 min at 37°C, treated 
with ProK overnight at 50°C, and then subjected to a phenol chloroform extraction. 10 µg 
of DNA was then digested overnight with HpaII, MspI, or BstB1 (New England Biolabs, 
Inc.) and run on a 1% agarose gel. DNA was transferred overnight to a nylon membrane 
using capillary action and fixed with 0.4 M NaOH. DNA of interest was detected using 
the Bright Star Biodetect kit (Ambion) with a nick-translated biotin-labeled probe for sat 
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II 1q12 (prepared as described in “In situ DNA and RNA hybridization”). The membrane 
was imaged with Chemidoc (Bio-Rad Laboratories). 
Supplemental and Online Material 
Videos 1 and 2 show a moving 3D rendering and a movie of each slice in the Z stack 
of Figure 2.1a Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201306073/DC1. Additional data are available in 
the JCB DataViewer at http://dx.doi.org/10.1083/jcb.201306073.dv. 
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Figure 2.S1 SADS is a Property Common to Many Different Senescence Models and 
Pathways. (A and B) β-Gal staining shows that LF1 fibroblasts infected with SMURF2 
(B) are senescent, whereas cells infected with a control (A) are not. (C) Percentage of BJ 
and LF1 cells with SAHF plotted as an independent variable (n = 200, representative of 
one of three repeats). (D and E) p21 staining (red) is not present in LF1 p21 knockout 
senescent cells as judged by the presence of SAHF (DAPI; negative antibody control). 
(F–H) SADS form in human breast epithelial p16 knockout cells as judged by distended 
α-sat (green) and sat II (red; G) and blown up in H, while others have tight satellite 
signals indicative of cycling cells (F). (I) Western blot demonstrating that senescentLF1 
p21-/- and 48R mammary epithelial cells lack p21 and p16 expression, respectively.  
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Figure 2.S1 SADS is a Property Common to Manny Different Senescence Models 
and Pathways  
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Figure 2.S2 CENP-A and -B Distribution on Individual Centromeres of Senescent 
Cells and LaminB1 Levels in Cycling and Senescent Cells. (A) CENP-A and –B 
staining in a senescent cell (top), cycling cell (middle), and late senescent cell with 
prominent SAHF (bottom). CENP-B staining distends in senescent cells (red), whereas 
CENP-A (green) does not. CENP-A staining levels on individual centromeres showed 
some variability, but were generally brighter in cycling and early senescent cells (middle 
and top) than late senescent cells (bottom). This is quantified by a line scan (expanded 
regions in A) shown in B where signal intensities (CENP-A, green; CENP-B, red) are 
plotted along the length of the drawn line. (C and D) LaminB1 (red) levels are not always 
lower in cells with distended satellites (green).   
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Figure 2.S2 CENP-A and -B Distribution on Individual Centromeres of Senescent 
Cells and LaminB1 Levels in Cycling and Senescent Cells 
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Figure 2.S3 H3K9Me3 Distribution Changes and H1 Levels Decrease with 
Senescence. H3K9Me3 (red) has a general nucleoplasmic signal in cycling (A, top) and 
senescent cells (B, middle). H3K9Me3 overlaps SAHF (DAPI) in late senescent cells (C, 
right). (D–F) Although both cells have distended α-sat (green), the top cell lacks SAHF 
(DAPI) and has robust H1 staining (red; 64%) and the bottom cell has SAHF and 
severely diminished H1 staining.   
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Figure 2.S3 H3K9Me3 Distribution Changes and H1 Levels Decrease with 
Senescence 
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Figure 2.S4 HP1γ Redistributes from Satellites to SAHF as Cells Undergo 
Senescence. (A and B) HP1γ (green) and CENP-B (red) colocalize in cycling cells with 
condensed centromeres (A) but not in cells with distended centromeres (B) in which 
HP1γ gathers at PML bodies and no longer colocalizes with the centromeres. The 
arrowhead indicates a particularly decondensed centromere (magnified in the inset). The 
merged image in B combines two different planes. (C) In late stage senescent cells, HP1γ 
colocalizes with SAHF (DAPI; gray inset) and centromeres are often found in areas that 
lack intense HP1γ staining (magnified on right).   
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Figure 2.S4 HP1γ Redistributes from Satellites to SAHF as Cells Undergo 
Senescence. 
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Figure 2.S5 Effects of Hypomethylation on Satellite Distension. (A and B) Cycling 
ICF cells do not display SADS or marked distension of nuclear α-sat (A) or sat II (B) on 
1q12. (C) Appearance of sat II 1q12 (green) signals that distend in senescent Tig1 
fibroblasts (bottom right), but are compact in cycling cells (top left). The inset shows a 
separate senescent cell with 1q12 signal that extends to the nuclear periphery. (D) A 
DNA methylation-sensitive Southern blot with ICF, senescent Tig1, and cycling Tig1 
cells digested by HpaII (H) or MspI (M) and detected with a probe for sat II 1q12 
sequences. The arrow points to a band size that is lacking in some of the methylation-
sensitive HpaII lanes, indicating that the 1q12 region is methylated in the corresponding 
cell types. It is important to note that 1q12 remains methylated in both cycling and 
senescent cells.   
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Figure 2.S5 Effects of Hypomethylation on Satellite Distension. 
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Chapter III: Unfolding the Story of Chromatin Organization 
in Senescent Cells 
Senescence and Heterochromatin: A Background 
Senescence, first reported in cultured cells by Leonard Hayflick, is the irreversible exit of 
a viable cell from the cell cycle (Hayflick, 1965). This exit can be triggered by a variety 
of mechanisms including shortened telomeres, oxidative stress, and DNA damage and 
results in cells that persist and remain metabolically active indefinitely. In vivo, 
senescence functions to prevent cancer and the formation of malignant tumors by 
stopping damaged or precancerous cells from dividing while also playing a role in the 
development of age-related disorders including osteoporosis and Alzheimer’s disease 
(Campisi, 2013; van Deursen, 2014). In addition to depleting the proliferative cell 
population, senescent cells can secrete a characteristic profile of cytokines and other 
soluble factors that influence the behavior of surrounding cells known as the Senescence 
Associated Secretory Phenotype (SASP) (Campisi, 2013). Senescent cells also undergo 
dramatic changes to DNA organization and chromatin packaging (Narita et al., 2003; 
Sadaie et al., 2013; Swanson et al., 2013), processes that are thought to be essential for 
the maintenance of the senescent state and will be our focus here. 
DNA is organized into two cytologically and molecularly distinct compartments: 
structurally open euchromatin which is more actively transcribed and predominantly 
located in the interior of the mammalian nucleus and transcriptionally repressed compact 
heterochromatin often enriched at the nuclear and nucleolar periphery. Heterochromatin 
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is further classified into two subtypes. The first is constitutive heterochromatin, defined 
as heterochromatin in all cell types and conditions, which includes tandem repetitive 
satellite repeats that form the structural domains at centromeres. The second is facultative 
heterochromatin which, despite being structurally similar to constitutive heterochromatin, 
consists of genes and genomic regions that are repressed in a developmental and cell-type 
specific manner, including the inactive X chromosome (Trojer and Reinberg, 2007). In 
eukaryotic cells, several levels of chromatin packaging are formed which not only 
accomplish compaction, but regulate gene expression patterns required for cellular 
function. The first level of compaction entails the wrapping of 147 base pairs of naked 
DNA around a core histone complex forming repeating nucleosomal units (Kornberg, 
1974). This gives rise to the 10 nm fiber (Olins and Olins, 1974; Woodcock et al., 1976), 
which is further organized into higher-order and often more compact structures.  
Currently, one avenue of research in the field of chromatin biology is focused on 
deciphering the mechanisms facilitating the higher-order organization of DNA from the 
10 nm fiber into the 10,000 fold more compact metaphase chromosome. We propose that 
insights into higher-order chromatin organization can be gleaned from the sweeping 
changes that accompany senescence, in particular the formation of Senescence 
Associated Heterochromatin Foci (SAHFs) and Senescence Associated Distension of 
Satellites (SADS). Here, we review what is known about these structures, what these 
changes can tell us about higher-order chromatin organization, and present preliminary 
observations that suggest new insights on these topics. 
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Heterochromatin Reorganization during Senescence: SAHFs 
SAHFs are DNA dense heterochromatic regions which form at numerous sites 
throughout the nucleus of many senescent human cell types (Narita et al., 2003; Swanson 
et al., 2013). Prior efforts have also demonstrated that each heterochromatic focus 
corresponds to one tightly compact chromosome territory marked by heterochromatin 
proteins and histone modifications associated with gene silencing, including HP1, 
H3K9Me3, H4 hypoacetylation, and MacroH2A (Adams, 2007; Funayama et al., 2006; 
Narita et al., 2003; Zhang et al., 2005). In addition, work of others and our own 
observations have shown that, when stained with DAPI, SAHFs appear similar in size 
and shape to the inactive X chromosome found in female cells (Barr body) (Fig 3.1) 
(Funayama et al., 2006; Narita et al., 2003), and contain several markers found on the 
inactive X chromosome (Chadwick and Willard, 2003; Narita et al., 2006; Zhang et al., 
2005). Similar to the Barr body, it has also been shown that the satellite sequences 
position at the periphery of SAHFs (Clemson et al., 2006; Funayama et al., 2006; 
Swanson et al., 2013). While genes on the inactive X chromosome, independent of their 
silencing state, are located on the periphery or outside of the Barr body, repeat ‘junk’ 
DNA is found in the interior (Chaumeil et al., 2006; Clemson et al., 2006). Furthermore, 
it is currently unknown if this organizational pattern repeats in SAHFs, due to a lack of 
rigorous studies on gene location in these bodies, but preliminary examinations have 
suggested that SAHFs suppress expression of the cell cycle genes sequestered within 
(Narita et al., 2003; Zhang et al., 2007a).  
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In addition to not knowing the pattern of genic organization or even the specific 
sequences that are reorganized into SAHFs, the precise role of SAHFs in senescence 
remains poorly understood. For example, SAHF formation occurs relatively late during 
the onset of senescence, does not form in every senescent cell or cell type (e.g. not 
observed in murine or HGPS cells), and they have not been observed in vivo (Kennedy et 
al., 2010; Kosar et al., 2011; Kreiling et al., 2011; Narita et al., 2003; Swanson et al., 
2013). It has also been shown that SAHF formation can occur in response to the 
expression of oncogenic RAS in a senescence-independent manner (Di Micco et al., 
2011). SAHF formation is thus an interesting model of chromatin repackaging that 
represents a dramatic gain of higher-order heterochromatin. However, its failure to occur 
early and consistently in response to senescence brings into question the importance of 
SAHFs in the senescence process.    
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Figure 3.1: SAHFs Appear Similar in Size and Shape to the Barr Body. a) The XIST 
RNA signal (red) shows the location of the Barr body (DNA DAPI, blue) in a cycling 
Tig1 fibroblast. b) The DNA DAPI staining from (a) is shown in grey scale to highlight 
the size and shape of the Barr body. c-d) DNA DAPI staining (grey) of two senescent 
cells with SAHFs, note the heterochromatin foci in these cells are similar in size and 
shape to the Barr body from (b). e) A SAHF positive senescent cells with XIST painting 
the Barr body.  
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Figure 3.1: SAHFs Appear Similar in Size and Shape to the Barr Body   
96 
 
Loss of “Constitutive” Satellite Heterochromatin in Senescence: SADS 
In contrast to SAHF formation, there are global chromatin changes that occur during 
senescence that are more consistent with loss of heterochromatin. For example, it has 
been shown that levels of the chromatin remodeling protein HMGA, which is typically 
associated with open regions of DNA, are increased in senescent cells, whereas the 
nucleosome linker histone, H1, is lost (Funayama et al., 2006; Narita et al., 2006). 
Furthermore, genome-wide methylation patterns in senescent cells resemble those seen in 
cancer cells (Cruickshanks et al., 2013), which are thought to be more open and less 
heterochromatic (Carone and Lawrence, 2013; Pageau et al., 2007).  
A more recent discovery supporting a loss of heterochromatin during senescence was our 
observation that all of the normally compact α-satellite and satellite II sequences at each 
peri/centromere dramatically distend in the senescence process, whereas other genomic 
loci examined (e.g. telomeres and a randomly selected region on chromosome 21) do not. 
This phenomenon, which we termed SADS (Senescence-Associated Distension of 
Satellites), was first observed in a subset of Tig-1 fibroblasts hybridized with probes to α-
satellite or satellite II repeats (Figure 3.2a) (Swanson et al., 2013). Upon further 
characterization, this distension was shown to be both specific and extremely consistent 
for senescent cells based not only on SA-β-galactosidase staining, but also on BrdU 
analysis of single cells for both replication and the presence of SADS (Swanson et al., 
2013). SADS were also observed in all forms of senescence induction examined, 
including by the Ras oncogene, oxidative stress, the upregulation of the ubiquitin ligase 
SMURF2, and replicative senescence (Swanson et al., 2013). Unlike SAHFs, SADS were 
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seen in all senescent human cell lines, in murine cells (MEFs), and in vivo in tissue 
sections of a benign, human Prostatic Intraepithelial Neoplasia (PIN) (Swanson et al., 
2013). These data allow us to conclude that SADS is a consistent, potentially ubiquitous 
new marker of senescence in single cells, but it also raises the intriguing possibility that 
the reorganization of centromeric chromatin may be an integral part of the senescence 
process.  
While the specific mechanisms that underlie SADS formation remain to be determined, 
this radical departure from “constitutive” condensed structures of centromere-associated 
heterochromatin may serve to strengthen the permanence of the senescent state by 
blocking cell division. Consistent with this functional role, SADS formation occurs early 
in senescence (beginning within 48 hours of the final cell cycle) and prior to SAHF 
formation, which occurs later (Funayama et al., 2006; Swanson et al., 2013). We also 
showed that CENP-B remains bound throughout the distended α-satellite repeats whereas 
the centromere specific histone H3 variant, CENP-A, is not visibly distended but 
decreases in senescent cells (Maehara et al., 2010; Swanson et al., 2013). Whether other 
centromere-associated proteins are impacted by SADS formation and if the distension 
directly contributes to blocking the continuation of the cell cycle by disrupting structural 
integrity of centromeres remains to be addressed.  
SADS and the Unraveling of Higher-Order Chromatin Folding 
The formation of SADS also represents a potentially unprecedented higher-order 
unfolding of the chromatin fiber in a mammalian cell nucleus on a scale visible by light 
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microscopy. The evidence supporting that this is a “higher-order unfolding” rather than a 
small-scale DNA condensation event (as occurs in transcriptional activation) is two-fold. 
First, the compaction ratio of distended α-satellite DNA was found to be a minimum of 
five times less than α-satellite regions in cycling cells. In fact, the compaction ratio of 
SADS approached previously measured levels for genic DNA (Lawrence et al., 1990). 
The loss of compaction, however, did not correlate with increased expression of satellite 
RNA, and is distinct in both scale and function from the “opening” of chromatin linked to 
transcription. While increases in satellite RNA expression have been reported 6-8 weeks 
after the induction of senescence (De Cecco et al., 2013), we examined cells within ten 
days, which could account for the contrasting results. Second, we noted that both the 
DNA methylation pattern and the enrichment of several canonical heterochromatin 
modifications (H3K9Me3, H3K27Me3, and to a slightly lesser extent H3K4Me3) in α-
satellite regions did not change during senescence despite the dramatic repackaging 
(Swanson et al., 2013). This leads us to speculate that SADS likely represent a change in 
the higher-order packaging of heterochromatin, which may be mediated by changes to 
structural proteins such as lamins, as discussed below.  
Changes in DNA Organization Occur while Many Histone Marks 
Remain 
Given the clearly apparent concentration of histone modifications, especially H3K9Me3, 
in SAHFs by light microscopy, it might be expected that the epigenetic landscape of 
histone modifications on genomic sequences would change dramatically. Surprisingly, 
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ChiP-Seq analysis found very little change in the distribution of several heterochromatin 
marks during senescence (Chandra et al., 2012; Swanson et al., 2013). This implies that 
these marks are not redistributed throughout the genomic DNA during senescence as 
might be expected; rather DNA containing these heterochromatin modifications appears 
to aggregate within the nucleus to form heterochromatin bodies (SAHFs).    
This question remains open, however, because recent work contrasts with results based 
on the data from Chandra et al. Specifically, large scale changes to the chromatin 
landscape of both the H3K27Me3 and H3K4Me3 histone modifications have been 
observed, in which regions of these modifications in senescent cells are either increased 
to form mesas or decreased to form canyons (Shah et al., 2013). These results could relate 
to earlier microarray data showing that genes with differential expression in senescent 
cells group together in blocks along the length of the chromosome (Zhang et al., 2003b). 
We note, however, that in Shah et al. (Supplemental Figure 5) the percentage of the 
genome either gaining or losing each histone modification is small and spread over large 
continuous ranges, and western blot analysis for histone modifications shows no change 
in the overall level of these modifications during senescence (Funayama et al., 2006; 
Shah et al., 2013). It is therefore possible to speculate that small changes in histone 
modification levels across the genome teased out by Shah et al. to form the canyons and 
mesas within senescent cells went undetected by Chandra et al., who were examining the 
genome for the type of gross overall changes that might be expected to occur during 
SAHF formation. Hence, we suggest that both studies may be more compatible than it 
appears and that these findings, together, with the large-scale cytological dimensions of 
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chromatin unfolding inherent in SADS point to the likelihood that SADS formation 
involves changes to the higher-order packaging of the genome.    
The Nuclear Lamina and its role in Heterochromatin Organization 
during Senescence 
Lamin proteins are key structural components throughout the nucleus which together 
form the nuclear lamina underlying the nuclear envelope. Furthermore, these proteins 
have long been implicated in the organization of chromatin into higher-order structures 
(Butin-Israeli et al., 2012). Since lamins interact with the Retinoblastoma protein (Rb), a 
regulator of both senescence and heterochromatin, and LaminB1 levels decline 
dramatically during senescence (Dorner et al., 2007; Freund et al., 2012; Gonzalo et al., 
2005; Marji et al., 2010; Shimi et al., 2011), the nuclear lamina may be a key player in 
both SADS and SAHF formation. In fact, it was recently shown that SAHF formation is 
aided by a decrease in LaminB1 (Sadaie et al., 2013). This is noteworthy and leads us to 
suggest that in some SAHF positive cells the organization of heterochromatin is flipped 
inside out as the peripheral heterochromatin compartment found in cycling cells may be 
broken down and possibly reorganized into SAHFs (Figure 3.2 and 3.3). It has also been 
demonstrated that pericentric heterochromatin (satellite DNA) is enriched in Lamin-
Associated Domains (LADs) (Guelen et al., 2008) and that the disruption of the nuclear 
lamina can alter satellite organization (Taimen et al., 2009). While recent genome wide 
analysis of LaminB1 did not address its binding to satellite DNA specifically, it showed 
that during senescence, LaminB1 is depleted from regions enriched in H3K9Me3 (Sadaie 
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et al., 2013), a histone modification known to be enriched in satellite DNA (Mikkelsen et 
al., 2007; Rosenfeld et al., 2009). Interestingly, single cell analysis showed that LaminB1 
loss occurs before SADS formation in over half of the cells, indicating that LaminB1 
depletion may be one of the factors facilitating the repackaging of satellite DNA during 
senescence (Swanson et al., 2013). 
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Figure 3.2: Closer Inspection of Satellite Structure Reveals the Presence of DNA 
Organized into Domains. a-b) Cycling (a) and senescent (b) Tig-1 fibroblasts have 
dramatically different α-satellite (green) and satellite II (red) organization at the 
resolution of light microscopy. However, closer inspection of grey scale images reveals 
evidence of organization within each satellite signal, whereby senescent satellites are 
organized such that globular domains are linked together by threads of more distended 
DNA. c-d) Using a probe specific to chromosome 17 α-satellite sequence (green) the 
signal appears punctuate in a cycling cell (c) but distends so that individual domains or 
globules of still condensed DNA become more visible in senescent cells (d). e) Confocal 
(left) and super resolution STED images (right) of chromosome 17 α-satellite in a cycling 
cell. These images are shown below in gray scale to increase visibility of more condensed 
domains (yellow arrows). f) Shows three chromosome 17 peri/centromeric α-satellite 
signals (green) from two different cells. The confocal images are on the left and the super 
resolution image is on the right. The yellow arrows point to some of the easily visible 
domains that are linked together by threads of DNA.  
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Preliminary Insights from a Closer Inspection of Satellite Structure    
To further our understanding of the higher-order chromatin changes that occur during 
SADS formation we have recently begun using super resolution light microscopy 
(STED), which can resolve structures down to 30nm in size. While these observations are 
preliminary, results raise the possibility that in both cycling and senescent cells, 
Chromosome 17 α-satellite DNA may be organized into tightly compacted domains or 
“globules” spaced by linker regions (Figure 3.2). The spacing between the compact 
domains, however, appears different between the two cell types, such that in senescent 
cells globular domains become further apart rather than clustered into a compact 
conformation. We hypothesize that in cycling cells domains or globules may be held in 
close proximity by an unknown factor that facilitates the higher-order organization of 
each satellite. During the senescence process, these factors may be lost from satellites, 
allowing the DNA linking the globular domains to extend into more linear 
conformations. Interestingly, these conformations appear to resemble models of 
chromatin organization predicted by chromatin conformation analysis (Baù et al., 2011; 
Gibcus and Dekker, 2013; Rao et al., 2014). In these models, the genome is organized 
into Topological Associated Domains (TADs) that are divided into subdomains based on 
the distribution of architectural proteins, like cohesins, mediator, and CTCF, that work 
independently or in combination to facilitate genomic organization (Phillips-Cremins et 
al., 2013). Depending on the combination of architectural proteins present, the size of 
these subdomains varies between less than 100 kb to greater than 1 Mb, which is loosely 
in the range that we would predict based on our images and the average size of a block of 
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tandem α-satellite repeat (2-4 Mbs) (Choo, 1997). Hence the loss of architectural proteins 
may play a role in SADS formation, as cohesins are not recruited to pericentromeric 
DNA during senescence (Wang et al., 2011). Moreover, recent reports in Drosophila have 
also indicated that the loss of condensins, which play a role in higher-order chromosome 
compaction and organization, results in a 10 fold increase in chromosome length (Bauer 
et al., 2012). Hence, we speculate that the loss of architectural proteins mentioned above 
in combination with LaminB1 may play a role in SADS formation.  
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Figure 3.3: Underlying Chromatin Structure of Centromeres. a) Correlative light 
microscopy and electron spectroscopic imaging (ESI) of three representative cycling and 
senescent WI-38 cells. Cells were labeled with gold-conjugated CENP-B antibodies and 
prepared for ESI. CENP-B fluorescence (red) was overlayed onto the low magnification 
mass image (black and white) generating the correlative image. Higher magnification ESI 
micrographs were taken of the corresponding CENP-B-containing structure (white box, 
scale bar 0.5 µm). Approximate boundaries of the centromere are indicated by a dashed 
line. Arrowheads indicate gold particles. Arrows point to the heterochromatin at the edge 
of the nuclear envelope (periphery). A higher magnification image of the region marked 
by the dashed line is shown under the correlative image (Scale bar, 0.2µm). In all ESI 
images, chromatin is pseudo colored yellow and protein-based structures cyan. b) CENP-
B labeling (red) of cycling and senescent WI-38 cells. Scale bar, 5 µm. c) Average 
phosphorus density of the centromeric and surrounding chromatin, and heterochromatin 
at the periphery of the nuclear envelope of the images shown in (a). d) Average thickness 
of the peripheral heterochromatin of the images shown in (a). 
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To examine the underlying chromatin structure of satellite-containing chromatin at high 
molecular resolution, we performed a preliminary analysis of centromeres using electron 
spectroscopic imaging (ESI). ESI is a specialized form of energy-loss transmission 
electron microscopy that provides a direct and quantitative measurement of chromatin 
density (Bazett-Jones and Hendzel, 1999; Dellaire et al., 2004). For example, integrative 
phosphorus and nitrogen density analyses of ESI micrographs of senescent IMR90 cells 
revealed differences in chromatin compaction within SAHFs as well as between SAHFs 
and the surrounding chromatin (Chandra et al., 2012). Hence, we examined the 
underlying chromatin structure of satellite-containing heterochromatin by obtaining ESI 
micrographs from nuclei of cycling and senescent WI-38 fibroblasts labeled with gold-
conjugated CENP-B antibodies. As these images were obtained from 70 nm sections, we 
were unable to observe the chromatin fibers linking the compact domains. We were, 
however, able to observe the CENP-B-containing compact structures reminiscent of the 
globules seen in the STED analysis. The average chromatin density within the CENP-B-
defined domain and the region surrounding it was determined by measuring the 
phosphorus signal in the net phosphorus images (Figure 3.3a,c). The results affirm that 
the compaction level of the satellite-containing chromatin domains are similar in the two 
cell states; however, they are distinct from both the chromatin surrounding the 
centromeres and the compact heterochromatin at the edge of the nuclear envelope (Figure 
3.3a,c). This observation is consistent with our current hypothesis that the discrete 
satellite-containing structures seen in cycling cells are comprised of globules tightly 
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packed together that become more spaced out in senescent cells, giving rise to the 
distended patterns seen in SADS.  
We also observed that the chromatin surrounding centromeres in cycling and senescent 
cells is different. In senescent cells, non-centromeric chromatin that does not include the 
SAHFs appears as a mesh of loosely dispersed fibers, whereas the chromatin surrounding 
centromeres in cycling cells is more compact. Indeed, a preliminary analysis of the 
average integrative phosphorus density of this non-centromeric (surrounding) chromatin 
reflects this observation as it is greater in cycling cells (21.7) compared to senescent cells 
(11.4) (Figure 3.3a,c). It should also be noted that although the volume of a senescent 
nucleus is larger than that of a cycling cell, we did not observe a clear correlation 
between nuclear volume and average integrative phosphorus intensity values. We 
determined the fold change in chromatin compaction between cycling and senescent 
centromeres, surrounding chromatin, and peripheral heterochromatin to be 1.3, 1.9, and 
1.0, respectively. Since the fold change is domain specific, the dispersed chromatin 
surrounding centromeres in senescent nuclei may not solely be attributed to increased 
nuclear size, but rather to global changes in chromatin organization. Interestingly, in our 
preliminary examination, peri/centric heterochromatin often appeared less compact than 
peripheral heterochromatin in both cycling and senescent cells, suggesting that not all 
constitutive heterochromatin domains contain the most highly compact chromatin in the 
nucleus (Figure 3.3a,c). Finally, we observed that the thickness of the heterochromatin 
compartment at the nuclear periphery is reduced in the senescent cells examined here 
with an average thickness of 200 and 100 nm for cycling and senescent cells, respectively 
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(Figure 3.3a,d). Despite the thinning of peripheral heterochromatin, the chromatin 
compaction within this region did not appear to change as the average integrated 
phosphorus values are 53 in cycling and 50 in senescent cells (Figure 3.3a, c).  The loss 
of peripheral heterochromatin in senescent cells suggested here helps to reinforce the 
previously mentioned possibility that peripheral heterochromatin is relocating to the 
interior of senescent nuclei and this process could be facilitated, at least in part, by 
LaminB1 depletion. Taken together, these results illustrate numerous differences in 
chromatin organization between cycling and senescent cells that when coupled with 
advanced imaging techniques such as ESI provides a rich opportunity to reveal properties 
of higher order chromatin architecture. 
Conclusion 
Senescence is accompanied by a multitude of changes to the packaging of DNA 
including the loss of higher-order chromatin packaging during SADS formation, the 
reorganization of chromatin into SAHFs, and the breakdown of the nuclear lamina. Not 
only are these changes important to the biology of senescence and may help contribute to 
the permanence of the senescent state but they also provide a potential model to study 
higher-order chromatin packaging. Since the packaging and organization of DNA from 
the 10 nm fiber to the metaphase chromosome remains a mystery new ways to examine 
these questions are needed. As the preliminary images shown here help to illustrate the 
dramatic changes that occur to heterochromatin during senescence we suggest that they 
may provide a foundation to enable new insights into the organization of higher-order 
heterochromatin.  
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Chapter IV: Initial Investigation of Proliferation Defects in 
Cultured Down Syndrome Cells  
This chapter will explore if the proliferation defects observed in previous studies of 
Down syndrome are caused by increased levels of cell senescence and will be broken 
down into three parts. The first is a review of the literature that analyzes known cellular 
and clinical observations of Down syndrome with regards to cell senescence. The second 
part describes preliminary experimental results to address whether the proliferative 
defects of Down syndrome cells may be caused by increased levels of cell senescence, 
potentially due to increased levels of oxidative stress, and includes proposals for 
additional experimentation. Lastly, as part of this study we examined microarray data for 
expression profiling originally obtained to assay the effectiveness of silencing the extra 
21st chromosome in DS iPSCs (Jiang et al., 2013). While we did not find any differences 
indicative of increased levels of senescence in this data set, possibly because pluripotent 
cells are by definition self-renewing and therefore a challenging system to study cell 
senescence in, other gene expression differences between DS and functionally disomic 
iPSCs were analyzed.   
Synthesis of DS Literature With Regards to Cell Senescence 
Down syndrome (DS) is one of the most common genetic causes of intellectual disability 
affecting 1 in every 700 live births in the United States. This disorder, first characterized 
by John Langdon Down in 1866, is caused by an additional 21st chromosome resulting in 
the over-representation of approximately 500 genes (Down, 1866; Lejeune, 1959). While 
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it is still unknown and a subject of great debate as to how individual genes, or groups of 
genes, contribute to DS cell pathologies and phenotypes, what is known is that Down 
syndrome individuals have a characteristic appearance including, small heads and ears, 
flat face, cleft palms, and shortened stature. In addition, congenital heart defects are 
present in half of all cases and immune and endocrine, particularly thyroid, deficiencies 
are common. Furthermore, the intellectual disability in individuals with DS ranges from 
mild to severe, and they commonly display impaired cognitive and mental capabilities, as 
well as language and verbal deficiencies (Patterson, 2009; Zigman, 2013). 
During the mid-20th century nearly 50% of individuals with DS did not survive past the 
age of one and others often died at young ages. However, with modern medicine the life 
expectancy for DS has reached 60 years, but with increased life expectancy many 
premature aging phenotypes have emerged (Zigman, 2013). For example, it has been 
noted that half of DS patients in their fifties have osteoporosis (Steingass et al., 2011) and 
vision and hearing loss is also common at this age (Van Buggenhout et al., 1999). 
Another well documented aging phenotype affecting DS patients is dementia. While 
cases in individuals as young as 30 have been reported, the mean age of onset of 
Alzheimer’s disease (AD) in DS patients is 50, and by age 60, over three-quarters of the 
DS population suffers from it (Head et al., 2007). Interestingly, amyloid-β (Aβ) plaques 
which are strong indicators and a possible cause of AD, are prevalent in DS individuals in 
their 30s and in nearly all DS individuals by 40 years of age, often before clinical 
symptoms and AD diagnosis (Mann, 1989; Wisniewski, 1985). The increase in the 
production of Aβ peptide in DS individuals is thought to occur, in part, due to the 
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increased expression of the amyloid precursor protein (APP) encoded on chromosome 21 
(Hardy and Selkoe, 2002).  
In addition to a third copy of APP, AD phenotypes are thought to be accelerated by 
increased levels of oxidative stress in individuals with DS (Cenini et al., 2012; Jovanovic 
et al., 1998). However, oxidative stress is not just a problem exclusive to later in life, as 
increased levels of oxidative stress have been found in utero of DS fetuses and in young 
DS mouse models (Ishihara et al., 2009; Perluigi et al., 2011; Perrone et al., 2007; Slonim 
et al., 2009). One potential cause for this increase is dysfunction in DS mitochondria 
from an early age. In fact, DS mitochondria have lower levels of key electron transport 
chain complexes resulting in higher production of free radical ROS (Valenti et al., 2011). 
Increased levels of oxidative stress may also be caused by increased expression of SOD-
1, a chromosome 21 gene responsible for metabolizing free radicals into hydrogen 
peroxide (Anneren and Epstein, 1987; de Haan et al., 1996; Feaster et al., 1977; 
Gulesserian et al., 2001). These radicals when not reduced can disrupt cellular functions 
and cause increased levels of DNA damage and subsequent activation of the senescence 
response.  
Children with DS also have an increased risk to develop myeloproliferative disorders 
(Roy et al., 2009), which leads to 20-40 fold higher risk of Acute Myelogeous Leukemia 
and a remarkable 500 fold increase in Acute Megakaryoblastic Leukemia (Hasle et al., 
2000). While it has received less attention, a remarkable “benefit” to trisomy 21 is that 
individuals with DS have a striking resistance to developing most types of solid 
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malignant tumors (Henrik, 2001; Nizetic and Groet, 2012). For example, there is a 
notable absence of breast cancer in DS females (Hasle et al., 2000) and a complete lack 
of neuroblastomas with zero cases of DS reported among the 6,724 infants with this type 
of cancer (Satgé et al., 1998). This profound lack of solid tumors has also been 
recapitulated in DS mouse models (Sussan et al., 2008; Yang and Reeves, 2011). One 
possible explanation for this tumor resistance is the inhibition of angiogenesis due to the 
overexpression of chromosome 21 gene RCAN1 (Baek et al., 2009; Minami et al., 2004; 
Reynolds et al., 2010). While the inhibition of angiogenesis, a process crucial to tumor 
growth, may play a part in tumor resistance, this would not protect against mutations 
involving tumor suppressors or oncogenes that lead to the tumorigenic conversion of 
individual cells. Given that hindering angiogenesis does not inhibit tumor initiation, it is 
of interest that other work in DS mouse models reported that the increased expression of 
Ets2, a chromosome 21 gene linked to increased levels of senescence, prevents both 
tumor formation and growth (Sussan et al., 2008). Despite these individual studies the 
question of what leads to lower incidence of solid tumors is far from resolved, and one 
major hypothesis has not been explored: that this reflects an increased sensitivity to cell 
senescence. 
There is also evidence that proliferation defects impact some DS cell types, which may 
be due to increased levels of senescence. For example, DS patient’s brains display 
hypocellularity that occurs due to poor cell proliferation during embryogenesis (Guidi et 
al., 2011). Defects in cell proliferation have also been reported in cultures of DS 
fibroblasts (Kimura et al., 2005) and it has been suggested that the hematopoietic stem 
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cells may be both deficient in number and have shorter telomeres in DS patients (Holmes 
et al., 2006). It has also been reported that the rate of telomere loss is accelerated in DS 
lymphocytes in vivo in comparison to age matched normal controls (Vaziri et al., 1993). 
Considering that shortened telomeres are indicative of senescence it is surprising that 
only one report in mouse Ts65Dn fibroblasts showed increased levels of cell senescence 
(Contestabile et al., 2009).  
Further plausibility for a role of cell senescence in DS is provided by analysis of 
chromosome 21 gene functions. For example, DYRK1A has been shown to inhibit the 
proliferation of neuronal cells by phosphorylating p53 (Litovchick et al., 2011; Park et 
al., 2010) and has also been implicated in neurodegenerative diseases, like AD, 
characterized by increased levels of senescence (Wegiel et al., 2011). In addition to 
DYRK1A, Ets2 a tumor suppressor gene expressed in response to oxidative stress can 
upregulate p16 expression to initiate senescence (Barradas et al., 2002; Lim et al., 2011; 
Sanij et al., 2001). Finally, increased expression of Usp16 which blocks the degradation 
of p16 and inhibits cell proliferation has been shown to promote senescence in a large 
variety of DS progenitor cells and fibroblasts (Adorno et al., 2013).  
Despite the above information synthesized from a thorough analysis of several decades of 
literature on Down syndrome and chromosome 21 encoded genes, the possibility that cell 
senescence is an important contributor to one or more major aspects of the Down 
syndrome phenotype is not widely discussed or considered among researchers in this 
field. However, considering that DS is characterized by cell proliferation defects, early 
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onset of aging, resistance to solid tumors, and higher levels of oxidative stress, all 
phenotypes that have been linked to senescence in other contexts, we hypothesize that 
increased sensitivity to senescence may be one of the driving physiological processes that 
underlie aspects of the DS phenotype. Accordingly, the next section presents preliminary 
evidence and suggests additional experiments to address this hypothesis.  
Preliminary Results and Proposed Experiments 
Proliferation Defects in Cultured DS Pluripotent Stem Cells 
Additional, evidence that trisomy 21 directly causes reduced cell proliferation came from 
an analysis of a novel system of DS iPSCs capable of effectively silencing the extra 21st 
chromosome through the doxycycline inducible expression of a targeted XIST construct 
(Jiang et al., 2013). We noted that in iPSCs cultures treated with doxcycline for just one 
week, cell numbers in the functionally disomic lines were increased by 18-34% in six 
independent sub-clones when compared to identical cultures of trisomic (no dox) controls 
(Figure 4.1a)(Jiang et al., 2013). Subsequent, analysis of this proliferation defect using 
BrdU labeling (for DNA replication), in two sub clones (3258-9 and 3131D-2), revealed 
that an additional 6-11% of cells were in S-phase in the silenced cultures (Figure 4.1b). 
These results indicate that the proliferation defect in the trisomic iPSCs is likely due to 
either a slower cell cycle (e.g. longer G1) or increased levels of senescence.  
As SADS analysis revealed that some cells at the edge of the iPSCs colonies were 
senescent (Figure 4.1c), we compared both the uncorrected trisomic iPSCs and corrected, 
functionally disomic, iPSCs for increased levels of senescence. However, these results 
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proved inconsistent because a decrease in SADS positive senescent cells was observed in 
clone 3258-9 upon doxcycline treatment (and silencing the extra 21st chromosome), 
consistent with our hypothesis, whereas in clone 3131D-2 the opposite was observed 
(Figure 4.1d). However, the analysis of senescence in iPSC cultures is complicated by the 
fact that there are varying levels of differentiated cells around the periphery of each 
colony and between cultures. As these putative differentiated cells often appeared 
senescent, future studies could use a differentiation marker in conjunction with SADS 
analysis to assay the numbers of differentiated cells that are senescent between 
conditions. This may show that the differentiated uncorrected DS iPSCs senesce with 
higher frequency. Alternatively, the slower proliferation of pluripotent trisomic cells may 
occur for other reasons distinct from cell senescence, and the frequency of senescent cells 
in iPSC culture may prove independent of the number of actively expressing 21st 
chromosomes. 
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Figure 4.1 Proliferation Defects are Present in DS iPSCs. a) Corrected functionally 
disomic DS iPSCs clones grew faster than either of the trisomic controls (marked CTL) 
(Jiang et al., 2013). b) A 20 minute BrdU pulse in two clones of DS iPSCs treated with or 
without doxycycline (Dox) revealed that more cells were in S-phase in the doxycycline 
treated functionally disomic cultures. c-d) α-satellite (green) and satellite II (red) DNA 
FISH in DS iPSC cells show that SADS positive senescent cells (c, bottom left) can be 
found on the periphery of iPSC colonies. These results are quantified in (d) for two 
different clones treated with or without doxycycline.   
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Initial Examination of Senescence Levels in Differentiated Trisomic iPSCs 
Since initial results comparing the level of senescence in silenced functionally disomic, 
versus unsilenced trisomic iPSCs were inconclusive we next performed a pilot 
experiment to examine levels of senescence in randomly differentiated 3131D-2 DS 
iPSCs. These cells were treated with doxcycline for 10 days to insure complete silencing 
before they were allowed to differentiate into random cell lineages (by removing FGF 
and knockout serum from the iPSC media), under the continued presence of doxycycline. 
After five days of undirected differentiation we did not observe a difference in the 
frequency of senescent cells between the doxycycline treated and untreated DS cells, as 
judged by the presence of SADS and SA-β-galactosidase staining (Figure 4.2a,b). 
Although there was no difference between the two conditions, surprisingly high levels of 
senescence were observed in both the trisomic and effectively disomic cells and prior 
experimentation showed that the cultures became almost entirely senescent after ten days 
of random differentiation (data not shown). We theorize that these cells may be senescing 
due to culture stress, perhaps from the lack of factors necessary for the cell types into 
which they are randomly differentiating. This may be a significant observation for 
general studies using the undirected differentiation of ES cells, as it is unknown if this 
senescence response occurs in normal cells too. Hence, future studies that allow both 
corrected and uncorrected DS iPSCs to differentiate through embryoid bodies directed 
with lineage-specific factors would be more interpretable and may result in reproducible 
differences in the number of senescent cells.   
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Interestingly we also observed that in some cells the distended satellites appeared 
particularly thread like and oriented around the nucleolus in both culture conditions. This 
interesting pattern was not observed in previous fibroblast studies (Figure 4.2c). 
However, it is not known why this organization occurs in randomly differentiated DS 
iPSCs.           
  
122 
 
Figure 4.2 Cultures of Differentiated Corrected and Uncorrected DS iPSCs Show 
Similar Frequency of Senescent Cells. After ten days of doxycycline treatment and five 
days of undirected differentiation SADS (a) and SA-β-galactosidase (b) analysis show 
little difference in the frequency of senescent cells between conditions. c-d) A subset of 
undirected differentiated  DS iPSCs have dramatically distended thread like satellites 
(arrow) that extend outwards towards the periphery from the nucleolus as revealed by 
DNA FISH to α-satellite (green) and satellite II (red). Both functionally disomic (No 
Dox) and trisomic (Dox) DS iPSCs differentiated into neuronal cells were cycling with 
similar frequencies based on BrdU analysis (e) and had very few senescent cells as 
judged by SA-β-galactosidase staining (f,g).   
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Figure 4.2 Cultures of Differentiated Corrected and Uncorrected DS iPSCs Show 
Similar Frequency of Senescent Cells   
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In addition to randomly differentiated cells, we also performed a preliminary assessment 
of senescence levels in one readily available sample of cultured neuronal precursors, with 
and without XIST-mediated chromosome silencing. In these cultures, similar numbers of 
cells were in S-phase in each condition as revealed by a six hour BrdU pulse, and very 
few but equal numbers of these cells were senescent as judged by SA-β-galactosidase 
staining (Figure 4.2e,f). As increased levels of senescence were not seen in these trisomic 
neural precursors, there may not be a difference in initiation of the senescence program in 
this cell type and stage. However, examining different cell lineages or culturing the 
neuronal precursors or more fully differentiated neuronal cells for longer could reveal 
differences in the number of senescent cells. 
Oxygen Level Impacts DS Cell Proliferative Capacity 
The Lawrence lab previously noted differences indicative of increased cell senescence in 
the culture of both human and DS mouse (Ts65Dn) fibroblasts. This was recapitulated 
here, as multiple human DS fibroblast samples were found to have reduced proliferative 
potential compared to normal fibroblast lines when cultured at any oxygen condition, and 
the extent of this ranged from mild to severe (Figure 4.3a). Similarly, Ts65Dn tail tip 
fibroblasts often appeared to have senescent cell morphology and defective proliferation. 
As these results support our hypothesis of increased senescence in DS fibroblasts, an 
important question which has not been considered or addressed in prior studies is whether 
there could be a link between increased cell senescence in Down syndrome and increased 
sensitivity to long term oxidative stress. To test this we compared DS and normal 
fibroblasts lifespans under physiological (5% O2) and atmospheric (20% O2) conditions. 
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When DS fibroblasts are cultured at physiological oxygen levels (5%), beginning with 
the earliest available passage, results suggested that some lines were more sensitive to 
oxygen level as they continued to proliferate and avoid senescence for extended periods 
of time when compared to cultures of normal fibroblasts grown in parallel (Figure 4.3a). 
This result was especially apparent in the DS fibroblast line AG13902 and less so in 
GMO2508 cells, a third line (GMO2067) was also used, but its cells failed to proliferate 
and senesced almost immediately independent of oxygen conditions (Figure 4.3a).  
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Figure 4.3 Higher Oxygen Levels Negatively Affect DS Cell Proliferation. a) The 
total proliferative potential measured by the passage number in which cultural senescence 
occurs for representative DS fibroblast lines in comparison to normal Tig1 fibroblasts. 
The percent increase in the number of additional passages gained by culturing cells in 
physiological conditions is also shown. b) DS iPSCs lines proliferate more rapidly when 
placed in low oxygen conditions over 10 days (cell number=x*103).    
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Figure 4.3 Higher Oxygen Levels Negatively Affect DS Cell Proliferation   
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To further this experiment and to attempt to generate more conclusive results, controlling 
for oxygen levels from the initial generation of individual cell lines would be optimal. 
Hence, we propose to use the same experimental setup as described previously, but to 
harvest embryonic MEFs from normal and Ts65Dn littermates in order to insure that all 
cell lines are treated equally and come from a similar genetic background. As normal 
MEFs cultured in physiological oxygen conditions avoid senescence even though they 
express both p16 and p19 (Parrinello et al., 2003) it would be of particular interest to see 
if the Ts65Dn MEFs act similarly. Furthermore, if the Ts65Dn MEFs grown in 
atmospheric oxygen conditions immortalize at a lower frequency than their normal 
counterparts it would suggest that DS cells may contain a mechanism for enhanced 
maintenance and regulation of the key tumor suppressing genes required for senescence 
and the prevention of cancer.  
We also observed that when we placed DS iPSCs in physiological versus high oxygen 
levels and examined proliferation over the course of ten days the cells in physiological 
oxygen levels proliferated faster than the parallel cultures placed in atmospheric 
conditions (Figure 4.3b). This suggests that culturing cells at atmospheric oxygen 
conditions hampers the proliferative potential of DS iPSCs, a result that may be 
attributable to an inability of DS cells to handle increased rates of oxidative stress leading 
to accelerated entry into senescence. However, this study should be repeated in parallel 
with DS iPSCs that have silenced the extra 21st chromosome to see if the proliferation 
defects associated with growing these cells in high oxygen are mitigated. 
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Pathway Analysis of Microarray Expression Data in Down Syndrome 
iPSCs  
While it was previously shown that the collective transcriptional output of Chromosome 
21 genes was reduced to near disomic levels (Jiang et al., 2013), an in-depth analysis of 
gene expression changes across the genome has not been published. Here we summarize 
findings from more in-depth analyses focused on pathways relevant to the aspects of 
Down syndrome cell biology discussed throughout this chapter. 
Expression Profiling does not Show Increased Levels of Oxidative Stress in 
Uncorrected DS iPSCs 
Increased levels of oxidative stress in Down syndrome individuals has been suggested to 
cause mitochondrial dysfunction and early aging phenotypes including early onset 
dementia and senescence (Coskun and Busciglio, 2012; de Haan et al., 1996). This is 
hypothesized to occur, in part, because of increased levels of free radicals generated by 
the overexpression of chromosome 21 gene SOD-1 and the lack of compensatory 
response in Catalase (Cat) and glutathione peroxidase (GPx)(de Haan et al., 1996; 
Perluigi and Butterfield, 2011). Further, genome wide expression analysis on amniotic 
fluid comparing DS and normal fetuses showed that oxidative stress genes are differently 
expressed in trisomic individuals (Slonim et al., 2009), and other work reported that 
oxidative stress genes, particularly Cat, are overexpressed in DS iPSCs and neuronal stem 
cells in comparison to disomic lines (Weick et al., 2013). However, our analysis revealed 
that SOD-1 expression does not significantly change between disomic and trisomic cells 
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(Table 4.1). In addition, we do not see significant change in Cat expression, despite 
previous reports, and pathway analysis did not suggest that that there were changes in the 
overall oxidative stress response (Table 4.2). In agreement with our findings, our analysis 
of recent microarray experiments in iPSCs from monozygotic twins discordant for 
trisomy 21 did not see differential expression in SOD-1 and Cat (Hibaoui et al., 2013).  
An Examination of Several Significantly Perturbed Pathways in DS iPSCs  
In addition to our pathway analysis not revealing any statistically significant changes to 
oxidative stress related pathways or genes, we did not observe any changes in senescence 
related pathways or individual genes (Table 4.1 and 4.2). However, analysis of our 
microarray data revealed that gene-sets differentially regulated between effectively 
disomic and trisomic iPSCs cells often contain genes that have been linked to the hypoxia 
response and the gene encoding hypoxia-inducible factor one, alpha (HIF-1α)(Table 4.2). 
Under hypoxic conditions this transcription factor is not degraded and plays a role in 
mediating cell proliferation through p21, angiogenesis, and metabolism (Semenza, 2013), 
all processes that have been suggested to be altered in DS (Contestabile et al., 2009; 
Helguera et al., 2013; Reynolds et al., 2010). Upon initial examination, it appeared 
unlikely that hypoxia could be responsible for these changes, as the DS iPSCs in this 
study were cultured under atmospheric oxygen conditions (20% O2) and hypoxic 
conditions occur at ≤1% O2. However, we still examined our data to determine whether 
HIF-1α RNA and the genes that play a role in degrading the HIF-1α protein under normal 
conditions (Semenza, 2013) are differentially expressed in trisomic cells. We found that 
the only significant expression difference occurred in PHD2 (EGLN1), one of three genes 
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responsible for initiating the degradation of HIF-1α. As PHD2 expression is increased in 
corrected cells the degradation of HIF-1α protein may be reduced in DS individuals. As a 
result of this finding, we examined a variety of HIF-1α targets and noted that p21 and 
VEGF, a factor key to angiogenesis, are not significantly changed. Interestingly, several 
genes that were significantly changed in these sets are associated with the mitochondria 
and aerobic metabolism, particularly PDK1, and BNIP3 (Table 4.1). Considering that DS 
patients have recently been reported to have abnormal mitochondria (Helguera et al., 
2013), the differential expression of these genes may help explain the differences seen in 
the hypoxia-related gene-sets. 
Gene set analysis also revealed significant differences in several sets comprised of genes 
that are expressed at higher levels in ES cells as compared to differentiated cell lines 
(Table 4.2). We observed that the uncorrected DS iPSCs expressed higher levels of these 
factors than corrected, functionally disomic cells. Interestingly, increased expression of 
genes characteristic of stem cells may hamper stem cell differentiation and explain why 
trisomic iPSCs differentiated into neuronal precursors slower than corrected DS iPSCs 
(Jiang et al., 2013). In addition, the poor differentiation of DS iPSCs may help to explain 
DS phenotypes such as hypocellularity of brain (Contestabile et al., 2009; Guidi et al., 
2011). 
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Table 4.1. Changes in Gene Expression upon Trisomic Correction. The genes listed 
here are selected due to their known relationship to cell senescence, oxidative stress, or 
hypoxia. Positive numbers correlate to increased expression in the corrected functionally 
disomic lines. Bolded changes are statistically significant.  
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Table 4.1. Changes in Gene Expression upon Trisomic Correction 
Gene Symbol Chromosome Fold Change Log 
(2) 
P 
Oxidative Stress       
SOD1 chr21 -0.10903 1.97E-01 
CAT chr11 -0.01040 9.13E-01 
GPX1 chr3 0.02087 7.75E-01 
Hypoxia       
HIF1A chr14 -0.00967 9.25E-01 
EGLN1 (PHD2) chr1 0.27290 1.03E-02 
EGLN2 (PHD1) chr19 -0.11910 7.40E-02 
EGLN3 (PHD3) chr14 -0.46909 5.17E-07 
VEGFC chr4 0.33261 2.33E-02 
VEGFA chr6 0.14334 1.96E-01 
VEGFB chr11 0.04112 5.05E-01 
CDKN1A (p21) chr6 -0.04791 7.46E-01 
PDK1 chr2 0.65543 2.00E-08 
BNIP3 chr10 -0.24994 1.42E-03 
ES Cell       
AMD1 chr6 -0.43193 2.76E-06 
Senescence    
CDKN2A (p16) chr9 0.28605 1.51E-01 
TP53 (p53) chr18 -0.03344 7.33E-01 
RB1 chr13 0.43821 2.04E-02 
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Table 4.2. Gene Set Analysis. The pathways included here are significantly perturbed 
when comparing between both the trisomic and the corrected DOX treated, functionally 
disomic iPSCs, (w/Dox). Bold numbers are significant p<.01. Oxidative stress and 
senescence related pathways were not significantly different and are not included here.  
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Table 4.2. Gene Set Analysis 
Gene Sets 
# of 
Genes   
Up 
w/Dox 
Down 
w/Dox 
Pluripotency         
BENPORATH_ES_1 370   0.6534 0.0001 
BENPORATH_ES_2 39   0.9943 0.0001 
          
Hypoxia         
ELVIDGE_HIF1A_TARGETS_UP 65   0.9912 0.0001 
FARDIN_HYPOXIA_9 7   0.0001 0.7382 
ELVIDGE_HIF1A_TARGETS_DN 90   0.0154 0.2758 
          
Cysteine and Methionine Metabolism         
KEGG_CYSTEINE_AND_METHIONINE_METABOLI
SM 34   0.2287 0.0001 
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We also noted that the cytosine-methionine pathway which plays a role in the synthesis 
of the two amino acids in its name as well as S-adenosyl methionine (SAM), which 
serves a methyl group donor, was upregulated in uncorrected, trisomic, DS iPSCs. 
Interestingly overexpression of DYRK1A, a chromosome 21 gene, has been shown to 
play a role in upregulating this pathway (Noll et al., 2009). The upregulation of this 
pathway, which includes DNA methyltransferases, could then be connected to a variety 
of other DS phenotypes reported in the literature including increases in global DNA and 
mitochondrial methylation (Infantino et al., 2011; Jin et al., 2013). It is also worth noting 
that, the AMD1 gene is the most differently expressed (increased in trisomic lines) 
member of this pathway. This is of note because AMD1 is required for stem cell self-
renewal (Zhang et al., 2012) and may provide additional explanation as to why 
uncorrected DS iPSCs differentiate into neuronal precursors at a slower rate when 
compared to functionally disomic DS iPSCs (Jiang et al., 2013). 
Concluding Remarks 
The analysis of DS literature presented here provides an abundance of evidence to 
suggest that there may be increased levels of senescence in Down syndrome patients, and 
that this hypothesis merits further consideration. However, the potential role(s) of 
increased levels of cell senescence in DS has not been significantly studied in any 
context. While our initial efforts examining a variety of DS cells did not reveal an 
increase in senescence, they did reveal proliferation defects in Down syndrome cultures 
that can be exacerbated by increased oxygen concentrations. Considering that visual 
evidence suggests that this difference does not appear to be due to apoptosis, further 
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experimentation is necessary to rule out the role of senescence in the slower proliferation 
rate observed for DS cells.  
Furthermore, as increased levels of oxidative stress is supposed to contribute to both 
aging and increased incidence of senescence it was of great interest if our microarray data 
could recapitulate prior observations showing an imbalance between SOD-1 and GPX 
and Catalase. However, unlike what was previously reported (Weick et al., 2013), there 
was no difference in SOD-1, GPX, and Catalase levels between effectively disomic cells 
and their isogenic trisomic counterparts. This disagreement likely occurs, in part, because 
the Cat gene has one of the largest variances in expression between normal ES and iPSC 
lines cultured in similar conditions (Bock et al., 2011). Finally, based on analysis of 
expression profiling, and recent work detailing disruptions to the mitochondria in DS 
(Helguera et al., 2013), the potential role of mitochondrial dysfunction should be further 
examined in this context.      
Materials and Methods 
Cell Culture 
DS iPSCs were cultured as described in Jiang et al. (Jiang et al., 2013). Non-directed 
differentiation of DS iPSCs was performed by culturing the cells in KO DMEM F12 with 
20% fetal bovine serum, .1% Non-essential amino acids, and .1mM BME. The 
differentiation of these cells into neuronal precursors was also performed as described 
previously (Jiang et al., 2013). Silencing of the extra 21st chromosome in the DS iPSCs 
was accomplished by using 500 ng/mL doxycycline over the course of ten days. Tig1 
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fibroblasts and DS fibroblasts (AG13902, GMO2508, GMO2067) (Coriell) were grown 
in MEM with 15% FBS, 1% L-glutamine, and 1% Pen/Strep. Cells were serially 
passaged in either low/physiological oxygen conditions (5% O2) or atmospheric 
conditions (20% O2). BrdU analysis was performed as described in Swanson et al. 
(Swanson et al., 2013). 
Detection of Senescence Markers 
SA-β-galactosidase staining and SADS analysis and image acquisition was performed as 
described previously (Swanson et al., 2013).  
Microarray Analysis  
The raw array data were normalized using the Robust Multichip Average method 
(Bolstad et al., 2003) in R (Team, 2008). The limma (Smyth et al., 2005) package was 
used to fit linear models for calculation of differential gene expression. The linear model 
was: y ~ 0+xist:dox + clone, where each factor, except “clone”, can be either true or 
false. The “clone” variable enforces explicit pairing between treated and untreated clonal 
partners: the resulting empirical Bayes-moderated t-tests are, therefore, paired t-tests. For 
comparison, we calculated t-scores for this model without including the no xist·no dox 
and no xist·dox parameters, thereby ignoring the effect of doxycycline on trisomic cells 
with no exogenous chromosome 21 XIST gene. In order to detect expression 
perturbations due to trisomy 21 at the level of gene-sets, we used the ROMER (Majewski 
et al., 2010) function of limma (Smyth et al., 2005) to test whether gene-sets from the 
curated (C2) collection at the MSigDB (v. 4.0) (Subramanian et al., 2005) are up-
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regulated, down-regulated or differentially expressed without a bias in direction. We used 
10,000 random rotations with the “mean50” function applied to t-scores as the summary 
statistic. 
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Concluding Remarks and Future Directions 
The work presented here demonstrates a new and fundamental property of senescent 
cells: the formation of Senescence Associated Distension of Satellites or SADS. This 
phenotype, which may be functionally linked to the cessation of cell division through the 
disruption of normal centromere and kinetochore structure, could also be important to the 
study of chromatin organization as this cytological-scale change is an unprecedented 
example of facultative heterochromatin loss. Lastly, it can serve as a marker of 
senescence as it is a defining and ubiquitous feature characteristic of all senescent cells 
observed to date. 
SADS: Do They Reflect, Reinforce, or Contribute to Cell Senescence?      
One could envision that this substantial change in the structure and packaging of α-
satellite and satellite II sequences at the peri/centromere may contribute to the inhibition 
of cell cycle progression and help to establish the permanence of senescence. However, 
we remain uncertain as to how these currently inseparable processes relate: do SADS 
play a role in initiating the senescence process or is this marked epigenetic change the 
result of cell senescence? This chicken or egg question is challenging to elucidate but is 
compelling given that we show SADS to be an early and very consistent event in the 
senescence process. This challenge arises because perturbing many of the factors that 
may play a role in inducing SADS formation also induces cell senescence, making it 
difficult to separate the two processes. For example, we suspect that the loss of LaminB1 
may play a role in SADS formation (as discussed in Chapters II and III) but since 
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knocking down or overexpressing levels of LaminB1 results in senescence (Dreesen et 
al., 2013; Shah et al., 2013; Shimi et al., 2011), this will likely not resolve if SADS form 
in response to changes in LaminB1levels or the onset of senescence itself.    
Another example of being unable to assay when SADS form in relation to senescence 
occurs with manipulations to a protein family that could play a role in facilitating SADS 
formation. HMGA family proteins are architectural chromatin factors normally 
associated with open chromatin that can organize large-scale domains of DNA (Reeves, 
2010). This family of proteins also contains three characteristic AT-hook domains that 
bind to the minor grove of DNA within AT rich sequences (Reeves, 2001), a motif that is 
enriched in satellite DNA. Hence, these proteins may play a role in SADS formation 
because levels of HMGA increase with senescence and help to reinforce the state of 
permanent cell cycle arrest (Narita et al., 2006). While it would be logical to ectopically 
express HMGA in cycling fibroblasts to determine if it plays a role in SADS formation, 
its overexpression can cause senescence (Narita et al., 2006). Once again, this would 
make it difficult to determine if increased levels of HMGA are key to SADS formation or 
if SADS form in response to the onset of senescence. What is clear and exciting from this 
challenge, however, is that SADS and cell senescence are very tightly linked and difficult 
to separate. 
Heterochromatin Changes Characteristic of SADS 
Here we showed that satellite distension represents a fivefold loss of DNA compaction 
that is much larger in scale than changes in chromatin packaging associated with gene 
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expression. Hence, it was surprising that despite these cytological scale changes to 
satellite DNA, levels of canonical histone modifications (H3K9Me3, H3K27Me3, and 
H3K4Me3) did not change in our analysis of published data on senescent cells (Figure 
2.7d)(Chandra et al., 2012). Further highlighting this, loss of DNA methylation on 
satellites in ICF cells did not result in distension of interphase satellites and a DNA 
methylation-sensitive Southern blot for both cycling and senescent cells did not reveal 
notable differences in methylation patterns (Figure 2.7g,h). 
In addition, our work shows that SADS formation occurs within 48hours of the last S-
phase in a process that is independent from both the remodeling of chromatin into SAHFs 
and other heterochromatin loss that occurs throughout the genome much later in 
senescence (Figure 2.2, 2.3, 2.S1, 2S3)(De Cecco et al., 2013; Funayama et al., 2006; 
Narita et al., 2003). While the changes observed in satellite packaging appear unique and 
may serve as a model to illuminate higher-order chromatin folding above the 10 nm fiber, 
probing SADS with genome wide approaches like chromosome conformation capture (to 
assay differences in the interactions and looping of satellites in cycling versus senescent 
cells) are technically challenging due to the highly repetitive and often unannotated 
sequences that comprise satellite DNA. However, initial super resolution microscopy 
images appear to support that this chromatin comprises a series of globular domains that 
become apparent as the links between them distend and linearize in senescent cells. 
Finally, our findings point to the possibility that some factor(s) is perturbed in satellite 
sequences at the onset of senescence which normally plays a role in maintaining the 
higher-order heterochromatin structure observed in cycling cells.   
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Expanding SADS as a New Marker of Senescence 
The work presented here establishes SADS as a reliable single-cell marker of senescence 
that unlike other markers has been characteristic of every type of senescence examined, 
including in vivo. Consequently, we have already applied SADS as a marker for 
senescence in DS (Chapter IV), and preliminary collaborative efforts have used this 
marker to identify senescence in mouse bone marrow cells and spleen tissue sections. 
Furthermore, the detection of SADS in live cells could greatly increase this markers 
utility and applicability. One strategy for accomplishing this would be to create cell lines 
that stably express CENP-B conjugated to GFP, allowing for the visualization of SADS 
formation in real-time. As SADS formation is an early event in senescence and our data 
show that the senescence process happens relatively quickly it is of interest to determine 
the time scale required for satellite distension to take place. 
In addition, while SADS appears both dramatic and unambiguous under the microscope 
to our trained eyes, more quantifiable parameters to define when a cell is SADS positive 
would be helpful. For example, development of  algorithms for high throughput 
microscopy would allow for the analysis of a large number of cells for senescence, a 
technique that has been used by other labs to examine the frequency of senescence in 
various cells and tissues (Freund et al., 2012; Zhao et al., 2010).   
Is DS Characterized by Increased Levels of Senescence? 
It is noteworthy that even though Down syndrome has features of premature aging and 
tumor resistance, there are few examples where this common genetic disorder has been 
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considered in relation to cell senescence (Chapter IV). Based upon the synthesis of the 
existing literature we believe that there is good rational for more focused attention to this 
question and higher levels of senescence may be present in both cultured DS cells and in 
vivo. While our preliminary studies using SADS as a marker showed that cultures of 
pluripotent and randomly differentiated stem cells contain substantial amounts of 
senescent cells, the DS iPSC system proved a difficult one in which to evaluate whether 
higher levels of senescence are associated with trisomy 21. However, initial results 
suggest that DS fibroblasts are more susceptible to prolonged oxidative stress which has a 
greater effect on shortening their lifespan in culture. Hopefully, with the completion of a 
few more key experiments we can establish that increased cell senescence is a feature of 
DS cells and thus prompt further studies of the role of senescence in the clinical 
pathology of DS. 
 
 
 
  
145 
 
References 
Acosta, J.C., A. Banito, T. Wuestefeld, A. Georgilis, P. Janich, J.P. Morton, D. Athineos, 
T.-W. Kang, F. Lasitschka, M. Andrulis, G. Pascual, K.J. Morris, S. Khan, H. Jin, 
G. Dharmalingam, A.P. Snijders, T. Carroll, D. Capper, C. Pritchard, G.J. Inman, 
T. Longerich, O.J. Sansom, S.A. Benitah, L. Zender, and J. Gil. 2013. A complex 
secretory program orchestrated by the inflammasome controls paracrine 
senescence. Nat Cell Biol. 15:978-990. 
Acosta, J.C., A. O'Loghlen, A. Banito, M.V. Guijarro, A. Augert, S. Raguz, M. 
Fumagalli, M. Da Costa, C. Brown, N. Popov, Y. Takatsu, J. Melamed, F. d'Adda 
di Fagagna, D. Bernard, E. Hernando, and J. Gil. 2008. Chemokine Signaling via 
the CXCR2 Receptor Reinforces Senescence. Cell. 133:1006-1018. 
Adams, P.D. 2007. Remodeling of chromatin structure in senescent cells and its potential 
impact on tumor suppression and aging. Gene. 397:84-93. 
Adorno, M., S. Sikandar, S.S. Mitra, A. Kuo, B.N. Di Robilant, V. Haro-Acosta, Y. 
Ouadah, M. Quarta, J. Rodriguez, D. Qian, V.M. Reddy, S. Cheshier, C.C. 
Garner, and M.F. Clarke. 2013. Usp16 contributes to somatic stem-cell defects in 
Down/'s syndrome. Nature. 501:380-384. 
Anneren, K.G., and C.J. Epstein. 1987. Lipid peroxidation and superoxide dismutase-1 
and glutathione peroxidase activities in trisomy 16 fetal mice and human trisomy 
21 fibroblasts. Pediatr Res. 21:88-92. 
Baek, K.-H., A. Zaslavsky, R.C. Lynch, C. Britt, Y. Okada, R.J. Siarey, M.W. Lensch, I.-
H. Park, S.S. Yoon, T. Minami, J.R. Korenberg, J. Folkman, G.Q. Daley, W.C. 
Aird, Z. Galdzicki, and S. Ryeom. 2009. Down's syndrome suppression of tumour 
growth and the role of the calcineurin inhibitor DSCR1. Nature. 459:1126-1130. 
Baker, D.J., C. Perez-Terzic, F. Jin, K.S. Pitel, N.J. Niederlander, K. Jeganathan, S. 
Yamada, S. Reyes, L. Rowe, H.J. Hiddinga, N.L. Eberhardt, A. Terzic, and J.M. 
van Deursen. 2008. Opposing roles for p16Ink4a and p19Arf in senescence and 
ageing caused by BubR1 insufficiency. Nat Cell Biol. 10:825-836. 
Baker, D.J., T. Wijshake, T. Tchkonia, N.K. LeBrasseur, B.G. Childs, B. van de Sluis, 
J.L. Kirkland, and J.M. van Deursen. 2011. Clearance of p16Ink4a-positive 
senescent cells delays ageing-associated disorders. Nature. 479:232-236. 
Balaban, R.S., S. Nemoto, and T. Finkel. 2005. Mitochondria, Oxidants, and Aging. Cell. 
120:483-495. 
Barascu, A., C. Le Chalony, G. Pennarun, D. Genet, N. Imam, B. Lopez, and P. Bertrand. 
2012. Oxidative stress induces an ATM‐independent senescence pathway through 
p38 MAPK‐mediated lamin B1 accumulation. The EMBO Journal. 31:1080-1094. 
Barradas, M., E.S. Gonos, Z. Zebedee, E. Kolettas, C. Petropoulou, M.D. Delgado, J. 
León, E. Hara, and M. Serrano. 2002. Identification of a Candidate Tumor-
Suppressor Gene Specifically Activated during Ras-Induced Senescence. 
Experimental Cell Research. 273:127-137. 
Bartkova, J., N. Rezaei, M. Liontos, P. Karakaidos, D. Kletsas, N. Issaeva, L.V. 
Vassiliou, E. Kolettas, K. Niforou, V.C. Zoumpourlis, M. Takaoka, H. Nakagawa, 
146 
 
F. Tort, K. Fugger, F. Johansson, M. Sehested, C.L. Andersen, L. Dyrskjot, T. 
Orntoft, J. Lukas, C. Kittas, T. Helleday, T.D. Halazonetis, J. Bartek, and V.G. 
Gorgoulis. 2006. Oncogene-induced senescence is part of the tumorigenesis 
barrier imposed by DNA damage checkpoints. Nature. 444:633-637. 
Baù, D., A. Sanyal, B.R. Lajoie, E. Capriotti, M. Byron, J.B. Lawrence, J. Dekker, and 
M.A. Marti-Renom. 2011. The three-dimensional folding of the α-globin gene 
domain reveals formation of chromatin globules. Nat Struct Mol Biol. 18:107-
114. 
Bauer, C.R., T.A. Hartl, and G. Bosco. 2012. Condensin II Promotes the Formation of 
Chromosome Territories by Inducing Axial Compaction of Polyploid Interphase 
Chromosomes. PLoS Genet. 8:e1002873. 
Bazett-Jones, D.P., and M.J. Hendzel. 1999. Electron Spectroscopic Imaging of 
Chromatin. Methods. 17:188-200. 
Beausejour, C.M., A. Krtolica, F. Galimi, M. Narita, S.W. Lowe, P. Yaswen, and J. 
Campisi. 2003. Reversal of human cellular senescence: roles of the p53 and p16 
pathways. EMBO J. 22:4212-4222. 
Benson, E.K., S.W. Lee, and S.A. Aaronson. 2010. Role of progerin-induced telomere 
dysfunction in HGPS premature cellular senescence. J Cell Sci. 123:2605-2612. 
Bentley Lawrence, J., C.A. Villnave, and R.H. Singer. 1988. Sensitive, high-resolution 
chromatin and chromosome mapping in situ: Presence and orientation of two 
closely integrated copies of EBV in a lymphoma line. Cell. 52:51-61. 
Bhat, R., E.P. Crowe, A. Bitto, M. Moh, C.D. Katsetos, F.U. Garcia, F.B. Johnson, J.Q. 
Trojanowski, C. Sell, and C. Torres. 2012. Astrocyte Senescence as a Component 
of Alzheimer’s Disease. PLoS ONE. 7:e45069. 
Binet, R., D. Ythier, A.I. Robles, M. Collado, D. Larrieu, C. Fonti, E. Brambilla, C. 
Brambilla, M. Serrano, C.C. Harris, and R. Pedeux. 2009. WNT16B Is a New 
Marker of Cellular Senescence That Regulates p53 Activity and the 
Phosphoinositide 3-Kinase/AKT Pathway. Cancer Research. 69:9183-9191. 
Blasco, M.A., H.-W. Lee, M.P. Hande, E. Samper, P.M. Lansdorp, R.A. DePinho, and 
C.W. Greider. 1997. Telomere Shortening and Tumor Formation by Mouse Cells 
Lacking Telomerase RNA. Cell. 91:25-34. 
Bock, C., E. Kiskinis, G. Verstappen, H. Gu, G. Boulting, Z.D. Smith, M. Ziller, G.F. 
Croft, M.W. Amoroso, D.H. Oakley, A. Gnirke, K. Eggan, and A. Meissner. 
2011. Reference Maps of Human ES and iPS Cell Variation Enable High-
Throughput Characterization of Pluripotent Cell Lines. Cell. 144:439-452. 
Bodnar, A.G., M. Ouellette, M. Frolkis, S.E. Holt, C.-P. Chiu, G.B. Morin, C.B. Harley, 
J.W. Shay, S. Lichtsteiner, and W.E. Wright. 1998. Extension of Life-Span by 
Introduction of Telomerase into Normal Human Cells. Science. 279:349-352. 
Bolstad, B.M., R.A. Irizarry, M. Astrand, and T.P. Speed. 2003. A comparison of 
normalization methods for high density oligonucleotide array data based on 
variance and bias. Bioinformatics. 19:185-193. 
Braig, M., S. Lee, C. Loddenkemper, C. Rudolph, A.H.F.M. Peters, B. Schlegelberger, H. 
Stein, B. Dorken, T. Jenuwein, and C.A. Schmitt. 2005. Oncogene-induced 
senescence as an initial barrier in lymphoma development. Nature. 436:660-665. 
147 
 
Burton, D.G.A., H. Matsubara, and K. Ikeda. 2010. Pathophysiology of vascular 
calcification: Pivotal role of cellular senescence in vascular smooth muscle cells. 
Experimental Gerontology. 45:819-824. 
Busuttil, R.A., M. Rubio, M.E.T. Dollé, J. Campisi, and J. Vijg. 2003. Oxygen 
accelerates the accumulation of mutations during the senescence and 
immortalization of murine cells in culture. Aging Cell. 2:287-294. 
Butin-Israeli, V., S.A. Adam, A.E. Goldman, and R.D. Goldman. 2012. Nuclear lamin 
functions and disease. Trends in Genetics. 28:464-471. 
Campisi, J. 2013. Aging, Cellular Senescence, and Cancer. Annual Review of Physiology. 
75:null. 
Cao, K., C.D. Blair, D.A. Faddah, J.E. Kieckhaefer, M. Olive, M.R. Erdos, E.G. Nabel, 
and F.S. Collins. 2011. Progerin and telomere dysfunction collaborate to trigger 
cellular senescence in normal human fibroblasts. J Clin Invest. 
Carone, D.M., and J.B. Lawrence. 2013. Heterochromatin instability in cancer: From the 
Barr body to satellites and the nuclear periphery. Seminars in Cancer Biology. 
23:99-108. 
Carrel, A., and A.H. Ebeling. 1921. Age and Multiplication of Fibroblasts. J Exp Med. 
34:599-623. 
Cenini, G., A.L.S. Dowling, T.L. Beckett, E. Barone, C. Mancuso, M.P. Murphy, H. 
LeVine Iii, I.T. Lott, F.A. Schmitt, D.A. Butterfield, and E. Head. 2012. 
Association between frontal cortex oxidative damage and beta-amyloid as a 
function of age in Down syndrome. Biochimica et Biophysica Acta (BBA) - 
Molecular Basis of Disease. 1822:130-138. 
Chadwick, B.P., and H.F. Willard. 2003. Chromatin of the Barr body: histone and non-
histone proteins associated with or excluded from the inactive X chromosome. 
Human Molecular Genetics. 12:2167-2178. 
Chandler, H., and G. Peters. 2013. Stressing the cell cycle in senescence and aging. 
Current Opinion in Cell Biology. 25:765-771. 
Chandra, T., K. Kirschner, J.-Y. Thuret, Benjamin D. Pope, T. Ryba, S. Newman, K. 
Ahmed, Shamith A. Samarajiwa, R. Salama, T. Carroll, R. Stark, R.s. Janky, M. 
Narita, L. Xue, A. Chicas, S. Ninez, R. Janknecht, Y. Hayashi-Takanaka, 
Michael D. Wilson, A. Marshall, Duncan T. Odom, M.M. Babu, David P. Bazett-
Jones, S. Tavaré, Paul A.W. Edwards, Scott W. Lowe, H. Kimura, David M. 
Gilbert, and M. Narita. 2012. Independence of Repressive Histone Marks and 
Chromatin Compaction during Senescent Heterochromatic Layer Formation. 
Molecular Cell. 
Chang, B.-D., E.V. Broude, M. Dokmanovic, H. Zhu, A. Ruth, Y. Xuan, E.S. Kandel, E. 
Lausch, K. Christov, and I.B. Roninson. 1999. A Senescence-like Phenotype 
Distinguishes Tumor Cells That Undergo Terminal Proliferation Arrest after 
Exposure to Anticancer Agents. Cancer Research. 59:3761-3767. 
Chaumeil, J., P. Le Baccon, A. Wutz, and E. Heard. 2006. A novel role for Xist RNA in 
the formation of a repressive nuclear compartment into which genes are recruited 
when silenced. Genes and Development. 20:2223-2237. 
148 
 
Chen, Q., and B.N. Ames. 1994. Senescence-like growth arrest induced by hydrogen 
peroxide in human diploid fibroblast F65 cells. Proceedings of the National 
Academy of Sciences. 91:4130-4134. 
Chen, Q., A. Fischer, J.D. Reagan, L.J. Yan, and B.N. Ames. 1995. Oxidative DNA 
damage and senescence of human diploid fibroblast cells. Proceedings of the 
National Academy of Sciences. 92:4337-4341. 
Chen, Q.M., J.C. Bartholomew, J. Campisi, M. Acosta, J.D. Reagan, and B.N. Ames. 
1998. Molecular analysis of H2O2-induced senescent-like growth arrest in normal 
human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem 
J. 332 ( Pt 1):43-50. 
Chen, Q.M., K.R. Prowse, V.C. Tu, S. Purdom, and M.H.K. Linskens. 2001. Uncoupling 
the Senescent Phenotype from Telomere Shortening in Hydrogen Peroxide-
Treated Fibroblasts. Experimental Cell Research. 265:294-303. 
Chen, Z., L.C. Trotman, D. Shaffer, H.-K. Lin, Z.A. Dotan, M. Niki, J.A. Koutcher, H.I. 
Scher, T. Ludwig, W. Gerald, C. Cordon-Cardo, and P. Paolo Pandolfi. 2005. 
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient 
tumorigenesis. Nature. 436:725-730. 
Choo, K.H. 1997. Centromere DNA dynamics: latent centromeres and neocentromere 
formation. Am J Hum Genet. 61:1225-1233. 
Classon, M., and E. Harlow. 2002. The retinoblastoma tumour suppressor in development 
and cancer. Nat Rev Cancer. 2:910-917. 
Clemson, C.M., L.L. Hall, M. Byron, J. McNeil, and J.B. Lawrence. 2006. The X 
chromosome is organized into a gene-rich outer rim and an internal core 
containing silenced nongenic sequences. Proc Natl Acad Sci U S A. 103:7688-
7693. 
Collado, M., J. Gil, A. Efeyan, C. Guerra, A.J. Schuhmacher, M. Barradas, A. Benguria, 
A. Zaballos, J.M. Flores, M. Barbacid, D. Beach, and M. Serrano. 2005. Tumour 
biology: Senescence in premalignant tumours. Nature. 436:642-642. 
Collado, M., and M. Serrano. 2006. The power and the promise of oncogene-induced 
senescence markers. Nat Rev Cancer. 6:472-476. 
Collado, M., and M. Serrano. 2010. Senescence in tumours: evidence from mice and 
humans. Nat Rev Cancer. 10:51-57. 
Conboy, I.M., M.J. Conboy, A.J. Wagers, E.R. Girma, I.L. Weissman, and T.A. Rando. 
2005. Rejuvenation of aged progenitor cells by exposure to a young systemic 
environment. Nature. 433:760-764. 
Contestabile, A., T. Fila, A. Cappellini, R. Bartesaghi, and E. Ciani. 2009. Widespread 
impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down 
syndrome. Cell Proliferation. 42:171-181. 
Coppé, J.-P., C.K. Patil, F. Rodier, A. Krtolica, C.M. Beauséjour, S. Parrinello, J.G. 
Hodgson, K. Chin, P.-Y. Desprez, and J. Campisi. 2010. A Human-Like 
Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells 
Dependent on Physiological Oxygen. PLoS ONE. 5:e9188. 
Coppé, J.-P., C.K. Patil, F. Rodier, Y. Sun, D.P. Muñoz, J. Goldstein, P.S. Nelson, P.-Y. 
Desprez, and J. Campisi. 2008. Senescence-Associated Secretory Phenotypes 
149 
 
Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor 
Suppressor. PLoS Biol. 6:e301. 
Coppe, J.-P., F. Rodier, C.K. Patil, A. Freund, P.-Y. Desprez, and J. Campisi. 2011. The 
tumor suppressor and aging biomarker p16INK4a induces cellular senescence 
without the associated inflammatory secretory phenotype. Journal of Biological 
Chemistry. 
Coskun, P.E., and J. Busciglio. 2012. Oxidative Stress and Mitochondrial Dysfunction in 
Down's Syndrome: Relevance to Aging and Dementia. Curr Gerontol Geriatr 
Res. 2012:383170. 
Cosme-Blanco, W., M.F. Shen, A.J. Lazar, S. Pathak, G. Lozano, A.S. Multani, and S. 
Chang. 2007. Telomere dysfunction suppresses spontaneous tumorigenesis in 
vivo by initiating p53-dependent cellular senescence. EMBO Rep. 8:497-503. 
Cristofalo, V.J. 1985. Cellular senescence: factors modulating cell proliferation in vitro. 
Basic life sciences. 35:241-253. 
Cristofalo, V.J. 2005. SA beta Gal staining: biomarker or delusion. Exp Gerontol. 
40:836-838. 
Cruickshanks, H.A., T. McBryan, D.M. Nelson, N.D. Vanderkraats, P.P. Shah, J. van 
Tuyn, T. Singh Rai, C. Brock, G. Donahue, D.S. Dunican, M.E. Drotar, R.R. 
Meehan, J.R. Edwards, S.L. Berger, and P.D. Adams. 2013. Senescent cells 
harbour features of the cancer epigenome. Nat Cell Biol. 15:1495-1506. 
De Cecco, M., S.W. Criscione, E.J. Peckham, S. Hillenmeyer, E.A. Hamm, J. 
Manivannan, A.L. Peterson, J.A. Kreiling, N. Neretti, and J.M. Sedivy. 2013. 
Genomes of replicatively senescent cells undergo global epigenetic changes 
leading to gene silencing and activation of transposable elements. Aging Cell:n/a-
n/a. 
de Haan, J.B., F. Cristiano, R. Iannello, C. Bladier, M.J. Kelner, and I. Kola. 1996. 
Elevation in the Ratio of Cu/Zn-Superoxide Dismutase to Glutathione Peroxidase 
Activity Induces Features of Cellular Senescence and This Effect Is Mediated by 
Hydrogen Peroxide. Human Molecular Genetics. 5:283-292. 
de la Rosa, J., J.M.P. Freije, R. Cabanillas, F.G. Osorio, M.F. Fraga, M.S. Fernández-
García, R. Rad, V. Fanjul, A.P. Ugalde, Q. Liang, H.M. Prosser, A. Bradley, J. 
Cadiñanos, and C. López-Otín. 2013. Prelamin A causes progeria through cell-
extrinsic mechanisms and prevents cancer invasion. Nat Commun. 4. 
De Sandre-Giovannoli, A., R. Bernard, P. Cau, C. Navarro, J. Amiel, I. Boccaccio, S. 
Lyonnet, C.L. Stewart, A. Munnich, M. Le Merrer, and N. Lévy. 2003. Lamin A 
Truncation in Hutchinson-Gilford Progeria. Science. 300:2055. 
Dellaire, G., R. Nisman, and D.P. Bazett-Jones. 2004. Correlative light and electron 
spectroscopic imaging of chromatin in situ. Methods Enzymol. 375:456-478. 
Di Micco, R., M. Fumagalli, A. Cicalese, S. Piccinin, P. Gasparini, C. Luise, C. Schurra, 
M. Garre, P. Giovanni Nuciforo, A. Bensimon, R. Maestro, P. Giuseppe Pelicci, 
and F. d/'Adda di Fagagna. 2006. Oncogene-induced senescence is a DNA 
damage response triggered by DNA hyper-replication. Nature. 444:638-642. 
Di Micco, R., G. Sulli, M. Dobreva, M. Liontos, O.A. Botrugno, G. Gargiulo, R. dal 
Zuffo, V. Matti, G. d'Ario, E. Montani, C. Mercurio, W.C. Hahn, V. Gorgoulis, S. 
150 
 
Minucci, and F. d'Adda di Fagagna. 2011. Interplay between oncogene-induced 
DNA damage response and heterochromatin in senescence and cancer. Nat Cell 
Biol. 13:292-302. 
Dimri, G.P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E.E. Medrano, M. 
Linskens, I. Rubelj, and O. Pereira-Smith. 1995. A biomarker that identifies 
senescent human cells in culture and in aging skin in vivo. Proceedings of the 
National Academy of Sciences of the United States of America. 92:9363-9367. 
Dorner, D., J. Gotzmann, and R. Foisner. 2007. Nucleoplasmic lamins and their 
interaction partners, LAP2α, Rb, and BAF, in transcriptional regulation. FEBS 
Journal. 274:1362-1373. 
Down, J.L. 1866. Observations on an ethnic classification of idiots. . Lond Hosp Clin 
Lect Rep. 250:436-437. 
Dreesen, O., A. Chojnowski, P.F. Ong, T.Y. Zhao, J.E. Common, D. Lunny, E.B. Lane, 
S.J. Lee, L.A. Vardy, C.L. Stewart, and A. Colman. 2013. Lamin B1 fluctuations 
have differential effects on cellular proliferation and senescence. The Journal of 
Cell Biology. 200:605-617. 
Du, J., Y. Li, and X. Zhu. 2010. Involvement of CENP-F in histone methylation. Acta 
Biochim Biophys Sin (Shanghai). 42:173-176. 
Ehrlich, M. 2009. DNA hypomethylation in cancer cells. Epigenomics. 1:239-259. 
Ehrlich, M., C. Sanchez, C. Shao, R. Nishiyama, J. Kehrl, R. Kuick, T. Kubota, and S.M. 
Hanash. 2008. ICF, an immunodeficiency syndrome: DNA methyltransferase 3B 
involvement, chromosome anomalies, and gene dysregulation. Autoimmunity. 
41:253-271. 
Eriko, M., K. Nakabayashi, T. Suzuki, S.C. Kaul, H. Ogino, M. Fujii, Y. Mitsui, and D. 
Ayusawa. 1999. 5-Bromodeoxyuridine Induces Senescence-Like Phenomena in 
Mammalian Cells Regardless of Cell Type or Species. Journal of Biochemistry. 
126:1052-1059. 
Eriksson, M., W.T. Brown, L.B. Gordon, M.W. Glynn, J. Singer, L. Scott, M.R. Erdos, 
C.M. Robbins, T.Y. Moses, P. Berglund, A. Dutra, E. Pak, S. Durkin, A.B. 
Csoka, M. Boehnke, T.W. Glover, and F.S. Collins. 2003. Recurrent de novo 
point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 
423:293-298. 
Fagagna, F.d.A.d., P.M. Reaper, L. Clay-Farrace, H. Fiegler, P. Carr, T. von Zglinicki, G. 
Saretzki, N.P. Carter, and S.P. Jackson. 2003. A DNA damage checkpoint 
response in telomere-initiated senescence. Nature. 426:194-198. 
Fang, J.Y., L. Yang, H.Y. Zhu, Y.X. Chen, J. Lu, R. Lu, Z.H. Cheng, and S.D. Xiao. 
2004. 5-Aza-2'-deoxycitydine induces demethylation and up-regulates 
transcription of p16INK4A gene in human gastric cancer cell lines. Chin Med J 
(Engl). 117:99-103. 
Feaster, W.W., L.W. Kwok, and C.J. Epstein. 1977. Dosage effects for superoxide 
dismutase-1 in nucleated cells aneuploid for chromosome 21. Am J Hum Genet. 
29:563-570. 
Feldser, D.M., and C.W. Greider. 2007. Short Telomeres Limit Tumor Progression In 
Vivo by Inducing Senescence. Cancer Cell. 11:461-469. 
151 
 
Finkel, T., and N.J. Holbrook. 2000. Oxidants, oxidative stress and the biology of ageing. 
Nature. 408:239-247. 
Freund, A., R.-M. Laberge, M. Demaria, and J. Campisi. 2012. Lamin B1 loss is a 
senescence-associated biomarker. Molecular Biology of the Cell. 
Freund, A., A.V. Orjalo, P.-Y. Desprez, and J. Campisi. 2010. Inflammatory networks 
during cellular senescence: causes and consequences. Trends in Molecular 
Medicine. 16:238-246. 
Freund, A., C.K. Patil, and J. Campisi. 2011. p38MAPK is a novel DNA damage 
response‐independent regulator of the senescence‐associated secretory phenotype. 
1536-1548 pp. 
Funayama, R., and F. Ishikawa. 2007. Cellular senescence and chromatin structure. 
Chromosoma. 116:431-440. 
Funayama, R., M. Saito, H. Tanobe, and F. Ishikawa. 2006. Loss of linker histone H1 in 
cellular senescence. J Cell Biol. 175:869-880. 
Gibcus, Johan H., and J. Dekker. 2013. The Hierarchy of the 3D Genome. Molecular 
Cell. 49:773-782. 
Gonzalez‐Suarez, I., A.B. Redwood, S.M. Perkins, B. Vermolen, D. Lichtensztejin, D.A. 
Grotsky, L. Morgado‐Palacin, E.J. Gapud, B.P. Sleckman, T. Sullivan, J. Sage, 
C.L. Stewart, S. Mai, and S. Gonzalo. 2009. Novel roles for A‐type lamins in 
telomere biology and the DNA damage response pathway. 2414-2427 pp. 
Gonzalo, S., and M.A. Blasco. 2005. Role of Rb family in the epigenetic definition of 
chromatin. Cell Cycle. 4:752-755. 
Gonzalo, S., M. Garcia-Cao, M.F. Fraga, G. Schotta, A.H.F.M. Peters, S.E. Cotter, R. 
Eguia, D.C. Dean, M. Esteller, T. Jenuwein, and M.A. Blasco. 2005. Role of the 
RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat 
Cell Biol. 7:420-428. 
Gordon, L.B., F.G. Rothman, C. López-Otín, and T. Misteli. 2014. Progeria: A Paradigm 
for Translational Medicine. Cell. 156:400-407. 
Guelen, L., L. Pagie, E. Brasset, W. Meuleman, M.B. Faza, W. Talhout, B.H. Eussen, A. 
de Klein, L. Wessels, W. de Laat, and B. van Steensel. 2008. Domain 
organization of human chromosomes revealed by mapping of nuclear lamina 
interactions. Nature. 453:948-951. 
Guidi, S., E. Ciani, P. Bonasoni, D. Santini, and R. Bartesaghi. 2011. Widespread 
Proliferation Impairment and Hypocellularity in the Cerebellum of Fetuses with 
Down Syndrome. Brain Pathology. 21:361-373. 
Gulesserian, T., R. Seidl, R. Hardmeier, N. Cairns, and G. Lubec. 2001. Superoxide 
dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in 
brains of patients with Down syndrome. J Investig Med. 49:41-46. 
Hardy, J., and D.J. Selkoe. 2002. The Amyloid Hypothesis of Alzheimer's Disease: 
Progress and Problems on the Road to Therapeutics. Science. 297:353-356. 
Harley, C.B., A.B. Futcher, and C.W. Greider. 1990. Telomeres shorten during ageing of 
human fibroblasts. Nature. 345:458-460. 
Hasle, H., I.H. Clemmensen, and M. Mikkelsen. 2000. Risks of leukaemia and solid 
tumours in individuals with Down's syndrome. The Lancet. 355:165-169. 
152 
 
Hayflick, L. 1965. The limited in vitro lifetime of human diploid cell strains. 
Experimental Cell Research. 37:614-636. 
Hayflick, L., and P.S. Moorhead. 1961. The serial cultivation of human diploid cell 
strains. Experimental Cell Research. 25:585-621. 
He, D., C. Zeng, K. Woods, L. Zhong, D. Turner, R.K. Busch, B.R. Brinkley, and H. 
Busch. 1998. CENP-G: a new centromeric protein that is associated with the 
alpha-1 satellite DNA subfamily. Chromosoma. 107:189-197. 
Head, E., I.T. Lott, D. Patterson, E. Doran, and R.J. Haier. 2007. Possible Compensatory 
Events in Adult Down Syndrome Brain Prior to the Development of Alzheimer 
Disease Neuropathology: Targets for Nonpharmacological Intervention. Journal 
of Alzheimer's Disease. 11:61-76. 
Helguera, P., J. Seiglie, J. Rodriguez, M. Hanna, G. Helguera, and J. Busciglio. 2013. 
Adaptive Downregulation of Mitochondrial Function in Down Syndrome. Cell 
Metabolism. 17:132-140. 
Henrik, H. 2001. Pattern of malignant disorders in individuals with Down's syndrome. 
The Lancet Oncology. 2:429-436. 
Herbig, U., M. Ferreira, L. Condel, D. Carey, and J.M. Sedivy. 2006. Cellular senescence 
in aging primates. Science. 311:1257. 
Herbig, U., W.A. Jobling, B.P.C. Chen, D.J. Chen, and J.M. Sedivy. 2004. Telomere 
Shortening Triggers Senescence of Human Cells through a Pathway Involving 
ATM, p53, and p21CIP1, but Not p16INK4a. Molecular Cell. 14:501-513. 
Hibaoui, Y., I. Grad, A. Letourneau, M.R. Sailani, S. Dahoun, F.A. Santoni, S. Gimelli, 
M. Guipponi, M.F. Pelte, F. Béna, S.E. Antonarakis, and A. Feki. 2013. 
Modelling and rescuing neurodevelopmental defect of Down syndrome using 
induced pluripotent stem cells from monozygotic twins discordant for trisomy 21. 
EMBO Molecular Medicine. 
Holmes, D.K., N. Bates, M. Murray, E.J. Ladusans, A. Morabito, P.H.B. Bolton-Maggs, 
T.A. Johnston, S. Walkenshaw, R.F. Wynn, and I. Bellantuono. 2006. 
Hematopoietic progenitor cell deficiency in fetuses and children affected by 
Down's syndrome. Experimental Hematology. 34:1611-1615. 
Huang, S., R.A. Risques, G.M. Martin, P.S. Rabinovitch, and J. Oshima. 2008. 
Accelerated telomere shortening and replicative senescence in human fibroblasts 
overexpressing mutant and wild-type lamin A. Experimental Cell Research. 
314:82-91. 
Infantino, V., A. Castegna, F. Iacobazzi, I. Spera, I. Scala, G. Andria, and V. Iacobazzi. 
2011. Impairment of methyl cycle affects mitochondrial methyl availability and 
glutathione level in Down's syndrome. Molecular Genetics and Metabolism. 
102:378-382. 
Ishihara, K., K. Amano, E. Takaki, A.S. Ebrahim, A. Shimohata, N. Shibazaki, I. Inoue, 
M. Takaki, Y. Ueda, H. Sago, C.J. Epstein, and K. Yamakawa. 2009. Increased 
lipid peroxidation in Down’s syndrome mouse models. Journal of 
Neurochemistry. 110:1965-1976. 
Itahana, K., J. Campisi, and G. Dimri. 2004. Mechanisms of cellular senescence in 
human and mouse cells. Biogerontology. 5:1-10. 
153 
 
Jeyapalan, J.C., M. Ferreira, J.M. Sedivy, and U. Herbig. 2007. Accumulation of 
senescent cells in mitotic tissue of aging primates. Mechanisms of Ageing and 
Development. 128:36-44. 
Jiang, J., Y. Jing, G.J. Cost, J.C. Chiang, H.J. Kolpa, A.M. Cotton, D.M. Carone, B.R. 
Carone, D.A. Shivak, D.Y. Guschin, J.R. Pearl, E.J. Rebar, M. Byron, P.D. 
Gregory, C.J. Brown, F.D. Urnov, L.L. Hall, and J.B. Lawrence. 2013. 
Translating dosage compensation to trisomy 21. Nature. 500:296-300. 
Jin, S., Y.K. Lee, Y.C. Lim, Z. Zheng, X.M. Lin, D.P.Y. Ng, J.D. Holbrook, H.Y. Law, 
K.Y.C. Kwek, G.S.H. Yeo, and C. Ding. 2013. Global DNA Hypermethylation in 
Down Syndrome Placenta. PLoS Genet. 9:e1003515. 
Johnson, C.V., J.A. McNeil, K.C. Carter, and J.B. Lawrence. 1991a. A simple, rapid 
technique for precise mapping of multiple sequences in two colors using a single 
optical filter set. Genet Anal Tech Appl. 8:75-76. 
Johnson, C.V., R.H. Singer, and J.B. Lawrence. 1991b. Fluorescent detection of nuclear 
RNA and DNA: implications for genome organization. Methods Cell Biol. 35:73-
99. 
Jovanovic, S.V., D. Clements, and K. MacLeod. 1998. Biomarkers of oxidative stress are 
significantly elevated in Down syndrome. Free Radical Biology and Medicine. 
25:1044-1048. 
Jun, J.-I., and L.F. Lau. 2010. The matricellular protein CCN1 induces fibroblast 
senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 
12:676-685. 
Jurk, D., C. Wang, S. Miwa, M. Maddick, V. Korolchuk, A. Tsolou, E.S. Gonos, C. 
Thrasivoulou, M. Jill Saffrey, K. Cameron, and T. von Zglinicki. 2012. 
Postmitotic neurons develop a p21-dependent senescence-like phenotype driven 
by a DNA damage response. Aging Cell:no-no. 
Katsimpardi, L., N.K. Litterman, P.A. Schein, C.M. Miller, F.S. Loffredo, G.R. 
Wojtkiewicz, J.W. Chen, R.T. Lee, A.J. Wagers, and L.L. Rubin. 2014. Vascular 
and Neurogenic Rejuvenation of the Aging Mouse Brain by Young Systemic 
Factors. Science. 344:630-634. 
Kennedy, A., T. McBryan, G. Enders, F. Johnson, R. Zhang, and P. Adams. 2010. 
Senescent mouse cells fail to overtly regulate the HIRA histone chaperone and do 
not form robust Senescence Associated Heterochromatin Foci. Cell Division. 
5:16. 
Kim, N.W., M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, P.L. Ho, G.M. 
Coviello, W.E. Wright, S.L. Weinrich, and J.W. Shay. 1994. Specific association 
of human telomerase activity with immortal cells and cancer. Science. 266:2011-
2015. 
Kimura, M., X. Cao, J. Skurnick, M. Cody, P. Soteropoulos, and A. Aviv. 2005. 
Proliferation dynamics in cultured skin fibroblasts from Down syndrome subjects. 
Free Radical Biology and Medicine. 39:374-380. 
Kind, J., and B. van Steensel. 2010. Genome–nuclear lamina interactions and gene 
regulation. Current Opinion in Cell Biology. 22:320-325. 
154 
 
Kiyono, T., S.A. Foster, J.I. Koop, J.K. McDougall, D.A. Galloway, and A.J. 
Klingelhutz. 1998. Both Rb/p16INK4a inactivation and telomerase activity are 
required to immortalize human epithelial cells. Nature. 396:84-88. 
Kornberg, R.D. 1974. Chromatin Structure: A Repeating Unit of Histones and DNA. 
Science. 184:868-871. 
Kosar, M., J. Bartkova, S. Hubackova, Z. Hodny, J. Lukas, and J. Bartek. 2011. 
Senescence-associated heterochromatin foci are dispensable for cellular 
senescence, occur in a cell type- and insult-dependent manner and follow 
expression of p16 (ink4a). Cell Cycle. 10:457-468. 
Kreiling, J.A., M. Tamamori-Adachi, A.N. Sexton, J.C. Jeyapalan, U. Munoz-Najar, A.L. 
Peterson, J. Manivannan, E.S. Rogers, N.A. Pchelintsev, P.D. Adams, and J.M. 
Sedivy. 2011. Age-associated increase in heterochromatic marks in murine and 
primate tissues. Aging Cell. 10:292-304. 
Krishnamurthy, J., C. Torrice, M.R. Ramsey, G.I. Kovalev, K. Al-Regaiey, L. Su, and 
N.E. Sharpless. 2004. Ink4a/Arf expression is a biomarker of aging. The Journal 
of Clinical Investigation. 114:1299-1307. 
Kuilman, T., C. Michaloglou, W.J. Mooi, and D.S. Peeper. 2010. The essence of 
senescence. Genes and Development. 24:2463-2479. 
Kuilman, T., C. Michaloglou, L.C.W. Vredeveld, S. Douma, R. van Doorn, C.J. Desmet, 
L.A. Aarden, W.J. Mooi, and D.S. Peeper. 2008. Oncogene-Induced Senescence 
Relayed by an Interleukin-Dependent Inflammatory Network. Cell. 133:1019-
1031. 
Langmead, B., C. Trapnell, M. Pop, and S.L. Salzberg. 2009. Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome. Genome Biol. 
10:R25. 
Lapasset, L., O. Milhavet, A. Prieur, E. Besnard, A. Babled, N. Aït-Hamou, J. Leschik, F. 
Pellestor, J.-M. Ramirez, J. De Vos, S. Lehmann, and J.-M. Lemaitre. 2011. 
Rejuvenating senescent and centenarian human cells by reprogramming through 
the pluripotent state. Genes & Development. 25:2248-2253. 
Lawrence, J.B., R.H. Singer, and J.A. McNeil. 1990. Interphase and metaphase resolution 
of different distances within the human dystrophin gene. Science. 249:928-932. 
Lawrence, J.B., K. Taneja, and R.H. Singer. 1989. Temporal resolution and sequential 
expression of muscle-specific genes revealed by in situ hybridization. 
Developmental Biology. 133:235-246. 
Lee, A.C., B.E. Fenster, H. Ito, K. Takeda, N.S. Bae, T. Hirai, Z.-X. Yu, V.J. Ferrans, 
B.H. Howard, and T. Finkel. 1999. Ras Proteins Induce Senescence by Altering 
the Intracellular Levels of Reactive Oxygen Species. Journal of Biological 
Chemistry. 274:7936-7940. 
Lee, B.Y., J.A. Han, J.S. Im, A. Morrone, K. Johung, E.C. Goodwin, W.J. Kleijer, D. 
DiMaio, and E.S. Hwang. 2006. Senescence-associated β-galactosidase is 
lysosomal β-galactosidase. Aging Cell. 5:187-195. 
Lejeune, J. 1959. [Study of somatic chromosomes from 9 mongoloid children]. Comptes 
rendus hebdomadaires des séances de l'Académie des sciences. 248:1721-1722. 
155 
 
Lim, J.S., S.-H. Park, and K.L. Jang. 2011. All-trans retinoic acid induces cellular 
senescence by up-regulating levels of p16 and p21 via promoter hypomethylation. 
Biochemical and Biophysical Research Communications. 412:500-505. 
Litovchick, L., L.A. Florens, S.K. Swanson, M.P. Washburn, and J.A. DeCaprio. 2011. 
DYRK1A protein kinase promotes quiescence and senescence through DREAM 
complex assembly. Genes Dev. 25:801-813. 
Liu, B., J. Wang, K.M. Chan, W.M. Tjia, W. Deng, X. Guan, J.-d. Huang, K.M. Li, P.Y. 
Chau, D.J. Chen, D. Pei, A.M. Pendas, J. Cadinanos, C. Lopez-Otin, H.F. Tse, C. 
Hutchison, J. Chen, Y. Cao, K.S.E. Cheah, K. Tryggvason, and Z. Zhou. 2005. 
Genomic instability in laminopathy-based premature aging. Nat Med. 11:780-785. 
Liu, H., M.M. Fergusson, R.M. Castilho, J. Liu, L. Cao, J. Chen, D. Malide, I.I. Rovira, 
D. Schimel, C.J. Kuo, J.S. Gutkind, P.M. Hwang, and T. Finkel. 2007. 
Augmented Wnt Signaling in a Mammalian Model of Accelerated Aging. 
Science. 317:803-806. 
Loffredo, Francesco S., Matthew L. Steinhauser, Steven M. Jay, J. Gannon, James R. 
Pancoast, P. Yalamanchi, M. Sinha, C. Dall’Osso, D. Khong, Jennifer L. 
Shadrach, Christine M. Miller, Britta S. Singer, A. Stewart, N. Psychogios, 
Robert E. Gerszten, Adam J. Hartigan, M.-J. Kim, T. Serwold, Amy J. Wagers, 
and Richard T. Lee. 2013. Growth Differentiation Factor 11 Is a Circulating 
Factor that Reverses Age-Related Cardiac Hypertrophy. Cell. 153:828-839. 
Luo, Y.B., C. Mitrpant, R.D. Johnsen, V.A. Fabian, S. Fletcher, F.L. Mastaglia, and S.D. 
Wilton. 2013. Investigation of age-related changes in LMNA splicing and 
expression of progerin in human skeletal muscles. Int J Clin Exp Pathol. 6:2778-
2786. 
Maehara, K., K. Takahashi, and S. Saitoh. 2010. CENP-A Reduction Induces a p53-
Dependent Cellular Senescence Response To Protect Cells from Executing 
Defective Mitoses. Molecular and Cellular Biology. 30:2090-2104. 
Maeshima, K., R. Imai, S. Tamura, and T. Nozaki. 2014. Chromatin as dynamic 10-nm 
fibers. Chromosoma:1-13. 
Maier, B., W. Gluba, B. Bernier, T. Turner, K. Mohammad, T. Guise, A. Sutherland, M. 
Thorner, and H. Scrable. 2004. Modulation of mammalian life span by the short 
isoform of p53. Genes Dev. 18:306-319. 
Majewski, I.J., M.E. Ritchie, B. Phipson, J. Corbin, M. Pakusch, A. Ebert, M. Busslinger, 
H. Koseki, Y. Hu, G.K. Smyth, W.S. Alexander, D.J. Hilton, and M.E. Blewitt. 
2010. Opposing roles of polycomb repressive complexes in hematopoietic stem 
and progenitor cells. Blood. 116:731-739. 
Mann, D.M. 1989. The pattern of acquisition of plaques and tangles in the brains of 
patients under 50 years of age with Down's syndrome. Journal of the neurological 
sciences. 89:169-179. 
Marji, J., S.I. O'Donoghue, D. McClintock, V.P. Satagopam, R. Schneider, D. Ratner, H. 
J. Worman, L.B. Gordon, and K. Djabali. 2010. Defective Lamin A-Rb Signaling 
in Hutchinson-Gilford Progeria Syndrome and Reversal by Farnesyltransferase 
Inhibition. PLoS One. 5:e11132. 
156 
 
Matsumura, T., Z. Zerrudo, and L. Hayflick. 1979. Senescent Human Diploid Cells in 
Culture: Survival, DNA Synthesis and Morphology. Journal of Gerontology. 
34:328-334. 
McClintock, D., D. Ratner, M. Lokuge, D.M. Owens, L.B. Gordon, F.S. Collins, and K. 
Djabali. 2007. The Mutant Form of Lamin A that Causes Hutchinson-Gilford 
Progeria Is a Biomarker of Cellular Aging in Human Skin. PLoS One. 2:e1269. 
Michaloglou, C., L.C. Vredeveld, M.S. Soengas, C. Denoyelle, T. Kuilman, C.M. van der 
Horst, D.M. Majoor, J.W. Shay, W.J. Mooi, and D.S. Peeper. 2005. BRAFE600-
associated senescence-like cell cycle arrest of human naevi. Nature. 436:720-724. 
Mikkelsen, T.S., M. Ku, D.B. Jaffe, B. Issac, E. Lieberman, G. Giannoukos, P. Alvarez, 
W. Brockman, T.K. Kim, R.P. Koche, W. Lee, E. Mendenhall, A. O'Donovan, A. 
Presser, C. Russ, X. Xie, A. Meissner, M. Wernig, R. Jaenisch, C. Nusbaum, E.S. 
Lander, and B.E. Bernstein. 2007. Genome-wide maps of chromatin state in 
pluripotent and lineage-committed cells. Nature. 448:553-560. 
Minami, T., K. Horiuchi, M. Miura, M.R. Abid, W. Takabe, N. Noguchi, T. Kohro, X. 
Ge, H. Aburatani, T. Hamakubo, T. Kodama, and W.C. Aird. 2004. Vascular 
Endothelial Growth Factor- and Thrombin-induced Termination Factor, Down 
Syndrome Critical Region-1, Attenuates Endothelial Cell Proliferation and 
Angiogenesis. Journal of Biological Chemistry. 279:50537-50554. 
Misteli, T. 2010. Higher-order genome organization in human disease. Cold Spring Harb 
Perspect Biol. 2:a000794. 
Mudhasani, R., Z. Zhu, G. Hutvagner, C.M. Eischen, S. Lyle, L.L. Hall, J.B. Lawrence, 
A.N. Imbalzano, and S.N. Jones. 2008. Loss of miRNA biogenesis induces 
p19Arf-p53 signaling and senescence in primary cells. J Cell Biol. 181:1055-
1063. 
Muñoz-Espín, D., M. Cañamero, A. Maraver, G. Gómez-López, J. Contreras, S. Murillo-
Cuesta, A. Rodríguez-Baeza, I. Varela-Nieto, J. Ruberte, M. Collado, and M. 
Serrano. 2013. Programmed Cell Senescence during Mammalian Embryonic 
Development. Cell. 155:1104-1118. 
Myung, N.-H., X. Zhu, I. Kruman, R. Castellani, R. Petersen, S. Siedlak, G. Perry, M. 
Smith, and H.-g. Lee. 2008. Evidence of DNA damage in Alzheimer disease: 
phosphorylation of histone H2AX in astrocytes. AGE. 30:209-215. 
Nakamura, A.J., Y.J. Chiang, K.S. Hathcock, I. Horikawa, O.A. Sedelnikova, R.J. Hodes, 
and W.M. Bonner. 2008. Both telomeric and non-telomeric DNA damage are 
determinants of mammalian cellular senescence. Epigenetics Chromatin. 1:6. 
Narita, M., V. Krizhanovsky, S. Nunez, A. Chicas, S.A. Hearn, M.P. Myers, and S.W. 
Lowe. 2006. A novel role for high-mobility group a proteins in cellular 
senescence and heterochromatin formation. Cell. 126:503-514. 
Narita, M., S. Nunez, E. Heard, A.W. Lin, S.A. Hearn, D.L. Spector, G.J. Hannon, and 
S.W. Lowe. 2003. Rb-mediated heterochromatin formation and silencing of E2F 
target genes during cellular senescence. Cell. 113:703-716. 
Nelson, G., J. Wordsworth, C. Wang, D. Jurk, C. Lawless, C. Martin-Ruiz, and T. von 
Zglinicki. 2012. A senescent cell bystander effect: senescence-induced 
senescence. Aging Cell. 11:345-349. 
157 
 
Nizetic, D., and J. Groet. 2012. Tumorigenesis in Down's syndrome: big lessons from a 
small chromosome. Nat Rev Cancer. 12:721-732. 
Noll, C., C. Planque, C. Ripoll, F. Guedj, A. Diez, V. Ducros, N. Belin, A. Duchon, J.-L. 
Paul, A. Badel, B. de Freminville, Y. Grattau, H. Bléhaut, Y. Herault, N. Janel, 
and J.-M. Delabar. 2009. DYRK1A, a Novel Determinant of the Methionine-
Homocysteine Cycle in Different Mouse Models Overexpressing this Down-
Syndrome-Associated Kinase. PLoS ONE. 4:e7540. 
Oh, J., Y.D. Lee, and A.J. Wagers. 2014. Stem cell aging: mechanisms, regulators and 
therapeutic opportunities. Nat Med. 20:870-880. 
Olins, A.L., and D.E. Olins. 1974. Spheroid Chromatin Units (ν Bodies). Science. 
183:330-332. 
Packer, L., and K. Fuehr. 1977. Low oxygen concentration extends the lifespan of 
cultured human diploid cells. Nature. 267:423-425. 
Pageau, G.J., L.L. Hall, S. Ganesan, D.M. Livingston, and J.B. Lawrence. 2007. The 
disappearing Barr body in breast and ovarian cancers. Nat Rev Cancer. 7:628-633. 
Pardee, A.B., R. Dubrow, J.L. Hamlin, and R.F. Kletzien. 1978. Animal Cell Cycle. 
Annual Review of Biochemistry. 47:715-750. 
Park, J., Y. Oh, L. Yoo, M.-S. Jung, W.-J. Song, S.-H. Lee, H. Seo, and K.C. Chung. 
2010. Dyrk1A Phosphorylates p53 and Inhibits Proliferation of Embryonic 
Neuronal Cells. Journal of Biological Chemistry. 285:31895-31906. 
Parrinello, S., E. Samper, A. Krtolica, J. Goldstein, S. Melov, and J. Campisi. 2003. 
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. 
Nat Cell Biol. 5:741-747. 
Passos, J.F., G. Nelson, C. Wang, T. Richter, C. Simillion, C.J. Proctor, S. Miwa, S. 
Olijslagers, J. Hallinan, A. Wipat, G. Saretzki, K.L. Rudolph, T.B.L. Kirkwood, 
and T. von Zglinicki. 2010. Feedback between p21 and reactive oxygen 
production is necessary for cell senescence. 
Patterson, D. 2009. Molecular genetic analysis of Down syndrome. Human Genetics. 
126:195-214. 
Pegoraro, G., N. Kubben, U. Wickert, H. Gohler, K. Hoffmann, and T. Misteli. 2009. 
Ageing-related chromatin defects through loss of the NURD complex. Nat Cell 
Biol. 11:1261-1267. 
Perluigi, M., and D.A. Butterfield. 2011. The identification of protein biomarkers for 
oxidative stress in Down syndrome. Expert Rev Proteomics. 8:427-429. 
Perluigi, M., F. di Domenico, A. Fiorini, A. Cocciolo, A. Giorgi, C. Foppoli, D.A. 
Butterfield, M. Giorlandino, C. Giorlandino, M. Eugenia Schininà, and R. Coccia. 
2011. Oxidative stress occurs early in Down syndrome pregnancy: A redox 
proteomics analysis of amniotic fluid. PROTEOMICS – Clinical Applications. 
5:167-178. 
Perrone, S., M. Longini, C.V. Bellieni, G. Centini, A. Kenanidis, L. De Marco, F. 
Petraglia, and G. Buonocore. 2007. Early oxidative stress in amniotic fluid of 
pregnancies with Down syndrome. Clin Biochem. 40:177-180. 
Phillips-Cremins, Jennifer E., Michael E.G. Sauria, A. Sanyal, Tatiana I. Gerasimova, 
Bryan R. Lajoie, Joshua S.K. Bell, C.-T. Ong, Tracy A. Hookway, C. Guo, Y. 
158 
 
Sun, Michael J. Bland, W. Wagstaff, S. Dalton, Todd C. McDevitt, R. Sen, J. 
Dekker, J. Taylor, and Victor G. Corces. 2013. Architectural Protein Subclasses 
Shape 3D Organization of Genomes during Lineage Commitment. Cell. 
153:1281-1295. 
Rao, Suhas S.P., Miriam H. Huntley, Neva C. Durand, Elena K. Stamenova, Ivan D. 
Bochkov, James T. Robinson, Adrian L. Sanborn, I. Machol, Arina D. Omer, 
Eric S. Lander, and Erez L. Aiden. 2014. A 3D Map of the Human Genome at 
Kilobase Resolution Reveals Principles of Chromatin Looping. Cell. 159:1665-
1680. 
Rebbaa, A., X. Zheng, F. Chu, and B.L. Mirkin. 2006. The role of histone acetylation 
versus DNA damage in drug-induced senescence and apoptosis. Cell Death 
Differ. 13:1960-1967. 
Reeves, R. 2001. Molecular biology of HMGA proteins: hubs of nuclear function. Gene. 
277:63-81. 
Reeves, R. 2010. Nuclear functions of the HMG proteins. Biochimica et Biophysica Acta 
(BBA) - Gene Regulatory Mechanisms. 1799:3-14. 
Ressler, S., J. Bartkova, H. Niederegger, J. Bartek, K. Scharffetter-Kochanek, P. Jansen-
Dürr, and M. Wlaschek. 2006. p16INK4A is a robust in vivo biomarker of 
cellular aging in human skin. Aging Cell. 5:379-389. 
Reynolds, L.E., A.R. Watson, M. Baker, T.A. Jones, G. D'Amico, S.D. Robinson, C. 
Joffre, S. Garrido-Urbani, J.C. Rodriguez-Manzaneque, E. Martino-Echarri, M. 
Aurrand-Lions, D. Sheer, F. Dagna-Bricarelli, D. Nizetic, C.J. McCabe, A.S. 
Turnell, S. Kermorgant, B.A. Imhof, R. Adams, E.M. Fisher, V.L. Tybulewicz, 
I.R. Hart, and K.M. Hodivala-Dilke. 2010. Tumour angiogenesis is reduced in the 
Tc1 mouse model of Down's syndrome. Nature. 465:813-817. 
Robles, S.J., and G.R. Adami. 1998. Agents that cause DNA double strand breaks lead to 
p16INK4a enrichment and the premature senescence of normal fibroblasts. 
Oncogene. 16:1113-1123. 
Rodier, F., and J. Campisi. 2011. Four faces of cellular senescence. J Cell Biol. 192:547-
556. 
Rodriguez, S., F. Coppede, H. Sagelius, and M. Eriksson. 2009. Increased expression of 
the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during 
cell aging. Eur J Hum Genet. 17:928-937. 
Rose, J., S. Söder, C. Skhirtladze, N. Schmitz, P.M. Gebhard, S. Sesselmann, and T. 
Aigner. 2012. DNA damage, discoordinated gene expression and cellular 
senescence in osteoarthritic chondrocytes. Osteoarthritis and Cartilage. 20:1020-
1028. 
Rosenfeld, J., Z. Wang, D. Schones, K. Zhao, R. DeSalle, and M. Zhang. 2009. 
Determination of enriched histone modifications in non-genic portions of the 
human genome. BMC Genomics. 10:143. 
Roy, A., I. Roberts, A. Norton, and P. Vyas. 2009. Acute megakaryoblastic leukaemia 
(AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a 
multi-step model of myeloid leukaemogenesis. British Journal of Haematology. 
147:3-12. 
159 
 
Sadaie, M., R. Salama, T. Carroll, K. Tomimatsu, T. Chandra, A.R.J. Young, M. Narita, 
P.A. Pérez-Mancera, D.C. Bennett, H. Chong, H. Kimura, and M. Narita. 2013. 
Redistribution of the Lamin B1 genomic binding profile affects rearrangement of 
heterochromatic domains and SAHF formation during senescence. Genes & 
Development. 27:1800-1808. 
Sager, R. 1991. Senescence As a Mode of Tumor Suppression. Environmental Health 
Perspectives. 93:59-62. 
Salminen, A., J. Ojala, K. Kaarniranta, A. Haapasalo, M. Hiltunen, and H. Soininen. 
2011. Astrocytes in the aging brain express characteristics of senescence-
associated secretory phenotype. European Journal of Neuroscience. 34:3-11. 
Sanij, E., T. Hatzistavrou, P. Hertzog, I. Kola, and E.J. Wolvetang. 2001. Ets-2 Is 
Induced by Oxidative Stress and Sensitizes Cells to H2O2-Induced Apoptosis: 
Implications for Down's Syndrome. Biochemical and Biophysical Research 
Communications. 287:1003-1008. 
Satgé, D., A.J. Sasco, N.L.T. Carlsen, C.A. Stiller, H. Rubie, B. Hero, B. de Bernardi, J. 
de Kraker, C. Coze, P. Kogner, F. Langmark, F.G.A.J. Hakvoort-Cammel, D. 
Beck, N. von der Weid, S. Parkes, O. Hartmann, R.J.J. Lippens, W.A. Kamps, 
and D. Sommelet. 1998. A Lack of Neuroblastoma in Down Syndrome: A Study 
from 11 European Countries. Cancer Research. 58:448-452. 
Scaffidi, P., and T. Misteli. 2005. Reversal of the cellular phenotype in the premature 
aging disease Hutchinson-Gilford progeria syndrome. Nature Medicine. 11:440-
445. 
Scaffidi, P., and T. Misteli. 2006. Lamin A-Dependent Nuclear Defects in Human Aging. 
Science. 312:1059-1063. 
Schmitt, C.A., J.S. Fridman, M. Yang, S. Lee, E. Baranov, R.M. Hoffman, and S.W. 
Lowe. 2002. A senescence program controlled by p53 and p16INK4a contributes 
to the outcome of cancer therapy. Cell. 109:335-346. 
Schnekenburger, M., C. Grandjenette, J. Ghelfi, T. Karius, B. Foliguet, M. Dicato, and 
M. Diederich. 2011. Sustained exposure to the DNA demethylating agent, 2′-
deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by 
promoting differentiation, senescence, and autophagy. Biochemical 
Pharmacology. 81:364-378. 
Sedelnikova, O.A., I. Horikawa, D.B. Zimonjic, N.C. Popescu, W.M. Bonner, and J.C. 
Barrett. 2004. Senescing human cells and ageing mice accumulate DNA lesions 
with unrepairable double-strand breaks. Nat Cell Biol. 6:168-170. 
Semenza, G.L. 2013. HIF-1 mediates metabolic responses to intratumoral hypoxia and 
oncogenic mutations. The Journal of Clinical Investigation. 123:3664-3671. 
Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle 
control causing specific inhibition of cyclin D/CDK4. Nature. 366:704-707. 
Serrano, M., A.W. Lin, M.E. McCurrach, D. Beach, and S.W. Lowe. 1997. Oncogenic 
ras provokes premature cell senescence associated with accumulation of p53 and 
p16INK4a. Cell. 88:593-602. 
160 
 
Severino, J., R.G. Allen, S. Balin, A. Balin, and V.J. Cristofalo. 2000. Is β-Galactosidase 
Staining a Marker of Senescence in Vitro and in Vivo? Experimental Cell 
Research. 257:162-171. 
Shah, P.P., G. Donahue, G.L. Otte, B.C. Capell, D.M. Nelson, K. Cao, V. Aggarwala, 
H.A. Cruickshanks, T.S. Rai, T. McBryan, B.D. Gregory, P.D. Adams, and S.L. 
Berger. 2013. Lamin B1 depletion in senescent cells triggers large-scale changes 
in gene expression and the chromatin landscape. Genes & Development. 27:1787-
1799. 
Shao, Z., Y. Zhang, G.C. Yuan, S.H. Orkin, and D.J. Waxman. 2012. MAnorm: a robust 
model for quantitative comparison of ChIP-Seq data sets. Genome Biol. 13:R16. 
Shay, J.W., O.M. Pereira-Smith, and W.E. Wright. 1991. A role for both RB and p53 in 
the regulation of human cellular senescence. Experimental Cell Research. 196:33-
39. 
Shay, J.W., B.A. van der Haegen, Y. Ying, and W.E. Wright. 1993. The Frequency of 
Immortalization of Human Fibroblasts and Mammary Epithelial Cells Transfected 
with SV40 Large T-Antigen. Experimental Cell Research. 209:45-52. 
Shay, J.W., and W.E. Wright. 2005. Senescence and immortalization: role of telomeres 
and telomerase. Carcinogenesis. 26:867-874. 
Shelton, D.N., E. Chang, P.S. Whittier, D. Choi, and W.D. Funk. 1999. Microarray 
analysis of replicative senescence. Current Biology. 9:939-945. 
Shen, M., Y. Luo, Y. Niu, L. Chen, X. Yuan, D. Goltzman, N. Chen, and D. Miao. 2013. 
1,25(OH)2D deficiency induces temporomandibular joint osteoarthritis via 
secretion of senescence-associated inflammatory cytokines. Bone. 55:400-409. 
Sherr, C.J., and J.M. Roberts. 1999. CDK inhibitors: positive and negative regulators of 
G1-phase progression. Genes & Development. 13:1501-1512. 
Shimi, T., V. Butin-Israeli, S.A. Adam, R.B. Hamanaka, A.E. Goldman, C.A. Lucas, 
D.K. Shumaker, S.T. Kosak, N.S. Chandel, and R.D. Goldman. 2011. The role of 
nuclear lamin B1 in cell proliferation and senescence. Genes & Development. 
Shumaker, D.K., T. Dechat, A. Kohlmaier, S.A. Adam, M.R. Bozovsky, M.R. Erdos, M. 
Eriksson, A.E. Goldman, S. Khuon, F.S. Collins, T. Jenuwein, and R.D. 
Goldman. 2006. Mutant nuclear lamin A leads to progressive alterations of 
epigenetic control in premature aging. Proceedings of the National Academy of 
Sciences. 103:8703-8708. 
Sinha, M., Y.C. Jang, J. Oh, D. Khong, E.Y. Wu, R. Manohar, C. Miller, S.G. Regalado, 
F.S. Loffredo, J.R. Pancoast, M.F. Hirshman, J. Lebowitz, J.L. Shadrach, M. 
Cerletti, M.-J. Kim, T. Serwold, L.J. Goodyear, B. Rosner, R.T. Lee, and A.J. 
Wagers. 2014. Restoring Systemic GDF11 Levels Reverses Age-Related 
Dysfunction in Mouse Skeletal Muscle. Science. 344:649-652. 
Slonim, D.K., K. Koide, K.L. Johnson, U. Tantravahi, J.M. Cowan, Z. Jarrah, and D.W. 
Bianchi. 2009. Functional genomic analysis of amniotic fluid cell-free mRNA 
suggests that oxidative stress is significant in Down syndrome fetuses. 
Proceedings of the National Academy of Sciences. 106:9425-9429. 
Smit, A.F.A.H., R. Green, P. 1996-2010. RepeatMasker Open-3.0. 
http://www.repeatmasker.org. 
161 
 
Smyth, G.K., J. Michaud, and H.S. Scott. 2005. Use of within-array replicate spots for 
assessing differential expression in microarray experiments. Bioinformatics. 
21:2067-2075. 
Stein, G.H., L.F. Drullinger, A. Soulard, and V. Dulic. 1999. Differential Roles for 
Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of 
Senescence and Differentiation in Human Fibroblasts. Molecular and Cellular 
Biology. 19:2109-2117. 
Steingass, K.J., B. Chicoine, D. McGuire, and N.J. Roizen. 2011. Developmental 
disabilities grown up: Down syndrome. J Dev Behav Pediatr. 32:548-558. 
Storer, M., A. Mas, A. Robert-Moreno, M. Pecoraro, M.C. Ortells, V. Di Giacomo, R. 
Yosef, N. Pilpel, V. Krizhanovsky, J. Sharpe, and William M. Keyes. 2013. 
Senescence Is a Developmental Mechanism that Contributes to Embryonic 
Growth and Patterning. Cell. 155:1119-1130. 
Subramanian, A., P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. 
Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov. 2005. Gene 
set enrichment analysis: a knowledge-based approach for interpreting genome-
wide expression profiles. Proc Natl Acad Sci U S A. 102:15545-15550. 
Sussan, T.E., A. Yang, F. Li, M.C. Ostrowski, and R.H. Reeves. 2008. Trisomy represses 
ApcMin-mediated tumours in mouse models of Down/'s syndrome. Nature. 
451:73-75. 
Swanson, E.C., B. Manning, H. Zhang, and J.B. Lawrence. 2013. Higher-order unfolding 
of satellite heterochromatin is a consistent and early event in cell senescence. The 
Journal of Cell Biology. 
Taimen, P., K. Pfleghaar, T. Shimi, D. Möller, K. Ben-Harush, M.R. Erdos, S.A. Adam, 
H. Herrmann, O. Medalia, F.S. Collins, A.E. Goldman, and R.D. Goldman. 2009. 
A progeria mutation reveals functions for lamin A in nuclear assembly, 
architecture, and chromosome organization. Proceedings of the National Academy 
of Sciences. 106:20788-20793. 
Takahashi, A., N. Ohtani, K. Yamakoshi, S.-i. Iida, H. Tahara, K. Nakayama, K.I. 
Nakayama, T. Ide, H. Saya, and E. Hara. 2006. Mitogenic signalling and the 
p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat 
Cell Biol. 8:1291-1297. 
Team, R.D.C. 2008. R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna. 
Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. 
Marshall, and J.M. Jones. 1998. Embryonic Stem Cell Lines Derived from Human 
Blastocysts. Science. 282:1145-1147. 
Ting, D.T., D. Lipson, S. Paul, B.W. Brannigan, S. Akhavanfard, E.J. Coffman, G. 
Contino, V. Deshpande, A.J. Iafrate, S. Letovsky, M.N. Rivera, N. Bardeesy, S. 
Maheswaran, and D.A. Haber. 2011. Aberrant Overexpression of Satellite 
Repeats in Pancreatic and Other Epithelial Cancers. Science. 331:593-596. 
Trojer, P., and D. Reinberg. 2007. Facultative Heterochromatin: Is There a Distinctive 
Molecular Signature? Molecular Cell. 28:1-13. 
162 
 
Tyner, S.D., S. Venkatachalam, J. Choi, S. Jones, N. Ghebranious, H. Igelmann, X. Lu, 
G. Soron, B. Cooper, C. Brayton, S. Hee Park, T. Thompson, G. Karsenty, A. 
Bradley, and L.A. Donehower. 2002. p53 mutant mice that display early ageing-
associated phenotypes. Nature. 415:45-53. 
Valenti, D., G.A. Manente, L. Moro, E. Marra, and R.A. Vacca. 2011. Deficit of complex 
I activity in human skin fibroblasts with chromosome 21 trisomy and 
overproduction of reactive oxygen species by mitochondria: involvement of the 
cAMP/PKA signalling pathway. Biochem J. 435:679-688. 
Van Buggenhout, G.J., J.C. Trommelen, A. Schoenmaker, C. De Bal, J.J. Verbeek, D.F. 
Smeets, H.H. Ropers, K. Devriendt, B.C. Hamel, and J.P. Fryns. 1999. Down 
syndrome in a population of elderly mentally retarded patients: genetic-diagnostic 
survey and implications for medical care. Am J Med Genet. 85:376-384. 
van Deursen, J.M. 2014. The role of senescent cells in ageing. Nature. 509:439-446. 
Vaziri, H., and S. Benchimol. 1998. Reconstitution of telomerase activity in normal 
human cells leads to elongation of telomeres and extended replicative life span. 
Current Biology. 8:279-282. 
Vaziri, H., F. Schachter, I. Uchida, L. Wei, X. Zhu, R. Effros, D. Cohen, and C.B. 
Harley. 1993. Loss of telomeric DNA during aging of normal and trisomy 21 
human lymphocytes. Am J Hum Genet. 52:661-667. 
Ventura, A., D.G. Kirsch, M.E. McLaughlin, D.A. Tuveson, J. Grimm, L. Lintault, J. 
Newman, E.E. Reczek, R. Weissleder, and T. Jacks. 2007. Restoration of p53 
function leads to tumour regression in vivo. Nature. 445:661-665. 
Wang, J., G.J. Geesman, S.L. Hostikka, M. Atallah, B. Blackwell, E. Lee, P.J. Cook, B. 
Pasaniuc, G. Shariat, E. Halperin, M. Dobke, M.G. Rosenfeld, I.K. Jordan, and 
V.V. Lunyak. 2011. Inhibition of activated pericentromeric SINE/Alu repeat 
transcription in senescent human adult stem cells reinstates self-renewal. Cell 
Cycle. 10:3016-3030. 
Wang, X., S.C.H. Wong, J. Pan, S.W. Tsao, K.H.Y. Fung, D.L.W. Kwong, J.S.T. Sham, 
and J.M. Nicholls. 1998. Evidence of Cisplatin-induced Senescent-like Growth 
Arrest in Nasopharyngeal Carcinoma Cells. Cancer Research. 58:5019-5022. 
Wegiel, J., C.-X. Gong, and Y.-W. Hwang. 2011. The role of DYRK1A in 
neurodegenerative diseases. FEBS Journal. 278:236-245. 
Weick, J.P., D.L. Held, G.F. Bonadurer, M.E. Doers, Y. Liu, C. Maguire, A. Clark, J.A. 
Knackert, K. Molinarolo, M. Musser, L. Yao, Y. Yin, J. Lu, X. Zhang, S.-C. 
Zhang, and A. Bhattacharyya. 2013. Deficits in human trisomy 21 iPSCs and 
neurons. Proceedings of the National Academy of Sciences. 110:9962-9967. 
Wisniewski, K.E. 1985. Occurrence of neuropathological changes and dementia of 
Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:278-282. 
Witkowski, J.A. 1980. Dr. Carrel's immortal cells. Medical history. 24:129-142. 
Woodcock, C.L., J.P. Safer, and J.E. Stanchfield. 1976. Structural repeating units in 
chromatin. I. Evidence for their general occurrence. Exp Cell Res. 97:101-110. 
Wright, W.E., and J.W. Shay. 1992. The two-stage mechanism controlling cellular 
senescence and immortalization. Experimental Gerontology. 27:383-389. 
163 
 
Xue, W., L. Zender, C. Miething, R.A. Dickins, E. Hernando, V. Krizhanovsky, C. 
Cordon-Cardo, and S.W. Lowe. 2007. Senescence and tumour clearance is 
triggered by p53 restoration in murine liver carcinomas. Nature. 445:656-660. 
Yang, A., and R.H. Reeves. 2011. Increased Survival following Tumorigenesis in 
Ts65Dn Mice That Model Down Syndrome. Cancer Research. 71:3573-3581. 
Yang, G., D.G. Rosen, Z. Zhang, R.C. Bast, G.B. Mills, J.A. Colacino, I. Mercado-Uribe, 
and J. Liu. 2006. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS 
signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. 
Proceedings of the National Academy of Sciences. 103:16472-16477. 
Ye, X., B. Zerlanko, R. Zhang, N. Somaiah, M. Lipinski, P. Salomoni, and P.D. Adams. 
2007. Definition of pRB- and p53-dependent and -independent steps in 
HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. 
Mol Cell Biol. 27:2452-2465. 
Yeo, E.J., Y.C. Hwang, C.M. Kang, I.H. Kim, D.I. Kim, J.S. Parka, H.E. Choy, W.Y. 
Park, and S.C. Park. 2000. Senescence-like changes induced by hydroxyurea in 
human diploid fibroblasts. Experimental Gerontology. 35:553-571. 
Yu, G.-L., J.D. Bradley, L.D. Attardi, and E.H. Blackburn. 1990. In vivo alteration of 
telomere sequences and senescence caused by mutated Tetrahymena telomerase 
RNAs. Nature. 344:126-132. 
Yudoh, K., N. van Trieu, H. Nakamura, K. Hongo-Masuko, T. Kato, and K. Nishioka. 
2005. Potential involvement of oxidative stress in cartilage senescence and 
development of osteoarthritis: oxidative stress induces chondrocyte telomere 
instability and downregulation of chondrocyte function. Arthritis Res Ther. 
7:R380 - R391. 
Zhang, D., T. Zhao, H.S. Ang, P. Chong, R. Saiki, K. Igarashi, H. Yang, and L.A. Vardy. 
2012. AMD1 is essential for ESC self-renewal and is translationally down-
regulated on differentiation to neural precursor cells. Genes & Development. 
26:461-473. 
Zhang, H. 2007. Molecular signaling and genetic pathways of senescence: Its role in 
tumorigenesis and aging. Journal of Cellular Physiology. 210:567-574. 
Zhang, H., and S.N. Cohen. 2004. Smurf2 up-regulation activates telomere-dependent 
senescence. Genes Dev. 18:3028-3040. 
Zhang, H., K.-H. Pan, and S.N. Cohen. 2003a. Senescence-specific gene expression 
fingerprints reveal cell-type-dependent physical clustering of up-regulated 
chromosomal loci. Proceedings of the National Academy of Sciences of the 
United States of America. 100:3251-3256. 
Zhang, H., K.H. Pan, and S.N. Cohen. 2003b. Senescence-specific gene expression 
fingerprints reveal cell-type-dependent physical clustering of up-regulated 
chromosomal loci. Proc Natl Acad Sci U S A. 100:3251-3256. 
Zhang, R., W. Chen, and P.D. Adams. 2007a. Molecular Dissection of Formation of 
Senescence-Associated Heterochromatin Foci. Molecular and Cellular Biology. 
27:2343-2358. 
Zhang, R., S.T. Liu, W. Chen, M. Bonner, J. Pehrson, T.J. Yen, and P.D. Adams. 2007b. 
HP1 proteins are essential for a dynamic nuclear response that rescues the 
164 
 
function of perturbed heterochromatin in primary human cells. Mol Cell Biol. 
27:949-962. 
Zhang, R., M.V. Poustovoitov, X. Ye, H.A. Santos, W. Chen, S.M. Daganzo, J.P. 
Erzberger, I.G. Serebriiskii, A.A. Canutescu, R.L. Dunbrack, J.R. Pehrson, J.M. 
Berger, P.D. Kaufman, and P.D. Adams. 2005. Formation of MacroH2A-
containing senescence-associated heterochromatin foci and senescence driven by 
ASF1a and HIRA. Dev Cell. 8:19-30. 
Zhang, Y., T. Liu, C.A. Meyer, J. Eeckhoute, D.S. Johnson, B.E. Bernstein, C. Nusbaum, 
R.M. Myers, M. Brown, W. Li, and X.S. Liu. 2008. Model-based analysis of 
ChIP-Seq (MACS). Genome Biol. 9:R137. 
Zhao, H., H.D. Halicka, F. Traganos, E. Jorgensen, and Z. Darzynkiewicz. 2010. New 
biomarkers probing depth of cell senescence assessed by laser scanning 
cytometry. Cytometry Part A. 77A:999-1007. 
Zigman, W.B. 2013. Atypical aging in down syndrome. Developmental Disabilities 
Research Reviews. 18:51-67. 
Zindy, F., D.E. Quelle, M.F. Roussel, and C.J. Sherr. 1997. Expression of the p16INK4a 
tumor suppressor versus other INK4 family members during mouse development 
and aging. Oncogene. 15:203-211. 
Zou, Y., A. Sfeir, S.M. Gryaznov, J.W. Shay, and W.E. Wright. 2004. Does a Sentinel or 
a Subset of Short Telomeres Determine Replicative Senescence? Molecular 
Biology of the Cell. 15:3709-3718. 
 
 
 
